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5The Pompidou Group
The Co-operation Group to Combat Drug Abuse and Illicit Trafficking in 
Drugs (the Pompidou Group) is an inter-governmental body formed in 1971. 
Since 1980 it has carried out its activities within the framework of the Council 
of Europe; and 35 countries are now members of this European multidisci-
plinary forum. It allows policy makers, professionals and experts to exchange 
information and ideas on a whole range of drug misuse and trafficking prob-
lems. Its mission is to contribute to the development of multidisciplinary, 
innovative, effective and evidence-based drug policies in its member states. 
It seeks to link policy, practice and science.
By setting up its group of experts in the epidemiology of drug problems in 1982, 
the Pompidou Group was a precursor of the development of drug research 
and monitoring of drug problems in Europe. The multi-city study, which 
aimed to assess, interpret and compare drug use trends, is one of its major 
achievements. Other significant contributions include the piloting of a range 
of indicators (such as the treatment demand indicator) and methodological 
approaches, such as a methodology for school surveys that gave rise to ESPAD 
(the European School Survey Project on Alcohol and other Drugs).1
In 2004, the Research Platform superseded the group of experts in epidemi-
ology. There was also a change of function, from developing data collection 
and monitoring methodologies to assessing the impact of research on policy. 
This started with the holding in 2004 of the Strategic Conference on Linking 
Research, Policy and Practice – Lessons learned, challenges ahead – which 
identified as a major gap the lack of exchange of knowledge.
The Research Platform’s prime role was to support better the use of research 
evidence in policy and practice, thus facilitating the development of evidence-
based policy. Moreover, it also signalled the latest issues arising from drug 
research in the social and biomedical fields and promoted interaction between 
research disciplines such as these and psychological drug research. Reports on 
these subjects have been published and are listed in the appendix.
Following the mandate given by ministers at the ministerial conference in 
November 2010, for the 2011-14 Pompidou Group work programme, the 
Research Platform has now been superseded by expert groups on specific 
topics. Coherent policies in the area of psychoactive substances were selected 
1. See the appendix for a list of Pompidou Group publications.
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as one such topic and hence the expert group was formed at the end of 2010 
and met four times in 2011 to produce this, the third publication in the series.
The activities of the Coherent Policy Expert Group follow on from an initial 
request and funding from the Federal Office of Public Health in Switzerland 
to acquire information on the ways in which drug policy is formulated/applied 
by other countries. This information provided the basis for the first publica-
tion – From a policy on illegal drugs to a policy on psychoactive substances – a 
retrospective analysis of drug policy in the 17 member countries, taking into 
account the social and cultural context. These contributions were aided by an 
overall synopsis that reflected on the change from single policies on alcohol, 
tobacco and drugs to one which incorporates all substances.
The second publication was a further attempt to understand the scientific basis 
for the choice of a single policy for each substance or one that incorporates 
all substances; in addition it provided empirical information on how such 
a choice is currently put into practice. Seven countries – Germany, Ireland, 
the Netherlands, Norway, Portugal, Switzerland and the United Kingdom – 
provided the means to address this issue. 
Thus, this third publication in this area attempts to make headway in the area 
of coherent policies for psychoactive substances. The opinions expressed in 
this publication are those of the authors and do not necessarily reflect those 
of the Council of Europe or of the Pompidou Group.
71.  Policy coherence framework: context, 
systems, measurement
Richard Muscat 
Department of Biomedical Sciences, University of Malta
As a follow-up to the publications From a policy on illegal drugs to a policy on 
psychoactive substances in 2008 and Towards an integrated policy on psycho-
active substances: a theoretical and empirical analysis in 2010, the objective of 
the present project is to arrive at a better understanding of what structures 
better suit integrated and coherent drug policies, and what models/ indicators 
may be developed to give better information about the outcome of such 
policies. The funds for this follow-up study have been provided by the Swiss 
authorities and the Pompidou Group is grateful to them for their continued 
support in this area of policy development.
The Pompidou Group’s major objective is to better support the use of research 
evidence in policy and practice, thus facilitating the development of evidence-
based policy.
The participating countries in this third phase of the project were Austria, 
Belgium, Ireland, Israel, the Netherlands, Norway, Portugal and Switzerland.
I was assigned the role of “primary investigator” while Brigid Pike researched 
the concept of “policy coherence”, which provided a framework for the coun-
try reviews in this volume. All participants were involved in the discussions 
held at the four meetings and the outcome is a result of their dedicated input, 
as seen in this publication.
The project has been organised in three parts to take into account these 
three aspects:
 − Context: understanding the factors that influence the particular politics/
policy interface in individual jurisdictions, in order to accommodate dif-
ferences between countries in the analysis, such as historical/cultural/
economical factors; governance arrangements; underlying beliefs and 
assumptions: in other words, the ideology that has provided the basis 
for the policy as it stands today;
 − Systems: structures and processes in place to enable the achievement 
of the desired policy outcomes: in other words, how does one translate 
ideas into political goals?
8Policy on psychoactive substances and beyond
 − Measurement: the means of evaluating effectiveness and efficiency of 
systems: in other words, if goals can be measured, then the coherence of 
these goals can also be measured too.
As a result of these three considerations, the following framework was pre-
pared after much discussion to provide the basis on which the participants 
may attempt to review policy in their respective countries, keeping these 
attributes in mind.
1.1. Context
With regard to the first item – context – it was agreed that the résumé should 
reflect the development of drug policy in the member countries based on 
historical/cultural factors and political ideology.
The résumé for each country should include the development of drug policy 
there, taking into account on a national level the ratification of any United 
Nations conventions, the adoption of European Union drug strategies and any 
major changes that may have influenced the path taken by the country con-
cerned and thus resulted in the actual state of play within that country today.
In addition, this development should be framed in the context of each par-
ticular country, taking into account its size, geographical position, its relation 
to its neighbours, the state of the drug problem and public opinion. This in 
turn must also be supported by the political context of the time, that is the 
political ideology.
Each country’s résumé must also record the impact of drug research on policy 
development, though this will probably refer mainly to drug epidemiology.
It also needs to be stressed that this account of the development of drug policy 
is strictly at national level, and not local level, though some insight should also 
be given into whether national drug policy has been followed at local level 
or whether it first developed at local level and then provided the impetus for 
national policy.
In the end it may be possible to reflect on the type of influences that have 
shaped drug policy over the period in question. In certain periods policy may 
have developed incrementally but, when problems arose, radical changes 
may have been sought and implemented to deal with the problems in hand. 
Moreover, political interest groups, civil society groups and public opinion may 
have had some say in shaping policy as we know it today. Advocacy groups, 
or networks in which alliances are formed around beliefs, also have a place 
in some countries and may have influenced drug policy. Finally, policy today 
and for the future seems to be increasingly under the influence of what can be 
termed evidence-based medicine, in that the question more frequently asked 
is “What works?” To answer such a question and inform policy, one needs 
evidence of what works and what does not. This policy model is sometimes 
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referred to as the rational and/or technical model, which has been adapted 
in public policy for a number of years in different spheres.
The first publication from the project, From a policy on illegal drugs to a policy 
on psychoactive substances (2008), was just such an attempt to contextualise 
drug, alcohol and tobacco policies in each of the 17 participating countries. In 
writing up the findings, I reported that the common denominator among all 
the national policies was an over-arching concern with health: this was the 
prime factor guiding most policy choices. To help analysis and understanding 
of the policy options, I suggested that, in future, it might be appropriate to 
frame substance-use policy within this context, and that the Council of Europe 
should take a lead in developing such a global policy framework.
I proposed a model based on the assumption that policy formulation in the 
area of substance use is influenced by three “proximal” factors – civil society, 
science and practice – which impact directly on the shape and direction of 
policy. These in turn may be modified by six “distal” factors – public opinion 
and political ideology inform civil society, theory and experiment inform 
science, and the evidence base and outcomes inform practice. The impact of 
these distal factors is less tangible but no less important.
1.2. Systems
By “systems” we mean the structures and processes in place in a country to 
enable achievement of the desired policy outcomes. In other words, how does 
one translate ideas into political goals? In the second phase of the project, to 
explore further the relationship between policy outcomes and “integration”, 
Dike van de Mheen and Cas Barendregt of the Addiction Research Institute 
in Rotterdam, undertook an empirical investigation in the seven countries 
participating, enquiring (1) what the term “integrated policy” meant in each 
of the seven countries, and (2) how “integrated policy” had been operation-
alised in these countries.
In the report Towards an integrated policy on psychoactive substances (2010), 
van de Mheen and Barendregt concluded that integration might refer to the 
combination of a variety of psychoactive substances in the one substance-
misuse policy. Alternatively, it might refer to the co-ordination of policies 
and actions in different government departments through a formal co-ordi-
nating mechanism. Underlying these two structural forms of integration, the 
researchers also discerned an integrating process of a more intangible and fluid 
nature – integration of ideas (politics) and action (policy). They explained: 
If the idea is that the consumption of psychoactive substances, other than tobacco 
or alcohol, is sinful or bad [i.e. the political view] it may lead to prohibition of 
these substances [i.e. policy response]. If the dominant idea is that legal and illegal 
substances can be viewed as potentially damaging to health, a health approach 
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to psychoactive substances comes into focus. Co-ordination of health-oriented 
interventions requires a different policy infrastructure from a merely prohibi-
tionist approach.2
1.3. Measurement
Measurement refers to the means of evaluating effectiveness and efficiency 
of systems. In other words, if goals can be measured, the coherence of these 
goals can also be measured too.
It is crucial that ideas be translated into tangible political goals if they are ever 
to see the light of day, and the drug issue is no exception. A drug policy per 
se, whether it takes into account all psychoactive substances or not, still must 
acknowledge this fundamental premise. Moreover, in the future drug policy 
will – depending on circumstances – have to decide which route it is to follow: 
independent policies for each substance or one policy that incorporates all 
substances. This in itself may become resolved when considering the systems 
and measures in place to monitor such policies.
However, all policies need to be goal-directed: they need to provide a valid 
outcome as a result of their implementation. Thus, a clear and concise goal 
needs to be formulated in the form of a mission statement, which now is 
commonplace among corporate organisations.
The discussions within the expert group during the third phase of the project 
have resulted in two formidable goals for drug policy: first, that the policy should 
provide for the “well-being” of the population targeted; and second, that the 
policy should prevent the harm caused by substance use. With regard to the first 
goal, that of well-being, this usually relates to three factors, namely the physical, 
mental and social state of an individual that enable him/her to be a full, active 
member of society. In defining the second goal, that of preventing harm from 
substance use, a scientific attempt has been made to define these harms using 
three categories, namely, physical, mental and social, to better inform policy 
makers and the public at large. It is (to say the least) odd that both sets of goals, 
well-being and the prevention of harm, use the same factors to define what it 
is they aim to do, and thus appear as two sides of the same coin. In effect, one 
may see the policy goal as providing the policy framework for health and social 
well-being, whereas the goal of harm prevention provides the safety net.
What needs to be considered to ensure that such policy outcomes can be real-
ised in any meaningful way? The analogy that came to the fore in the 2010 
publication was that structure sub-serves function; thus this would appear 
to be the foundation on which a systems approach might be considered. 
“Systems” implies that the whole is made up of a number of parts and these 
2. R. Muscat, D. van de Mheen, C. Barendregt et al. (2010), Towards an integrated policy on 
psychoactive substances: a theoretical and empirical analysis. Strasbourg: Council of Europe, p. 57.
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in turn need to function in a coherent manner to produce the desired outcome. 
One may then also talk of the different levels of analysis within the system, 
describing matters in an ideological fashion and at the same time on a different 
level referring to the services on offer. A systems approach assumes that all 
the components are to an extent integrated to produce the coherent response.
During the third phase of the project, the expert group focused increasingly on 
the relationship between integration and coherence, and how this might assist 
in developing a means of measuring the achievement of policy outcomes. In 
the discussion that follows, an attempt is made to define what “integration” 
and “coherence” mean and so provide concepts that might form the basis for 
devising a framework of benchmarking criteria.
Searching online for definitions of integration and coherence suggests there 
is a fundamental difference in meaning:
 − Integration is about combining parts into a single, unified whole.
 − Coherence is about sticking a number of parts together in a logically 
consistent manner.
Integration is like a chemical process: it is irreversible and the whole is greater 
than the parts, whereas coherence is more like a physical process that is 
reversible, and in which the elements can be separated out again.
An attempt is made to combine integration and coherence as two dimen-
sions indicating the extent of fusion of policies (coherence) and of structures 
(integration) – see Figure 1 below. The term “integration” refers to structures 
insofar as they are either integrated, with the different parts interlinked and 
sharing some systems, or they are not integrated and function independently 
of one another. The term “coherence” refers to policies, and the extent to 
which they align with each other and are mutually supportive while retaining 
their individual and separate characters.
Integrated structure, 
where governance arrange-
ments bind components 
together in relations charac-
terised by co-dependency
Incoherent policies, e.g. 
policies are not logically 
consistent and cancel out 
the effects of one another
Coherent policies, e.g. 
logical consistency between 
policies on different sub-
stances and they are mutu-
ally reinforcing
Separate structures, 
where different bodies do 
not share functions, respon-
sibilities or accountabilities
Figure 1: Coherence and integration as two dimensions, indicating how far poli-
cies have fused (coherence) and how far structures have fused (integration).
12
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Gauging the extent of integration is useful for getting a broad-brush under-
standing of a particular set of policy and structural arrangements, of their 
character. Gauging the degree of coherence yields a more detailed, more fine-
grained picture, which may increase the capacity of policy makers to respond 
flexibly as a policy domain changes over time; that is, the framework may be 
a tool for policy makers to both understand the overall nature of their policy 
approach and manage their policies in a timely and responsive manner.
This framework is explored in more detail in the next chapter and in the 
country reports that follow.
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2. Policy coherence: notes towards a concept
Brigid Pike 
Evidence Generation and Knowledge Brokering Unit,  
Health Research Board, Dublin
2.1. Definitions
According to the Oxford English Dictionary, coherence means “the action or 
fact of cleaving or sticking together”, while coherency means “the quality of 
being coherent or hanging together in any respect” – one is an action; the 
other is a quality. In this chapter, “coherence” is used when referring to policy 
coherence as a policy tool, because it connotes a process of becoming more, or 
less, coherent; “coherency” is used for the goal, the final state to be achieved by 
implementing the policy coherence instrument, a set of fully coherent policies.
Following the characterisation of “policy coherence” given in the previous 
chapter, a more formal definition of the concept is now proposed. Policy 
coherence refers to the extent to which different public policies complement 
or support each other. At best, policy coherence creates synergies between 
different public policies; it leverages capacity to realise a common policy goal. 
At a minimum, it ensures that different policies do not undermine one another 
or cancel each other out.
A consequence of this layered definition (layered in that there are gradations, 
namely, ever greater degrees of coherence) is that policy coherence depends on 
alignment and consistency not only across policies directly related to a specific 
goal or set of goals, but also across other unrelated policies that may have an 
impact on directly related policies. A further consequence is that coherence 
at different levels, from international to local, also needs to be considered.
2.2. Measuring policy coherence
Six possible indicators of the degree of coherence between different policies 
are proposed.
 − Conceptualisation of the problem: how are problems associated with 
different psychoactive substances (illicit drugs, alcohol and tobacco) 
described, and how do research evidence, media coverage, cultural mores 
or social, economic and political considerations shape the nature of the 
“problem”? To what extent do these elements converge? (This indicator 
is comparable to mapping the profile of policy influencers outlined in 
phase 1 of the project.)
14
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 − Policy context: where are psychoactive substance policies located within 
the overall policy environment, e.g. in criminal justice, in the medical 
context or within the context of a value set such as social inclusion, 
human rights or equality? To what extent is there a consistent approach 
across different psychoactive substances?
 − Legislative/regulatory framework: how are various psychoactive sub-
stances controlled and regulated? To what extent are the controls and 
regulations complementary and supportive of the desired outcomes?
 − Strategic framework: what are the goals and aspirations, the objectives, 
of drug, alcohol and tobacco policies? How far do they overlap with one 
another?
 − Responses/interventions: are interventions logically consistent and mutu-
ally supportive, in line with over-arching policy goals and aspirations?
 − Structures and resources: to what extent does the organisation of struc-
tures and resourcing support the co-ordination and/or integration of drug, 
alcohol and tobacco policies? (The structural aspect of this indicator was 
explored in phase 2 of the project.)
In Chapter 5, Ireland’s national policies on illicit drugs, alcohol and tobacco 
are assessed against these six indicators. The outcome of this pilot test sug-
gests that, though the assessment may not lead to precise measurement of the 
various policies against an external benchmark, the process does facilitate 
identification of options for strengthening the impact of different policies 
relating to the misuse of psychoactive substances.
2.3. Making policies coherent
Some questions need to be answered in order to test the validity of this con-
ceptual model and to translate it into a practical policy tool.
 − How sensible or useful is it to spend time wondering about abstract 
concepts such as “policy coherence”? Does it add value? Does it ensure 
our policies on psychoactive substances are more relevant and effective?
 − How feasible is it for different countries, each with their own unique set 
of policy priorities, to agree a common policy goal or goals?
 − How possible is it to devise systems, structures and processes to support 
the adoption of a policy coherence model?
2.3.1. Reality check
How relevant is the concept of policy coherence? Will it contribute to desired 
policy outcomes? Has “policy coherence” been used in any other policy areas? 
To answer the last question first, yes, the concept of policy coherence has 
been tried elsewhere. With leadership from the Organisation for Economic 
Co-operation and Development (OECD), in conjunction with the United 
15
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Nations (UN), the concept has been applied to the formulation of policy on 
international development aid and to assist in managing the diverse policies 
that come together in this area, including agriculture, environment, transport, 
energy, finance, fisheries, migration, science, technology, intellectual property 
rights, security and trade.3
The International Labour Organization has also made use of the concept to 
assist countries in formulating and adopting policy portfolios that support 
coherence between the objectives of economic growth and the generation of 
decent work for all. Elements of this approach are (a) a better balance between 
objectives such as sustainable growth, equity, employment and “decent work”, 
(b) a more comprehensive policy mix and better sequencing to obtain these 
objectives, and (c) the creation of more policy space to implement national 
policy.4
So far, so good, but how relevant and viable is the concept of policy coher-
ence in psychoactive-substances policy? There are notable parallels between 
the psychoactive-substances policy domain and these other policy domains, 
which suggest the concept is both relevant and viable: a global market, a 
global problem, close links with other policy domains and the complication 
of different models, cultures and ideologies.
Psychoactive substances are deeply implicated in the political economy of 
globalisation. The markets for them comprise suppliers and consumers spread 
around the world, who are part of a complex web of trade relationships and 
interdependencies.
The global markets in psychoactive substances encompass under-developed, 
developing and developed regions of the world. In 2008, the Latin American 
Commission on Drugs and Democracy published the conclusions of its year-
long deliberations on the problems associated with illicit drugs on the South 
American continent. The authors made a plea for a global policy on drugs 
controlled under the UN conventions to ensure coherence between the poli-
cies of these different global regions:5
The question is not to find guilty countries and allocate blame for this or that 
action or inaction, but to reiterate that the United States and the European 
Union share responsibility for the problems faced by our countries, insofar as 
their domestic markets are the main consumers of the drugs produced in Latin 
America. It is, thus, pertinent for us, Latin Americans, to ask them as partners 
to design and implement policies leading to an effective reduction in their levels 
of drug consumption and, as a consequence, in the overall scope of the narcotics 
criminal activities.
3. For full details visit www.oecd.org/department/0,3355,en_2649_18532957_1_1_1_1_1,00.
html.
4. For more information, visit www.ilo.org/integration/themes/pci/lang--en/index.htm.
5. The report was downloaded on 16 August 2011 from www.drogasedemocracia.org.
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In 2011, in Recommendation 10 of its final report, the Global Commission 
on Drug Policy similarly called for coherence in what is a global problem:6
The United Nations system must provide leadership in the reform of global drug 
policy. This means promoting an effective approach based on evidence, supporting 
countries to develop drug policies that suit their context and meet their needs, 
and ensuring coherence among various UN agencies, policies and conventions.
As in the case of policy on international development aid, policy on psycho-
active substances is closely interlinked with a number of policy domains 
– health, education, social inclusion, regulation and law enforcement. To 
integrate such disparate policy domains would be a huge challenge; ensuring 
that they complement and support one another appears to be a more easily 
achieved solution.
Finally, policies on psychoactive substances are often infused with conflict-
ing ideological, moral and cultural assumptions and attitudes, which result 
in different policy preferences; but, if policy coherence is the objective, this 
need not be a stumbling block in the search for a common outcome.
These parallels suggest that the concept of policy coherence is as relevant in 
the area of psychoactive substances as in the area of international develop-
ment aid. Although I have not explored such parallels in the areas of alcohol 
and tobacco, I expect that similar parallels exist there.
Regarding viability, the policy coherence framework and tools developed 
in the past 10 to 15 years in the domains of international development and 
international labour policy appear capable of being used to find workable and 
useful solutions in the face of conflicting and competing interests, which are 
unlikely ever to be fully resolved. It would seem reasonable to suggest that 
similar approaches may also be useful in developing tools to build greater 
coherency in the psychoactive-substances policy domain, where differences 
are also not readily amenable to compromise.
2.3.2. Common goals
The adoption of health as an over-arching policy goal, within which policy 
on a variety of licit and illicit psychoactive substances can be combined, was 
identified in phase 1 of the project, and confirmed in phase 2. In the final 
phase, the need for a common over-arching goal, to provide the focal point 
around which policies can cohere and to justify investment in seeking greater 
coherency, was agreed – and again health was identified as the likely goal.
So just where could common goals acceptable to a wide variety of countries 
come from? The answer we arrived at is the goals and aspirations of the 
international organisations established in the wake of the Second World War 
6. The report was downloaded on 16 August 2011 from www.globalcommissionondrugs.org.
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and afterwards, such as the United Nations, the Council of Europe and the 
European Economic Community, precursor to the European Union. Many 
countries belong to these various bodies. Given that the Pompidou Group, 
which set up the expert group on policy coherence, is a constituent part of 
the Council of Europe, the expert group adopted a pragmatic approach: the 
health-related goals articulated by the Council of Europe provide the neces-
sary and sufficient objectives; the expert group did not undertake any a priori 
investigation or justification of the choice of goals.7
The primary aim of the Council of Europe is to create a common democratic 
and legal area over the whole continent, ensuring respect for fundamental values 
like human rights, democracy and the rule of law. These values are regarded 
as the foundations of a tolerant and civilised society, and indispensable for 
European stability, economic growth and social cohesion. On the basis of 
these fundamental values, members of the Council of Europe try to find 
shared solutions to major problems like terrorism, organised crime, corrup-
tion, cyber crime, bioethics, cloning, violence against children and women, 
and trafficking in human beings.
More specifically relevant to promoting a public health approach to the issues 
associated with psychoactive substances is Article 11 of the Council of Europe’s 
European Social Charter. Article 11 provides for the right to protection of health 
and stipulates that, with a view to ensuring the effective exercise of the right to 
protection of health, the parties to the social charter undertake to take appro-
priate measures designed, inter alia, to remove as far as possible the causes of 
ill-health, to provide advisory and educational facilities to promote health and 
encourage individual responsibility in matters of health, and to prevent as far 
as possible epidemic, endemic and other diseases, as well as accidents.
Even though the right to health has been included in a considerable number of 
human rights treaties at the international, regional and national levels, it has 
been found difficult to pinpoint exactly what it entails. Jurisprudence dealing 
with the right to health, even though limited, has helped to clarify and define 
the right, and has demonstrated that it is a right closely related and dependent 
on other human rights, such as the rights to life, non-discrimination, privacy, 
access to information and freedom from torture or inhuman and degrading 
treatment.
7. The following account of the Council of Europe’s articulation of health-related goals has 
been taken from an unpublished survey by the Pompidou Group Secretariat, led by Thomas 
Kattau. Acknowledging the important role of jurisprudence in clarifying and defining the right 
to health, and demonstrating its close association with and dependence on other human rights, 
the Secretariat also listed the Council of Europe instruments in which these rights are set out, 
including the Convention for the Protection of Human Rights and Fundamental Freedoms, the 
Convention for the Protection of Individuals with regard to Automatic Processing of Personal 
Data and the Convention on Human Rights and Biomedicine.
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2.3.3. Systems, structures and processes
Not only has the OECD published guidelines on how to strengthen policy 
coherency, but the EU and national bodies have also taken up the chal-
lenge. In 2005 the European Council adopted the European Policy Coherence 
on Development (PCD), which provides for strengthening PCD proce-
dures, instruments and mechanisms at all levels in the EU. The European 
Commission has since published two progress reports on PCD in the EU.8 At 
national level, in the Netherlands the government has established a dedicated 
Policy Coherence Unit. In Ireland the Institute for International Integration 
Studies in Trinity College Dublin (TCD) has set up a Policy Coherence Unit 
which manages a website devoted to exploring the many dimensions of Irish 
policy coherence for development. In the following brief overview I draw on 
the work of the OECD and the TCD-based unit.
Operationalising policy coherence (that is, turning the concept into a set of 
tangible objectives, in relation to which actions can be identified) might focus 
on four main objectives and related action areas.9
1. Seek to eliminate policy inconsistencies – the elimination of inconsisten-
cies is the starting point for policy coherence. The ideal end point for this 
stage is for all policies to be at least neutral in their effect on the supply 
of and demand for psychoactive substances.
2. Identify opportunities for policy enhancement – which involves a deliber-
ate decision to make policies unrelated to psychoactive substances also 
work for objectives in the psychoactive-substances policy domain. This 
includes taking opportunities to tweak policies not related to psychoactive 
substances to achieve pay-offs at relatively little cost, or using resources 
to leverage the positive impact of policies on psychoactive substances 
policy.
3. Develop mitigation policies to overcome the adverse effects of policies not 
related to psychoactive substances – by developing alternative policies 
and programmes, by which the adverse effects, whether intentional or 
otherwise, of non-psychoactive-substances-related policies may be offset.
4. Ensure consistency in advocacy – use the national voice at international 
forums to put forward arguments and policy options consistent with the 
objective of a coherent policy on psychoactive substances.
8. EU 2009 Report on Policy Coherence for Development, Brussels, 17 September 2009. 
COM(2009) 461 final, SEC(2009) 1137 final. Downloaded on 17 August 2011 from http://
ec.europa.eu/europeaid/what/development-policies/policy-coherence/index_en.htm.
9. This operationalisation model is based on a typology outlined in F. Barry, M. King and 
A. Matthews (2009), Policy coherence for development: the state of play in Ireland. A scoping 
report commissioned by the Advisory Board for Irish Aid. Dublin: Institute for International 
Integration Studies, TCD, pp.  21-3. Downloaded on 17 August 2011 at www.tcd.ie/iiis/
policycoherence/.
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Implementing policy coherence might depend on carrying out four related 
tasks, forming part of a continuous cycle.10
1. Set and prioritise objectives: determine which policy objectives take prior-
ity in pursuit of the overall policy aim, either annually or over a longer 
period. Impact assessments can help to prioritise competing options. 
Political commitment and policy statements are other key tools in this 
stage of the cycle.
2. Co-ordinate policy and its implementation: work out how policies and 
implementing them can be modified to maximise synergies and minimise 
incoherence. As well as departmental and other statutory policy co-ordi-
nation mechanisms, parliamentary oversight by committee (Oireachtas 
committees in Ireland) and an annual parliamentary debate could be 
considered. Non-governmental organisations (NGOs) could be encour-
aged to assess coherence issues and contribute to the knowledge base on 
policy coherence in relation to psychoactive substance policies.
3. Monitor, analyse and report: the impacts of policies, separately and in 
combination, need to be monitored and analysed, and the findings fed 
back to policy makers and those with the task of holding policy mak-
ers and their political masters accountable. Policy coherence indicators 
should be independently published bi-annually to ensure legitimacy.
4. Build capacity and capability: training (explicitly on policy coherence) 
officials and others working in the area of psychoactive substances and 
initiating a research programme (within the context of overall aims and 
short-term policy priorities) to assess a range of coherence issues, will 
help to build capacity (resources) and capability (knowledge).
2.4. Conclusion
One other issue, beyond the remit of the expert group, but which policy 
makers need to bear in mind, is the need to maintain a historical perspective 
on policy coherence and/or integration, and on the dynamics of the system 
whereby the building blocks (the underlying beliefs, principles and assump-
tions) continue to alter and shift over time, upsetting any balance that may 
have been temporarily achieved between competing policy demands.11
10. This implementation framework is based on the “policy coherence cycle” outlined in 
Understanding policy coherence for development: building blocks for policy coherence for development, 
OECD 2009, Chapter 2 (downloaded 17 August 2011 from www.oecd.org/department/0,33
55,en_2649_18532957_1_1_1_1_1,00.html) and on the “Model of PCD Support for Ireland” 
outlined in Barry, King and Matthews (2009), Policy coherence for development: the state of play 
in Ireland, op. cit. Dublin: TCD, pp. 28-31 (downloaded 17 August 2011 from www.tcd.ie/iiis/
policycoherence/).
11. These final remarks are based on observations by a member of the expert group, Irmgard 
Eisenbach-Stangl.
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When an appropriate mix of policy initiatives has been achieved, when an 
acceptable degree of coherency between policies has been realised, policy 
makers cannot relax. Policy makers need to be constantly vigilant and con-
tinuously monitor developments – in international regulatory frameworks, in 
national cultural and social reactions, and in the evidence base and notions of 
good practice in relation to addressing the issues associated with psychoactive 
substances – and reflect on how such developments, however insignificant, 
may impact on the overall balance and coherence between policies.
The goal of policy coherency is a never-ending quest.
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3.  Integration and coherence of policies  
for alcohol, illicit drugs and tobacco  
in Austria: the past 100 years
Irmgard Eisenbach-Stangl 
European Centre for Social Welfare Policy and Research, Vienna
3.1. Introduction
An assessment of the available literature and other documents prompted 
the decision to present the Austrian case in historical phases defined by the 
degree of “coherence” of national alcohol, drug and tobacco policies, that is, 
of selected addiction or dependency policies. Policies here are considered to be 
coherent if they coincide in their evaluation of relevant objects and acts, and 
are consistent with each other in their regulations and measures. Coherence 
is thus a way to look at policies on addictions or dependencies in a compara-
tive way, but it does not touch on the internal structure of policies (Muscat 
2011). The consistency of single policies is referred to under the concept of 
integration, looking at frictions and contradictions in evaluations of objects 
and acts as well as in reactions to them. But, though integration is not of less 
interest, the focus of the following discussion is on coherence.
Coherence was assumed to be given if national policies on alcohol, illicit 
drugs and tobacco coincided in three crucial areas: (1) leading definitions 
of behaviour and problems related to alcohol, drugs and nicotine, (2) the 
main organisations in the alcohol, drug and tobacco field that intervene by 
organising or providing controls and services, and (3) national policy goals 
(imprinting legislation) and the degree of their enforcement.
This concept allows one to distinguish periods of higher and lower coherence 
of the three addiction policies. The qualitative approach used to distinguish 
them is in need of further development and systematisation. This analysis 
mostly considers manifest interventions and neglects policy concepts and 
programmes; as a result, it does not systematically shed light on the difference 
and interplay between “action” and “discourse”. And (as well as integration) 
it ignores how far national policies are worked out – in terms of putting the 
policy across orally or in writing – and how far state programmes, plans, strate-
gies and actions are matched by enforcement and public opinion. Policies that 
are fully worked out are more often likely to be integrated than patchy ones 
consisting of various competing, hidden or even unconscious concepts and 
interventions contradicting each other. But patchy policies are not necessarily 
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unintegrated or harder to reconcile with other policies. In Austria as in many 
other European countries alcohol interventions by the state are not under-
stood as “alcohol policy” – a term hardly known and hardly used – and such 
documented concepts and programmes are missing. Nevertheless, it is not 
difficult to identify a consistent underlying concept that to a high degree is 
coherent with worked-out drug and tobacco policies.
Finally, the discussion below concentrates on alcohol, tobacco and illicit drug 
policy, and ignores the regulation of psycho-pharmaceutical drugs, which are 
partly identical with illicit substances, but marketed and used in different 
societal contexts under different labels. This means that, for a wide variety 
of substances, only half of the policies were observed and the most incoherent 
and unintegrated policies were ignored.
3.2.  Coherent legislative tolerance: prelude  
in the Austro-Hungarian Empire
The degree of coherence of alcohol and drug policy under the sign of tolerance 
was very high in the 19th century, unlike earlier centuries (Lehner 1996). 
Since special organisations providing controls and services were hardly devel-
oped, coherence must be assessed by policy and legislation.
Tolerance of alcohol consumption, intoxication and alcohol-related problems 
in the time of the monarchy is indicated by a unique law on “full intoxica-
tion”, part of the penal code of 1803. Full intoxication, according to this law, 
had a mitigating effect that can be summarised as follows: offenders who had 
committed a crime when fully intoxicated were sentenced for a misdemean-
our; those who had committed a misdemeanour were not sentenced at all. 
In a restricted version, the law is still valid today, though it is rarely applied.
There was also tolerance of public intoxication. When temperance movements 
grew in the second part of the 19th century and there were increasing demands 
to criminalise public inebriety, the Austrian Parliament (Zisleithanien) refused 
to pass such a law at Austrian level and agreed only to a restricted local regula-
tion (“public intoxication causing annoyance”) in Galicia, where the strongest 
request came from (Eisenbach-Stangl 1993).
In line with the rejection of penal responses to the alcohol question, Austrian 
politicians with backgrounds in law or medicine agreed on the disease concept 
of inebriety and argued against arresting drunkards, as practised in Germany, 
and in favour of voluntary and compulsory treatment in special sanatoria – 
which never got established during the monarchy.
Opiate addicts, whose numbers increased after the wars in the second half 
of the 19th century, were also considered to be ill, and prohibitive responses 
to drug problems were rejected. The monarchy was represented at the First 
Opium Conference in Shanghai in 1909, which had no results, because it did 
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not sign the 1912 the International Opium Convention of The Hague. But, like 
other European countries (among them Germany and the United Kingdom), 
the republic had to sign the treaty eight years later, as part of the Treaty of 
Saint Germain-en-Laye (Pilgram 1992).
The coherence of dependency concepts and related interventions is most vis-
ible in the Incapacity Law of 1916, which legislated for the total incapacity of 
the mentally ill and for the limited capacity of three groups: “drunkards, those 
dedicated to nerve poisons [drugs] and wasters”. Limited capacity reduced 
their civil rights to those of adolescents (7 to 14 years old) and allowed for 
the development and modulation of pressure put upon people to undergo 
treatment. Limited incapacity was, so to say, a sophisticated precursor of the 
regulations allowing “therapy instead of punishment” developed 60 years later 
in the frame of the Drug Law. The courts in control of enforcing incapacitation 
interpreted the regulations in favour of any dependants and prevented com-
pulsory admissions and treatment (Eisenbach-Stangl 1991: 234; Lehner 1983).
3.3.  Imported policies and a step towards discrepancy: 
the First Republic, 1918-1934/8
During the First Republic, the Austrian temperance movement imported 
numerous alcohol policy concepts from countries such as Switzerland, Sweden 
and the United States, where temperance forces were stronger or had a longer 
tradition. Among them were the reduction of availability by restriction of out-
lets; the right of communities to decide on the prohibition of retail sales (with 
the hope of eventually achieving national prohibition by these measures) and 
earmarking a part of alcohol taxes for alcoholism treatment and prevention. 
But none of these concepts none was seriously considered by Parliament. 
What remained from the movement, which was losing influence already after 
1923, accorded with local traditions: a law prohibiting the supply of alcoholic 
beverages to young people in a public place (already being discussed at the end 
of the 19th century) and a well-structured professional system of voluntary 
treatment in the framework of the mental asylum and social administra-
tion in Vienna, whose outpatient departments were closed down after the 
Austrian Civil War in 1934, whereas the inpatient departments remained 
active until the Anschluss in 1938. The outpatient services in all nine states 
(the Bundesländer) run by abstinence organisations and churches after 1938 
remained active only underground. They tried to help their clients avoid 
sterilisation and detention in work camps (Eisenbach-Stangl 2003).
Signing the peace treaty signed in St Germain in 1920 meant that Austria 
had to import certain foreign policy concepts, but the First Republic fulfilled 
the obligations hesitantly and reluctantly. In 1921 the opium convention was 
acknow ledged by a decree which, roughly speaking, submitted to restrictions 
all those who processed opiates and cocaine. A first law only followed in 1928: 
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it did not regulate only narcotics but poisons in general and was accordingly 
called the Giftgesetz (Federal Law on Poisons). Although the penalties con-
tained in this law still were mild, they heralded stricter drug policies, even 
penal sanctions – a novelty in Austria with regard to drugs – and they crimi-
nalised not only acquisition but also possession. But, since drug users at this 
time – especially cocaine users – were mostly upper-class, the Giftgesetz was 
hardly enforced.
3.4.  Alcohol and drug policy depart further:  
the Second Republic 1945-1968
In 1946 the Law on Poisons became the Suchtgiftgesetz – the first law con-
centrating on drugs with much stricter sanctions (minimum sentences were 
50 times higher, maximum sentences 20 times). Only two years later the law 
was amended to criminalise possession for personal use. These legal innova-
tions did not respond to new drug problems. But Austria at this time was an 
occupied country and the United States, one of the four occupying forces and a 
main agent of tight international drug controls, may have exerted its position.
This escalation of restrictions was only at the legal level – and the new Drug 
Law was seldom enforced. An analysis of court records shows an average of 16 
convictions per year between 1948 and 1968; most of them had started drug 
use in a medical context, either as patients who had been prescribed narcotic 
substances as painkillers, or as nurses and medical doctors and their wives, 
who had easy access to controlled substances. The convicted were middle-aged 
and a remarkable percentage were female (Graßberger 1969). It must remain 
an open question to what extent the small numbers of drug offenders mirror a 
small iatrogenic drug scene and to what extent drug problems had secondary 
priority for criminal policy. However, few were convicted and criminalised.
Alcohol policy and controls in this period developed in opposite directions. 
To some extent alcohol policy was conceived of as a policy cutting across 
many policy fields and accordingly was “normalised” and “representative”. 
This is indicated by the establishment in 1955 of the alcohol advisory board 
at the ministry of social affairs (at this time responsible for health), which 
was comprised of honorary representatives from the temperance movement, 
specialists in the treatment of alcoholism, wine and spirit producers, but also 
employees and employers (the Sozialpartner). The advisory board at first com-
mitted itself to the re-establishment and extension of professional voluntary 
treatment for alcoholics – soon called alcohol-sickness, to counteract stigma-
tisation. Already in 1953 insurance companies had acknowledged alcoholism 
as a disease and paid for cures. At the same time, calls for a law on compul-
sory admission, retention and treatment of alcoholics, which had been raised 
since the First Republic, were finally rejected. And, at the end of the period, 
the limited incapacitation of alcoholics dropped to zero – a sign not only of 
enduring tolerance for alcoholics but also of the successful establishment of 
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special voluntary treatment (Eisenbach-Stangl 1991). In 1984 the Law on 
Trustees, without special regulations for addicts and users, replaced the Law 
on Incapacity.
But the advisory board was also influential in establishing repressive measures 
against alcohol consumption in a well-circumscribed area. A blood alcohol 
limit of 0.8 per mille for drivers was introduced by the traffic law of 1960. 
The regulation built on an amendment to the penal code in 1952, which con-
sidered intoxication as an aggravating circumstance when the safety of others 
had been endangered or violated (Eisenbach-Stangl 1991). The regulation of 
intoxication in road traffic law, the penal code and their administrative and 
penal sanctions has been continually tightened up ever since. Thus, tolerance 
of alcohol consumption and intoxication has endured in general, but toler-
ance changed to strictness in the road traffic context. Whether this strictness 
should be considered as a sign of the disintegration of alcohol policy under 
the pressure of new problems originating in new social contexts (and, if so, 
to what extent) has to remain an open question.
3.5.  Rapprochement with legal and social limits:  
1968 and 1995
The so-called international drug wave, carried forward by young people, some 
of whom were well-educated, stimulated a controversial public debate and gave 
reason to diversify drug policy, though it is better seen not as diversification, 
but as an ever-widening split. Since the amendment to the Drug Law in 1970, 
drug users are urged to submit to medical and therapeutic controls “instead of 
punishment” whereas drug dealers are often imprisoned. Sentences for dealing 
have been continually raised since 1970, whereas diminishing percentages of 
other drug offenders have been imprisoned (at most about 10%). And, due to 
extended regulations but also to extended services, increasing numbers and 
percentages of drug users have been given “therapy instead of punishment”. 
The divide is artificial and a sign of disintegration, but has proved useful to 
legitimise the increasing replacement of penal by medical controls for users 
– who, because of their continually growing numbers, otherwise would over-
crowd prisons. The divide has also allowed a rapprochement between drug 
and alcohol services, and between drug (treatment) and alcohol (treatment) 
policy, with the result that at the end of the period drug services and treatment 
became more innovative and took the lead.
The introduction of “therapy instead of punishment” in 1970 involved the 
drug services in the enforcement of drug law, so thereafter the law governed 
their development and the state subsidised them. The few services available 
in the 1970s mainly offered long-term residential treatment and most of the 
beds were within the prison system 10 years later, the extended drug services 
mostly provided outpatient care on a voluntary basis comparable to alcohol ser-
vices. With the appearance of HIV and AIDS in the mid-1980s, the extension 
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and diversification of services accelerated. Substitution treatment – never 
prohibited in Austria but not considered to be a medically adequate cure – 
was officially introduced in 1987 and a few years later syringe exchange was 
established. Harm reduction thus fell in step with the abstinence cure and 
overtook it in the 1990s – especially in Vienna, the only metropolitan city of 
Austria. Another major innovation was low-threshold services.
If the extension and diversification of drug services was meant to enlarge 
their coverage, to reach HIV- and AIDS-infected drug users and to protect 
the health of all, it also compensated drug users for the – more or less overt 
– exclusion of general medical and social services. The new standards set by 
innovations in the voluntary drug-service sector a few years later were partly 
adopted by the drug services in prisons. And, in a rudimentary form, they 
were also taken over by the alcohol services, which – apart from an increase 
of capacity, mainly in the 1970s and 1980s – had not changed much since the 
inter-war period. In addition, common services for alcoholics and drug addicts 
were established during this period – mainly shelters and day centres – but 
were not accepted by the clientele, reinforcing a limit to integration that was 
already known (Gratz and Werdenich 1980). According to their mirror-image 
hierarchy, alcoholics despise drug addicts, and drug addicts despise alcoholics.
In prevention, too, drugs became the leading substance area in policy inno-
vation under the sign of coherence. In 1980 an amendment to the Drug 
Law called for the establishment of prevention services on a state basis, 
which – after long public and professional debate – was realised in the early 
1990s. “Addiction prevention institutes” (Suchtpräventionsinstitue) were 
established, mainly dealing with drugs but also with alcohol and other addic-
tions (Fellöcker and Franke 2000). For the first time alcoholism prevention 
was institutionalised and professionalised, though it remained (and still is) 
subordinate to drug prevention.
Last but not least, the administration of alcohol policy also profited from politi-
cal innovations in the field of drugs. During the 1990s, drug co-ordinators 
and their bureaus were established as part of the state administrations, which 
decide on and finance most health, social and educational matters. Many of 
the new state-employed drug professionals were also made responsible for 
alcohol and other addictions. The drug co-ordination bureaus – conceived as 
“policy enforcement units cutting across policy fields” – were given consider-
able power: initiative in decisions and a budget. This was far more than the 
alcohol advisory board had ever been granted. They operated at the level of 
the federal state (weak in health, social and educational matters) without 
contract or budget.
The advisory board was dissolved in the early 1990s. Already in 1971 it had 
taken over drugs and “other addictive substances” which, as anticipated, domi-
nated discussions and activities from then on. It became dispensable not only 
27
Austria
because of the establishment of powerful addiction structures at state level, 
but also because of new structures at European level, as discussed in the next 
chapter. What remains to be mentioned here is that with the advisory board, 
the last organisation disappeared that in an operational context at federal 
level, where decisions on laws were taken could broach the disparate legal 
status of the addictive substances in question. Another insight inherent to its 
operational context was ignored in the increasing discrepancy in legal status 
of different substances in contrast to the increasing coherence of definitions 
and services for drug and alcohol problems.
3.6.  Discrepancy and coherence: Austria  
as an EU member state since 1995
Austria joined the European Economic Area in 1993 and became a member 
of the EU in 1995. Membership required adaptation to EU drug policy in 
legislation and administration. Adaptation of laws took place in the first half 
of the 1990s, adaptation of administration in the second half. In 1997, a few 
years after the demise of the alcohol advisory board, federal drug co-ordination 
was established at the Ministry of Health, responsible for the enforcement 
of drug law. The co-ordination panel consists of three drug co-ordinators, 
representing the ministries of health, justice and the interior; it is chaired 
by the first-named. The federal drug co-ordination panel co-operates with 
drug co-ordination at state level via administrative directives, but also via an 
advisory structure, the so-called Bundesdrogenforum (Federal Drug Forum), 
besides the drug co-ordinators of the states, who are drug professionals and 
experts (Pietsch 2011).
The federal drug structure differs from that developed for alcohol a few years 
later, again at the request of the EU. The alcohol structure too – still name-
less (this is no accident) – is chaired by a representative of the Ministry of 
Health, responsible for alcohol matters at federal level, and advised by a forum 
of stakeholders and experts – the Alkoholforum – established in 2007. But, 
because it is poorly developed, the alcohol structure lacks partners at state 
level. In other words, the national alcohol and drug structures built up at the 
request of the EU differ strongly from those previously built up on national 
traditions.
Independently of this drifting apart of national alcohol and drug policy 
structures, a new merging of controls has come about since the turn of the 
millennium in a circumscribed area of selected urban public places (Schmidt-
Semisch and Wehrheim 2005). Irrespective of the substances being used, the 
police, prevention and addiction professionals all take action to settle conflicts 
and maintain order in central areas of cities. Professions partly co-operate 
and partly compete: for instance, the police occasionally take care of intoxi-
cated persons and prevention professionals may settle violent conflicts. In 
Vienna the merger reached the level of services: the police established a drug 
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service providing advice and care to drug users, whereas the drug services 
were enriched by a facility providing mediation of conflicts in selected public 
areas. It remains an open question as to whether this local development is 
to be considered as a precursor of a merger of controls and policy structures 
at higher level.
3.7.  Coherence of repressive controls: when Austria 
joins the EU, tobacco comes under national 
substance policies
Treatment for smokers was established in 1980 as outpatient therapy, and 
from 1997 also as residential therapy in a few special facilities (Schoberberger 
and Rieder 2005). As with alcohol and drugs, treatment/therapy for smok-
ing is covered by insurance though with restrictions, most prominently of 
(expensive) substitution therapy. The awakening interest in tobacco-related 
problems was possibly also expressed by anti-smoking campaigns, but since 
campaigns on national level are neither co-ordinated by nor assigned to a 
special ministry or organisation, they may have been launched later. What 
is certain is that the political interest in health aspects of smoking developed 
years after the establishment of treatment, and it came with the relevant EU 
recommendations, becoming stringent with accession to the EU in 1995.
The first milestone of tobacco policy was the Tobacco Law of 1995, which 
for the first time in Austria regulated the quality of tobacco products for 
health reasons, introduced obligatory warning labels on tobacco products and 
restricted advertising in regard to quantity, number of products and target 
groups, variety of messages and forms of advertising. Following further EU 
recommendations and an international World Heath Organization conven-
tion, the law was rigorously tightened up in 2004.
The amendment of 2004 that can be considered as a second milestone was 
one that changed the paradigm of tobacco controls because smoking became 
defined as deviant behaviour and non-smoking the norm. The prohibition 
of smoking in public places and of advertising protected the non-smoker as 
potential victim. In 2008 the prohibition of smoking was extended to restau-
rants, and penalties were defined for violators of the regulations – fines for 
those responsible for the enforcement of prohibition and smaller ones for 
smokers themselves.
The protection of victims of behaviour related to psychoactive substance con-
sumption under the sign of health is also a goal governing the development of 
(repressive) controls related to alcohol and drugs: the early established and 
continually tightened drunk-driving regulations and the continually increasing 
penalties for drug dealers. But unifying victim protection takes place within 
regulatory systems with different consequences for violators: drug dealers are 
criminalised and often imprisoned, whereas drunk drivers can expect such 
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penalties only if the health of their victims was severely diminished. Smokers 
only have to pay an administrative fine. These discrepancies partly express 
the degree of problematisation of the different behaviours and issues within 
the country; they are partly a product of the period when the regulations 
were established and of the international bodies in charge of the conventions.
Within health administration and prevention, tobacco joined alcohol and 
drugs as a minor latecomer. Like the alcohol agenda and enforcement of the 
Drug Law, the Tobacco Law is the responsibility of the federal Ministry of 
Health, where all three are organised in one department. But, unlike alcohol 
and drug administration, tobacco administration seems to be best developed 
at national level; at state and local level it seldom attracts attention.
3.8. Conclusions
This broad assessment of the development of alcohol, drug and tobacco policy 
in Austria during the past 100 years indicates that coherence was promoted 
by various factors, some effective only in restricted periods. Those that seem 
most important are summarised below, though it must be kept in mind that 
they may differ from the main factors effective in other countries.
In the Austrian case, coherence seems to be rooted in tolerance of substance 
use, intoxication and other effects, because of the local production of most 
substances and traditionally high consumption levels. In contrast, substance-
related problems are met with ambivalence: partly with support, but partly 
also with stigmatisation and exclusion.
But the medicalisation of alcohol, drug and tobacco problems – their defini-
tion as disease and dependence or addiction – contributed to the coherence of 
alcohol, drug and tobacco policy. It would be of interest to study the changing 
concepts of disease referred to in debates, laws and discussions, and their 
political consequences. But all concepts used in the period under analysis 
seem to have promoted a scientific view of the behaviour and problems in 
question – at the expense of a moral view – and all of them put the emphasis 
on internal processes, such as compulsion instead of external ones (e.g. drug 
profit).
Seen from another angle, disease and addiction concepts and the medical view 
gained importance in parallel with the process of individualisation speeding up 
in the period under analysis, and each promoted the other. Psychoactive sub-
stances lost their social significance, and the individual meaning of consump-
tion and its effects became more important, which furthered the coherence 
of “addiction” policy, especially of treatment and prevention interventions.
Coherence of Austrian policy on the substances in question has especially 
developed with “addiction” administration and preventive “addiction” inter-
ventions at state level. The professional, practice-oriented and local responses, 
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irrespective of interesting differences between the states, seem to have empha-
sised the normal, everyday character of the problems, instead of their unique-
ness, and directed attention to specific individual problems, rather than 
societal problems such as low productivity, poor morals or poverty.
Discrepancies were mostly promoted by external influences and partly by 
the compulsory import of foreign (repressive) policies, which – as mainly 
moral policies – drove a wedge between Austrian alcohol and drug policies. 
The imported policies came from international drug treaties, American drug 
laws and EU recommendations inspired by other European cultures. Imported 
measures in the long run became better integrated in Austrian policies, but 
they still impair coherence.
Moral views lost importance but found a refuge in the protection of non-users, 
where the penalties for violations express the weighting of the substances: 
according to the sentences given, alcoholic beverages – the substances most 
familiar in the country – are best because least dangerous for non-users, 
whereas foreign illicit drugs are the worst/most dangerous, and tobacco is 
in between. Moral views thus seem to work equally against coherence and 
integration in that prevailing policies are tolerant, medicalised and aimed at 
local reactions.
Coherence of substance policy seems to have two main limits, to some extent 
linked: a limit at policy level determined by the legal status of the substance 
(criminalisation of illicit drugs in international convention) and a limit set 
by the users (alcohol and drug users despise and discriminate against each 
other, which impairs the establishment of services for both).
3.9. References
Eisenbach-Stangl I. (1991), Eine Gesellschaftsgeschichte des Alkohols. Produktion, 
Konsum und soziale Kontrolle alkoholischer Rausch – und Genussmittel in 
Österreich 1918-1984, Campus, Frankfurt am Main/New York
Eisenbach-Stangl I. (1993), “The beginnings of Austrian and Galician alcohol 
policy: a common discourse on dependence” in Contemporary Drug Problems, 
Vol. 20, No. 4, pp. 705-18
Eisenbach-Stangl I. (2003), “Austria” in Jack S. Blocker et al. (eds), Alcohol 
and Temperance in Modern History. An International Encyclopedia, ABC CLIO, 
Santa Barbara/Denver/Oxford, pp. 79-82
Fellöcker K. and Franke S. (eds) (2000), Suchtvorbeugung in Österreich, 
Springer, Vienna/New York
Graßberger H. (1969), “Suchtgiftmissbrauch und Kriminalität” in BMI (ed.), 
Kriminalpolitische Schriftenreihe, Vol. 2, Part 2, Vienna, pp. 111-43
31
Austria
Gratz W. and Werdenich W. (1980), “Von den Schwirigkeiten, wenn unter 
Gefängnisbedingungen Süchtige entwöhnt werden” in Rudolf Mader and 
Hans Strotzka, Drogenpolitik zwischen Therapie und Strafe, Jugend und Volk, 
Vienna, pp. 233-62
Lehner O. (1983), “Drogenpolitk in Österreich, dargestellt am Beispiel der 
Alkoholgesetzgebung vom 15. Bis ins frühe 19. Jahrhundert” in Werner 
Ogris and Walter H. Rechberger, Gedächtnischrift Herbert Hofmeister, Manz, 
Vienna, pp. 347-68
Muscat R. (2011), Draft Framework, Integrated Policy Expert Group, 
Pompidou Group, Council of Europe
Pietsch F. (2011), “Gesundheitspolitik und Suchttherapie – Internationale 
Perspektiven”, paper given at the conference 30 Jahre Suchttherapie in 
Österreich (Thirty Years of Seeking Treatment in Austria), Vienna, 23-25 
March 2011
Pilgram A. (1992), “Mit dem Gesetz gegen Drogen – zur Geschichte des 
österreichischen Suchtgiftgesetzes” in Beiträge zur historischen Sozialkunde, 
1992, pp. 26-32
Schmidt-Semisch H. and Wehrheim J. (2005), “Exkludierende Toleranz. 
Ordnung und Kontrolleim Kontext akzeptierende Drogenarbeit” in Bernd. 
Dollinger and Wolfgang Schneider (eds), Sucht als Prozess, Verlag für 
Wissenschaft und Bildung, Berlin, pp. 221-38
Schoberberger R. and Rieder A. (2005) “Geschlechtsspezifische Behandlung 
der Nikotinabhängigkeit” in Eisenbach-Stangl I., Lentner S. and Mader R. 
(eds), Männer, Frauen, Sucht, Facultas, Vienna, pp. 205-21

33
4.  The long road to an integral  
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4.1. The drug phenomenon in Belgium: a late discovery
In Belgium, the drug phenomenon became apparent rather late. By the late 
1980s and early 1990s, some of the major cities faced a steep increase in fre-
quent crime, so-called “petty crime”, which caused a great deal of discontent 
and seriously affected livability in a number of impoverished neighbourhoods. 
The idea spread (though not backed up by data) that problem drug users, 
and in particular the acquisitive crimes they committed, were causing the 
rise in crime and nuisance. An extreme right-wing political party used these 
feelings of insecurity in their election campaign in 1991, resulting in their 
breakthrough in November of that year. The traditional political parties were 
suddenly confronted by a serious political problem, one that was augmented 
by a societal phenomenon they were for the most part unfamiliar with; not 
only that, there was hardly a hint of a drug policy at the time. 
In Belgium, as in many other European countries, a drug law was in force. 
This law was passed in 1921 to fulfil Belgium’s international obligations 
under the International Opium Convention of the Hague of 1912. In 1975, 
this Drug Law was amended, again partly to fulfil international obligations 
(namely the United Nations Single Convention of 1961 and the UN Drug 
Convention of Vienna of 1971). The minister of justice at the time, acting as 
a moral crusader, overzealously endorsed the prohibitionist philosophy of the 
UN treaties. On the upside, the 1975 amendment did expand the options for 
probation measures for drug users, enabling faster diversion into drug treat-
ment, though the prevention and treatment offer was scarce. The few initia-
tives that did exist were private clinics that based their treatment methods 
on the ones used in the Netherlands.
It was only after the societal and political changes of the early 1990s that the 
Belgian Government took numerous initiatives. At that time, they were not 
targeted at any particular problem, though they proved to be necessary later 
on. Firstly, the government tried to gain insights into the nature and extent 
of the drug phenomenon through (limited) scientific research. Then, in 1992, 
the government set up safety and prevention contracts to sustain local authori-
ties in their response to crime and nuisance. In 1993, subsidies – for drug 
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prevention, street-corner work, drug treatment and local drug co-ordinators – 
focused on specifics of the drug phenomenon. In 1994, a conference involving 
all relevant actors in the field (doctors, drug treatment and justice) established 
guidelines for good practice in methadone substitution.
In 1995, socio-medical treatment centres were established in all nine provinces 
of the country. These low-threshold centres worked with a multidisciplinary 
team and were aimed at the most problematic drug users. These centres were 
based on the way low-threshold drug treatment was organised in the Dutch 
city of Amsterdam. Indeed, quite a lot of methods adopted in Belgium – in 
drug prevention, drug treatment, co-operation between justice and treatment, 
and local drug co-ordination –were based on good practice established in the 
Netherlands.
In retrospect, Belgium’s late discovery of the drug phenomenon proved to be 
an important advantage since it was possible to learn from Dutch experience, 
negative as well as positive. In the Netherlands, it had become clear by the 
mid-1990s that the system of tolerated distribution of cannabis through coffee 
shops was not a successful strategy. The flood of foreign drug tourists resulted 
in more coffee shops and their development into commercial enterprises that 
did not respect the tolerance criteria. This also resulted in increased nuisance 
in major Dutch cities and border towns, explosive growth in illegal cannabis 
production and the spread of illegal sales points for drug tourists. In fact, 
these changes resulted in a failure of the planned division of the markets. 
Learning from this Dutch experience, consensus grew in Belgium that coffee 
shops were not an option.
4.2.  The development of Belgian drug policy:  
a bottom-up story
In the first half of the 1990s, Belgium did not pursue a coherent drug policy at 
all. Belgian Government initiatives were unco-ordinated and unlinked. With 
the increased visibility of the drug problem in Belgian society, every competent 
minister “discovered” the drug phenomenon separately and announced sepa-
rate initiatives without any discussion with other members of the government, 
let alone with those at other policy levels. Indeed, 24 ministers in federal and 
regional government had drugs within their competence, so several policy 
initiatives (both specific measures and policy plans) were begun for differ-
ent policy levels (federal, regional, local) and domains (justice department, 
internal affairs, public health, social affairs, federal urban policy, welfare). 
According to the conclusions of the parliamentary working group on drugs, 
these initiatives were perceived as extremely chaotic by the relevant sectors. 
The policy measures issued in this period were entirely incoherent, not tuned 
to one another and absolutely not embedded in public health or social poli-
cies. Even worse, certain policy measures counterbalanced one another. For 
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instance, the minister of justice issued a circular in 1993 demanding that the 
public prosecutor act upon every violation of the Drug Law. This demand 
was at odds with several prevention initiatives aimed at applying a preven-
tive health approach to experimental users. Another striking example was 
the Ten Points plan of 1995, when the government issued 10 measures that 
were completely divergent from each other. Thus one could not speak of an 
univocal approach to the drug phenomenon. Despite this lack of co-ordination 
these initiatives were strongly appreciated by those working in the field. One 
must remember that at the time there was no Belgian drug policy, and politi-
cians hardly had any experience of the drug phenomenon.
This situation changed when in 1996 the Chamber of Representatives decided 
to establish a parliamentary working group on drugs with the clear mission to 
inform itself about every aspect of the drug phenomenon and, based on this 
information, to give clear recommendations to the federal government. The 
group chose a brave working method: they asked national and international 
experts, working in all domains of drug policy (epidemiology, prevention, 
treatment, the social sector, repression) to convey their analysis and their 
recommendations. The working group followed most of these recommenda-
tions. Across the different domains there was a striking consensus about the 
need for a multidisciplinary and coherent approach to the multi-dimensional 
drug phenomenon. The conclusion from this appears to be that there was 
no integrated policy in the past and that we were still dealing with separate 
structures. According to the parliamentary working group, policy harmonisa-
tion was a necessary condition for any future Belgian drug policy. The final 
report of the working group mirrored the needs and expectations of the dif-
ferent domains in the field and in the academic world. These would become 
the pillars of Belgian drug policy.
The report recommended developing an integrated and integral drug policy, 
with both vertical policy co-ordination between different policy levels (fed-
eral, regional, provincial and local) in the domains of prevention, treatment 
and social policy, and horizontal co-ordination between the various policy 
domains and at the various levels. Remarkably, only at the local level was 
there a fully-fledged consultative structure available in that period. In some 
communities and cities, a local drug co-ordinator acted as president/supervi-
sor/facilitator to chair these local steering groups or committees on drugs. 
It is striking that the security (justice and police) and education sectors also 
participated in these local steering groups on drugs. It is not an exaggeration to 
state that in this case a bottom-up approach was followed, in order to develop 
the structures needed to make a coherent drug policy possible. Epidemiology, 
which hardly existed before that time in Belgium, would provide the facts and 
figures for drug policy. Structural and person-orientated prevention was to 
become the priority. For drug users experiencing problems, a wide variety of 
drug-treatment services and general treatment services (from low-threshold 
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to high-threshold) had to be established. As for highly problematic drug users, 
a harm-reduction approach was chosen, with the provision of substitution 
treatment aimed at protecting the individual as well as society, in particular 
from drug-related crime and nuisance.
The working group proposed to limit repression to drug producers and traffick-
ers striving for profit. The criminal justice system had to try, when possible, 
to divert problem drug users to (drug) treatment (based on the philosophy of 
the last resort). Furthermore, priorities were set for investigation and prosecu-
tion policy: possession of a consumer quantity of cannabis by a non-problem 
drug user was to receive the lowest priority. This recommendation led to the 
comment by some observers that Belgian policy would resemble Dutch policy 
(apart from the tolerated coffee shops). Despite these objections, the conclu-
sions and recommendations of the working group were almost unanimously 
approved by the Chamber of Representatives. The foundations of Belgian 
drug policy were laid on a firm political basis.
4.3.  The federal policy note on drugs (2001):  
a clear answer
The response from the federal government took more time than anticipated 
because of the Dutroux crisis in the summer of 1996 and the political attention 
it received in its aftermath. Following a parliamentary inquiry, this crisis led 
to the biggest reform of the police and of justice that Belgium had ever seen. 
In January 2001 the Verhofstadt government approved the first federal policy 
note on drugs in Belgian political history. Since the federal note, for the most 
part, copied the recommendations of the parliamentary working group on 
drugs, political support for these recommendations continued.
The starting point of the federal policy note was that drug use is a matter of 
public health. Therefore the federal minister for public health is in charge of 
the integrated and integral drug policy and chairs the inter-ministerial confer-
ence of the 24 competent ministers in order to develop the necessary vertical 
policy co-ordination. The General Drugs Policy Cell was created, under the 
chairmanship of the national drug co-ordinator. This cell prepares the deci-
sions of the inter-ministerial conference and guards the integrated character 
of the policy measures.
The drug phenomenon is considered to be a permanent social reality and 
thus drug policy is aimed at rational risk-control. From this starting point, 
the note follows the recommendations of the parliamentary working group 
on epidemiology, prevention, treatment and repression. The federal note is 
in accordance with European Union drug policy and respects United Nations 
drugs treaties. For 10 years now, the diverse elements of the federal note have 
been implemented.
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At epidemiological level, an early warning system was set up, at first for 
ATS (amphetamine-type stimulants) and later on for new synthetic drugs 
and psychotropic substances. This stimulated evaluation research, which 
contributed to the development of an evidence-based policy. Nonetheless, we 
have to admit that for epidemiology Belgium remains a weak partner within 
the EU, as becomes abundantly clear in the annual reports of the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
At prevention level (which is strictly speaking the competence of the com-
munities), although the number of prevention workers has increased, pre-
vention is still far from achieving its priorities. Public expenditure research 
demonstrates that the means available for prevention represent but a fraction 
of the means for treatment and repression.
At treatment level, the most pressing needs were answered. Following pilot 
projects, there was increased capacity in crisis centres and for double-diagnosis 
patients. Treatment circuits were installed to counter shopping around for 
treatment and especially to optimise use of the diverse treatment offer. Ten 
years after the methadone conference, a legal framework was established for 
substitution treatment (following a law on needle exchange). Funding for 
drug treatment increased (more treatment centres and focus on drug-using 
parents and minors).
Criminal policy on drugs was provided with a clear framework. This policy 
is anchored in an adaptation of the Drug Law and a number of ministerial 
circulars. The starting points formulated by the parliamentary working group 
on drugs were maintained to the full: the criminal justice response is primar-
ily aimed at drug production and drug trade. Problem drug users who come in 
contact with the criminal justice system because of drug-related crime need to 
be promptly diverted to (drug) treatment, making use of the existing legal provi-
sions on different levels of the criminal justice system (prosecution, sentencing 
and execution of sentence). The possession of less than three grams of cannabis 
or one female cannabis plant has the lowest prosecution priority except in the 
case of nuisance, the presence of minors or indications of problem drug use.
Prioritising drug production and trade proved necessary because the 
Netherlands increased the pressure on professional cannabis cultivators and 
synthetic drug laboratories from about 2000, leading Dutch organisers to shift 
their activities to Germany and (particularly) Belgium.
Co-operation between the criminal justice system and treatment services 
increased in the first decade of the 21st century, not least because of the suc-
cess of the “Test care” and “Drug treatment court” pilot projects, both in the 
judicial district of Ghent. The criminal justice system in particular is willing 
to extend these projects to all judicial districts. The problem is the limited 
capacity of drug-treatment services and the differences in geographical spread 
of drug treatment. Some Belgian regions lack the capacity even to respond to 
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treatment demands from criminal justice clients, and the limited number of 
regions that do have sufficient treatment capacity still cannot respond fully 
to all treatment requests.
4.4. The current state of affairs in Belgium
Belgium has clearly chosen an integral and integrated drug policy (as described 
above). To what extent has this approach been implemented? The structures 
to develop and monitor an integral and integrated drug policy are present, both 
at federal and at local level. Evaluation research has indicated that local steer-
ing groups or committees on drugs, supervised by a local drug co-ordinator, 
can be considered as good practice. These co-ordination structures, including 
all domains and actors, enable co-operation that increases the efficiency of 
interventions in the domains involved. The extra value of developing a policy 
at local level is that the policy is based on the drug phenomena that are most 
frequently manifested. Furthermore, evaluation research has indicated that 
pilot projects on co-operation between the criminal justice system and treat-
ment services (described above) can also be labelled as good practice. However, 
the planned and desired generalisation of these projects faces capacity and 
financial obstacles.
Research into co-operation between criminal justice and treatment has dem-
onstrated that better results can be obtained when several life domains (such 
as housing and employment) are included and improved. For problem drug 
users, this involves the homeless sector, social housing, social economy and 
general social services, all of which lack sufficient funds. It is clear that the 
success of a drug policy is determined by the financial means it can use. Public 
expenditure studies conducted in Belgium clearly demonstrate increased 
financial means over recent decades. Nonetheless it is also clear that public 
expenditure in Belgium is still far from the level of expenditure in Sweden 
and the Netherlands.
The development of a coherent, integrated drug policy is an ongoing process. 
On 25 January 2010, the Inter-Ministerial Conference on Drugs approved a 
joint declaration, which carries on the principles adopted in the Federal Drug 
Policy Note of 2001. The General Drugs Policy Cell and the inter-ministerial 
conference are entitled to develop policy on illegal drugs, alcohol, tobacco 
and psychoactive medication. Use of the first three substances is primarily 
considered to be a public health issue. However, this phenomenon should 
be seen in its global context, including the different domains by which it is 
being influenced and affected: welfare, social integration, education, security, 
justice and the economy. With regard to the latter, there is a permanent area 
of tension between the economic imperatives of the pharmaceutical industry 
and the consequent public health policy on psychoactive medication.
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4.4.1. The alcohol policy
At both international and national levels, growing awareness of the detri-
mental effects of alcohol use has resulted in several policy documents and 
strategies. On the European level, the European Charter on Alcohol from the 
WHO can serve as an example. In Belgium, the Inter-Ministerial Conference 
on Public Health fulfilled the need for an integral and integrated approach in 
tackling the alcohol problem by adopting a “Joint declaration on future alcohol 
policy in Belgium” (2008). The objectives of this new policy are: (1) preventing 
and reducing alcohol-related harm, (2) tackling the problematic use of alcohol 
(not only the dependency problem) and (3) pursuing a policy addressed to 
high-risk groups and risky situations. In implementation of this declaration, 
several measures and actions were executed concerning availability, legisla-
tion, advertising, alcohol in traffic and prices policy, with young people and 
pregnant women as specific target groups that require extra attention.
For instance, the Law of 10 December 2009 (on various conditions on the 
subject of health) stated a clear health message by lowering the age limits 
for selling and serving alcohol to young people with a ban on selling and 
serving alcoholic beverages to younger minors (under-16s), and liquors to 
minors (under-18s). Another example is the institutionalising of the Belgian 
Covenant on Behaviour and Advertising on the subject of Alcoholic Beverages 
(2005), an agreement between the federal minister for public health, the 
catering industry and consumer organisations, on the limitations of alcohol 
advertising (particularly restrictions in advertising to young people). The 
Law of 12 July 2009 introduced alcohol as a possible aggravating factor when 
committing a traffic offence.
4.4.2. The tobacco policy
In the first decade of the 21st century, Belgium moved towards a more restric-
tive policy on tobacco, which received a lot of attention from the legislator. The 
Federal Drug Policy Note of 2001 recommended working-out an anti-tobacco 
policy in order to reduce tobacco use and its health-related consequences. 
Restrictions on the use and supply of tobacco were meant to be accompanied 
by awareness campaigns.
In order to obtain these objectives through a global approach, the federal gov-
ernment adopted a plan to combat the use of tobacco, which was executed in 
2003-7. As part of this plan several royal decrees were implemented, helping 
the evolution towards the criminalisation of smoking in public places. In 2005, 
some protective measures on minors were issued, whereby selling tobacco to 
persons under the age of 16 was prohibited. Alongside this restriction, ciga-
rette vending machines were equipped with a secure system. Furthermore, 
the cost of counselling to quit smoking was refunded to pregnant women and 
their partners. Since 2007, a pack of cigarettes has had to show a combined 
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warning: an illustration with a small text to inform the smoker about the 
possible consequences of smoking.
In 2006, the principles of courtesy, which had informally regulated smoking 
in the working environment since 1993, were superseded by legal restrictions 
giving employees the right to a smokeless area to protect their health. Also, 
there was a complete ban on smoking in closed public spaces. Both regula-
tions were taken into account in a new law of 22 September 2009 that also 
restricted smoking in restaurants. From 1 January 2010, smoking was prohib-
ited in closed public spaces, working environments and restaurants. It was, 
however, still allowed in bars that did not serve food. This last exception has 
since been annulled and, from 30 June 2011, smoking in bars is only allowed 
in separated smoking rooms.
4.5. Conclusion
Since the early 1990s, Belgium has continued to develop a coherent drug 
policy. A lot of effort through the years has established the core princi-
ples in the approach to the multi-dimensional drug phenomenon. A global 
and integrated policy requires prevention, early detection and intervention, 
treatment including risk-reduction and repression. Repression towards the 
users, however, remains a last resort (ultimum remedium). The drug policy 
currently being pursued relies on objective and scientific data, which have 
a sufficient basis and are subject to validation of good practices in the dif-
ferent sectors of the work field. Belgian drug policy is part of international 
treaties and European policy plans, to ensure consistency with international 
and European policy. The General Drugs Policy Cell (and its three working 
cells: Drug Health Policy Cell, Control and International Co-operation) and 
the Inter-Ministerial Conference on Drugs are the fora for co-ordination and 
consultation in putting the global and integrated drug policy and the joint 
declaration into practice.
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5.  Coherency of Irish policies on illicit drugs, 
alcohol and tobacco Ireland
Brigid Pike 
Evidence Generation and Knowledge Brokering Unit, Health Research Board, 
Dublin12
5.1. Introduction
This chapter seeks to assess the coherency of Ireland’s policies on  alcohol, 
tobacco and those psychoactive substances controlled under the United 
Nations drug conventions (referred to as “illicit drugs” in this chapter) in 
relation to an over-arching health objective. Following the approach outlined 
in Chapter 2, each policy is assessed against the following six indicators:
 − problem conceptualisation,
 − policy context,
 − legislative/regulatory framework,
 − strategies,
 − responses,
 − structures and resources.
The definition of health in this chapter is that used by the World Health 
Organization (WHO) in its founding charter and adopted in Ireland’s cur-
rent national health strategy: “a complete state of physical, mental and social 
well-being and not merely the absence of disease or infirmity” (Department 
of Health and Children 2001). In pursuit of this over-arching health objective, 
the Irish Government has developed a “population health” approach, defined 
as “one which promotes and protects the health of the whole population 
or sub-groups, with particular emphasis on reducing inequalities” (Health 
Service Executive 2008).
Ireland’s policies on illicit drugs, alcohol and tobacco, all included in Ireland’s 
national health strategy, are here assessed in terms of whether and how 
they contribute to realising this over-arching population health objective. 
Particular attention is paid to how the three policy areas make use of preven-
tion measures, based on the health promotion model, which seek to elicit 
12. The author wishes to acknowledge comments by Cliona Murphy of Alcohol Action Ireland 
(http://alcoholireland.ie), a national charity for alcohol-related issues, on an earlier version of 
this chapter. All errors and omissions are the author’s.
Ireland en blanc pour 
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individualistic responses (behavioural and lifestyle choices to prevent illness) 
and structural responses (strengthening environmental factors to maintain 
good health) (Butler 2002).
For an account of the context and development of Ireland’s drug policy since 
the 1970s and its links with alcohol and tobacco policies, readers are referred 
to the chapter on Ireland in the first report from this project, published in 
2008 (Muscat 2008). The main substantive change in Ireland’s policy envi-
ronment since then has been the political decision to combine illegal drugs 
and alcohol in one policy domain. The first action listed in the National 
Drugs Strategy 2009-16 was to “establish a Steering Group in autumn 2009 
to develop proposals for an overall Substance Misuse Strategy” (Department 
of Community, Rural and Gaeltacht Affairs 2009). The recommendations of 
the Steering Group were presented to the Minister of State, Ms Róisín Shortall 
TD, on the 7th February 2012. A consultation process will now commence 
with an action plan being presented to Government during 2012. Tobacco 
still constitutes a separate and distinct policy domain.
In 2011, the new government transferred responsibility for co-ordinating illicit 
drugs policy to the Department of Health, where responsibility for alcohol 
policy also resides. The department has not had responsibility for drugs since 
the mid-1990s, when the link between illicit drug use and social and economic 
disadvantage was officially recognised. As a result, lead responsibility was 
transferred to government departments with responsibility in the areas of 
local and community development (Ministerial Task Force on measures to 
reduce the demand for drugs 1996). This shift back to health may foreshadow 
a shift in policy emphasis, but this had not been articulated at the time this 
report went to press, so it is not taken into account in assessing the degree of 
coherency among the different policies.
5.2. Problem conceptualisation
How are the problems associated with the three categories of psychoactive 
substances described? How do research evidence, media coverage, cultural 
expressions, social, economic and political considerations shape the nature 
of the problem?
A notable feature of problem conceptualisation is how perceptions of 
the toxicity associated with each of the three categories of psychoactive 
substance, be that toxicity physiological or behavioural (see Table 1), are 
mediated by various factors including scientific evidence, expert opinion, 
media coverage, public debate and cultural attitudes. In this section, the 
101 % et +10 pour 
avoir une ligne en 
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interplay between toxicity and mediating factors is not discussed, only the 
mediating factors.13
Table 1: Prevalence of illicit drug, alcohol and tobacco use and associated 
problems in Ireland 14 15 16 17 18 19 20
Illicit drugs Alcohol Tobacco
Prevalence 
in adult 
population
7% of Irish adults 
reported using an 
 illegal drug in the past 
year (2010/11).14 
About 81% of adults 
reported drinking 
alcohol in 2007.15 
The smoking rate for 
Irish adults in 2007 
was 29%.16
Related 
deaths 
There were 293 deaths 
per annum by poison-
ing (deaths directly 
due to the toxic effect 
of the presence in the 
body of one or more 
illicit drugs) in 2008.17
Every seven hours, 
someone in Ireland 
dies from an alcohol-
related illness (about 
1 251 people each 
year).18
Each year over 6 500 
Irish people die pre-
maturely from the 
effects of tobacco.19
Other 
costs
To date, no study of 
the social costs associ-
ated with illicit drug 
use in Ireland has 
been conducted.
Alcohol-related prob-
lems were estimated 
to cost Ireland €3.7 
billion in 2007 – or 
€3  318 on each per-
son paying income 
tax – including costs 
a s s o c i a t e d  w i t h 
health, absenteeism, 
workplace accidents, 
crime, vandalism and 
alcohol-related road 
collisions.20 
No data available.
13. For a more detailed account of how the problems linked to the various categories have been 
conceptualised, see Muscat R. et al. (2008). 
14. National Advisory Committee on Drugs and Public Health Information and Research Branch 
(2011), Drug use in Ireland and Northern Ireland: first results from the 2010/2011 drug prevalence 
survey, Bulletin 1, National Advisory Committee on Drugs, Dublin.
15. Morgan K. et al. (2009), SLÁN 2007: Survey of lifestyle, attitudes and nutrition in Ireland. 
Alcohol use in Ireland: a profile of drinking patterns and alcohol-related harm from SLAN 2007. 
Dept of Health and Children. Dublin: The Stationery Office. 
16. Brugha R. et al. (2009), SLÁN 2007: Survey of lifestyle, attitudes and nutrition in Ireland. 
Smoking patterns in Ireland: implications for policy and services, Dept. of Health and Children, 
The Stationery Office, Dublin.
17. Health Research Board (2011), Drug-related deaths and deaths among drug users in Ireland: 
2008 figures from the national drug-related deaths index, www.hrb.ie/publications/alcohol-drugs. 
Accessed on 24 November 2011
18. http://alcoholireland.ie/alcohol-facts/alcohol-related-harm-facts-and-statistics/. Accessed 
on 24 October 2011.
19. Tobacco Control Unit (2010), Tobacco control fact sheet January 2010, www.dohc.ie/
fact_sheets/tobacco_control_sept2011.pdf?direct=1. Accessed on 24 November 2011.
20. http://alcoholireland.ie/alcohol-facts/alcohol-and-costs/. Accessed on 24 October 2011.
Notes 14 à 20 en blanc
46
Policy on psychoactive substances and beyond
5.2.1. Illicit drugs
The “heroin epidemic” in Dublin in the mid- to late 1980s coincided with 
the emergence of HIV/AIDS as a public health issue. This led to the develop-
ment in 1991 of a government drugs strategy that addressed the public health 
risk and the need to reduce harms associated with intravenous drug use 
(Department of Health 1991). In 1996, the Ministerial Task Force on Measures 
to reduce the demand for drugs used epidemiological data on problem drug 
use to highlight the association between problem drug use, especially of opi-
ates, and social exclusion and poverty. This framing of the drug problem has 
continued to underpin government policy on illicit drugs.
5.2.2. Alcohol
Although the problems associated with alcohol consumption in Ireland were 
already recognised in the mid-1990s, it has been difficult to reach a consensus on 
how these problems should be addressed. To this day, there is no national alco-
hol strategy and no coherent approach to the problems associated with alcohol 
use. This difficulty has been attributed to divergent cultural attitudes: alcohol 
has been regarded as part of everyday life in Ireland and “essentially benign”, 
while illicit drugs have been regarded as “unspeakably evil” (Butler 2002).
Ten years after the first report of the ministerial task force on measures to 
reduce the demand for drugs, which suggested that a “coherent, integrated” 
drug and alcohol strategy should be developed, a joint Oireachtas committee 
(comprising members of the upper and lower houses of Parliament) pub-
lished a report on whether and how such a strategy might be developed (Joint 
Committee on Arts, Sport, Tourism, Community, Rural and Gaeltacht Affairs 
2006). The report noted that public support for alcohol-control measures was 
growing, citing a recent survey which showed that most people were aware 
of Ireland’s problem with alcohol, but that only about a quarter believed that 
the government was doing enough to tackle the problem. Treatment data also 
showed a growing problem of polydrug use, involving consumption of both 
alcohol and illicit drugs.
Notwithstanding the growing call for combining strategies, the different 
perceptions of alcohol and illicit drugs persisted. In her foreword to the 
2006 parliamentary report, the chair explained that the committee believed 
the combined strategy should be called a “substance-misuse” strategy rather 
than a “drug and alcohol” strategy because they were “loath to have alcohol 
classified alongside heroin and cocaine etc., and all that entails”. As noted in 
Section 5.1 above, in 2009 the government took the political decision to include 
both illicit drugs and alcohol in a “substance-misuse strategy”. Following the 
presentation of the recommendations of the Steering Group to the minister 
in February 2012, a consultation process will now commence and an action 
plan will be presented to the government in 2012.
99 % et -5 sur le §
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5.2.3. Tobacco
Following a comprehensive review of the international evidence, in 2000 a 
Tobacco-Free Policy Review Group assessed tobacco-related risks as follows: 
“Tobacco products are not just another consumer product with regrettable 
adverse products. These products, when used in the manner intended by 
the manufacturer, cause addiction followed by illness and premature death.” 
(Tobacco-Free Policy Review Group 2000). However, the review group did not 
see prohibition as an option because: “A complete ban would, in our opinion, 
lead to the emergence of a substantial black market in smuggled products with 
its associated criminality” (ibid: 42). 
Dr Tony Holohan, Chief Medical Officer at the Department of Health, has 
highlighted the need for an integrated approach to tobacco and alcohol con-
trol. Noting that Ireland was at an advanced stage in reviewing its tobacco 
policy, he said at a forum on obesity that they needed to look at relationships 
between lifestyle factors – including tobacco use, alcohol consumption and 
obesity – and their effects on health: “There is no way these complex, societal 
challenges which face all of us can be confronted unless we can find a way of 
working together.” (Gartland 2011).
5.3. Policy context
Where are drug and alcohol policies located in the overall policy environment? 
Are they in criminal justice or medicine, or in a value set like social inclusion, 
human rights or equality?
Ireland has tended to be a policy taker in relation to policies on the three cat-
egories of psychoactive substances: it has followed the policy priorities agreed 
internationally.21 Policy may also be influenced by the “political rationalities” 
of the day, which bring different political values and aspirations to the fore, 
such as welfarist, neo-conservative or neo-liberal (McKeganey 2011; Houbourg 
and Bjerge 2011). All these influences can be seen at work in the Irish policy 
arena at various times.
5.3.1. Illicit drugs
Following ratification of the UN conventions on drugs, Ireland translated 
the provisions into law. As a consequence, Irish drug policy is partly located 
in a criminal justice context, in which the customs and police authorities 
work to reduce the supply of, and demand for, drugs through law enforce-
ment. Since the first recognition of a drug problem in Ireland, the national 
response has also been partly health-based. Initially, this meant treatment 
21. For example, UN drug conventions; the WHO European Charter on Alcohol; its Framework 
Convention on Tobacco Control; EU directives on alcohol and tobacco policy; EU strategies/
action plans on illicit drugs and alcohol-related harm. 
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for individual drug users. From the late 1980s, following acknowledgement 
of the links between the spread of infectious diseases and injecting drug use, 
harm-reduction measures were also introduced, but at local level, being only 
gradually absorbed into mainstream policy (Butler and Mayock 2005).
As noted earlier, the 1996 report of the ministerial task force on measures to 
reduce the demand for drugs recognised the link between problem drug use 
and socio-economic deprivation, and Ireland’s first national drugs strategy was 
positioned within the broader domain of social inclusion policy. The review 
group that drafted the strategy commented: 
The review group fully recognises that, notwithstanding the obvious benefits 
for communities affected by the drugs problem of having a specific drugs strat-
egy, the best prospects for these communities, in the longer term, rest with a 
social inclusion strategy which delivers much improved living standards to 
areas of disadvantage throughout the country.22
5.3.2. Alcohol
As noted in Section 5.2 above, there has so far been no national alcohol 
strategy and no coherent approach to problems associated with alcohol use. 
Although responsibility for alcohol policy resides in the Department of Health, 
this has not resulted in a policy approach noticeably rooted in a public health 
philosophy. For example, there has been no over-arching policy objective 
stating that the aim of alcohol policy is to lower alcohol use; furthermore, in 
recent years, the government has enacted policies and legislation that have 
countered a public health approach by increasing availability of alcohol prod-
ucts and access to them.
5.3.3. Tobacco
Ireland’s tobacco policy is located entirely in a population health context, 
which includes both the health of tobacco users themselves and the wider 
environmental health risks created by tobacco smoke. The overall objective is 
to achieve a “tobacco-free society” (Tobacco-Free Policy Review Group 2000).
5.4. Legislative/regulatory framework
How are the various psychoactive substances controlled and regulated?
Legislative provisions are in place to (1) control the supply and quality of 
the three categories of psychoactive substances, (2) regulate the markets in 
those substances, and (3) reduce the external costs associated with trade in 
the substances and their consumption.
22. Department of Tourism, Sport and Recreation (2001), Building on experience: National Drugs 
Strategy 2001–2008. Dublin: Stationery Office, paragraph 6.1.9.
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The Irish Medicines Board, a statutory body, licenses the manufacture, prepa-
ration, importation, distribution and sale of medicinal products, including all 
drugs, in Ireland. The Misuse of Drugs Regulations 1988, drafted on foot of 
the Misuse of Drugs Acts (MDA) 1977 and 1984, include schedules of the 
substances controlled under the UN conventions. The quality of alcohol and 
tobacco products available in Ireland is also controlled in line with Ireland’s 
international agreements and commitments.
Trade in illicit psychoactive substances is prohibited in Ireland: under the 
MDA, the importation, manufacture, trade in and possession, other than 
by prescription, of the scheduled substances are all criminal offences. In 
response to the emergence of head shops23 selling “legal highs”, the Criminal 
Justice (Psychoactive Substances) Act 2010 was enacted, making it a criminal 
offence to sell or supply substances which might not be specifically controlled 
under the MDA but which have psychoactive effects. As a consequence of 
prohibition, there are no measures controlling the quality of the substances 
traded in this illegal market or regulating the market itself. With regard to 
the legality or otherwise of harm-reduction measures, a review of Irish leg-
islation governing the production, possession and supply of controlled drugs 
found that methadone treatment by medical practitioners and pharmacists 
is provided for under the MDA but it is not permissible to legally operate a 
drug-consumption facility in Ireland (Moore et al. 2004). Given the residual 
uncertainty surrounding the legality of other harm-reduction measures, such 
as advice on safe drug use or needle exchange, organisations providing these 
types of service in Ireland have been advised to seek legal advice and to com-
municate and work co-operatively with local police personnel (Moore et al. 
2004; Kiely and Egan 2000). In Dublin needle exchange services are provided 
through HSE clinics and through voluntary sector providers. The HSE is in the 
process of rolling out a needle exchange service through community pharma-
cies at various locations outside Dublin to facilitate broad national coverage.
The markets in tobacco and alcohol in Ireland are controlled, increasingly 
strictly, under the Public Health (Tobacco) Acts 2002, 2004 and 2009, and 
the Intoxicating Liquor Acts 2000, 2003 and 2008. A key objective behind 
this growing body of legislation is to ensure that young people are neither 
exposed to nor able to have access to tobacco or alcohol products. The legal 
minimum age for purchasing tobacco and alcohol is 18 years.
By law, the advertising and display of tobacco products is prohibited on televi-
sion, in shops and around cigarette vending machines, and access to tobacco 
products in retail outlets and licensed premises is strictly controlled. Health 
warnings on tobacco products occupy 32% of the front of each packet and 
45% of the back. Legislation has recently been introduced in Ireland to pro-
vide for combined text and photo warnings on tobacco products. Given the 
23. A head shop sells goods related to illicit drugs or of interest to the drug culture.
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finding that tobacco price elasticity is comparatively high among low income 
groups and young people, pricing of tobacco products is used in Ireland as a 
policy tool to discourage people, including children, from purchasing tobacco; 
tax represents about 80% of the retail price of cigarettes. It is illegal to sell 
cigarettes in packs of less than 20, again to deter people, especially children, 
from buying them.
The alcohol market is not as tightly controlled. Legislation specifies the 
opening hours for licensed premises and off-licences, and prohibits a “happy 
hour”, a limited period in any day when alcohol is sold at reduced prices, but 
there is little control of alcohol marketing at point of sale, such as product 
promotions or placements in mixed retail outlets like supermarkets. By law, 
it is an offence to supply alcohol to a drunken person or to admit a drunken 
person to a bar.24 Moreover, children under the age of 18 are only allowed in 
licensed premises if they are with a parent or guardian, subject to certain time 
and other restrictions, and may not drink there;25 similarly, children may not 
enter an off-licence premisis unless accompanied by an adult.
Voluntary codes on alcohol advertising and sponsorship are negotiated 
between the Department of Health and representatives of the Irish alcohol 
and advertising industries. The codes aim to reduce the exposure of young 
people to alcohol advertising and marketing, and limit the volume and place-
ment of alcohol advertisements across all media in Ireland. The effectiveness 
of the codes in discouraging inappropriate consumption of alcohol has never 
been evaluated. The Department of Health is currently engaged in a review 
of the need for legislative measures in relation to alcohol advertising, promo-
tions and sponsorships.
Ireland has used pricing as a policy tool to reduce tobacco use, but not to cut 
alcohol intake.26 According to an EU report, in 2004 Ireland was one of six 
countries in the EU where alcohol had become 50% more affordable than 
eight years earlier, primarily because of increased disposable income in Ireland 
(Rabinovich et al. 2009). Furthermore, alcohol prices in Ireland have recently 
fallen while average prices have risen: according to the Central Statistics Office 
Consumer Price Index, average prices rose by 2.6% in the year to September 
2011, while alcohol prices fell by 1% in the same period. And finally, in 2010 
excise rates on alcohol in Ireland were cut by around 20% with a resulting 
rise in alcohol consumption, from 11.3 litres per capita in 2009 to 11.9 in 
2010. In the public debate ahead of the development of a National Substance 
Misuse Strategy, the policy option of a minimum price for alcohol products 
is being widely debated. It is argued that, as minimum pricing affects people 
directly in relation to how much they drink, it will primarily affect those 
24. Intoxicating Liquor Act 2003, s. 4.
25. Children may only drink alcohol in a private residence and only with the permission of 
their parents.
26. This paragraph uses information from Alcohol Action Ireland (2011). 
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who drink most, and also children and young people who tend to consume 
low-cost alcohol. The legality of minimum pricing under Irish law has yet to 
be established.
Regarding external costs, the prohibition of the market in illicit drugs led in 
the 1990s and 2000s to a surge in drug-related criminal activity. In response, 
successive Irish governments have enacted a large body of criminal justice 
legislation to tackle drug trafficking/smuggling and money laundering, giv-
ing powers to detain and interrogate suspects, to impose harsher sentencing 
for offences relating to possession of drugs for supply, to confiscate illegally-
acquired assets, to tackle organised crime and to combat drug dealing in 
communities and in prisons.27 The consequences of intoxication by alcohol 
and/or drugs are also addressed jointly in a range of laws dealing with public 
order, anti-social behaviour and dangerous driving.28
With regard to the public “bads” associated with tobacco, in line with the 
WHO Framework Convention on Tobacco Control, Ireland enacted legisla-
tion in 2005 to protect third parties, such as workers, from the ill-effects of 
exposure to second-hand smoke. Compliance with this legislation is reported 
to be as high as 95% across all sectors (Tobacco Control Unit 2010). At the 
same time, Europol recently reported that, on account of its comparatively 
high tax on tobacco, Ireland is becoming one of several preferred destinations 
for organised crime groups who are increasingly active in cigarette smuggling, 
which is seen as “an attractive alternative to drug smuggling because of the 
lower penalties and larger profits” (Europol 2011).
5.5. Strategies
What are the goals and aspirations, and the objectives of illicit drug, alcohol 
and tobacco policies?
Since 2001 Ireland’s strategic approach to the challenges of illicit drugs and 
tobacco has been set out in national strategy documents. They reflect the 
population-health aims and objectives set out in the national health strategy 
and population-health strategy, as described in section 5.1. In line with the 
previous eight-year national drugs strategy, the National Drugs Strategy 
2009-2016 has this over-arching strategic objective – “to continue to tackle 
the harm caused to individuals and society by the misuse of drugs through a 
concerted focus on the five pillars of supply reduction, prevention, treatment, 
rehabilitation and research” – and its strategic aims include a safer, healthier 
27. See, for example, Criminal Justice (Drug Trafficking) Act 1996; Criminal Assets Bureau Act 
1996; Europol Act 1997; Criminal Justice (Theft and Fraud Offences) Act 2000; Criminal Justice 
Acts 1999 (sections 4-6), 2006 and 2007.
28. See, for example, Road Traffic Act 1994; Criminal Justice (Public Order) Acts 1994 and 2002; 
Maritime Safety Act 2005; Safety, Health and Welfare at Work Act 2005; Railway Safety Act 
2005; Intoxicating Liquor Act 2008. 
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society, comprehensive treatment and rehabilitation services for individual 
problem drug users, and sound and relevant data on the extent and nature of 
problem substance use, to help inform future policy decisions (Joint Committee 
on Arts, Sport, Tourism, Community, Rural and Gaeltacht Affairs 2006).
Since 2000, Towards a Tobacco-free Society (Tobacco-Free Policy Review Group 
2000) has provided the basis for government policy on tackling the tobacco 
problem. The mission is to “promote a tobacco-free society” and four “key 
strategic objectives” seek to change attitudes, help people give up smoking, 
protect people from passive smoke and focus on children. 
With regard to alcohol, as already noted, the recommendations of the Steering 
Group of the “national substance misuse strategy” were presented to the 
Minister in February 2012, a consultation process will now commence with 
an action plan being presented to Government during 2012. It is expected to 
set out strategic aims and objectives for alcohol within a population health 
context.
5.6. Responses
Are interventions logically consistent and mutually supportive?
The National Drugs Strategy 2009-2016 contains operational objectives and 
63 actions, which are designed to ensure that the strategic objective and aims 
(noted in section 5.5) are met. The objectives and related actions align with 
the population-health approach already indicated by the overall strategic aims 
and objectives (see Table 2).
Table 2: Responses to drug-related problems: National Drugs Strategy 
2009-201629
Policy approach Operational objectives
Supply-reduction 
actions focus on tack-
ling and reducing 
community drug prob-
lems as well as closing 
down the market in 
illicit drugs
–  Significantly reduce the volume of illicit drugs available 
in Ireland
–  Prevent the emergence of new markets and the expansion 
of existing markets for illicit drugs
–  Disrupt the activities of organised criminal networks 
involved in the illicit drugs trade in Ireland and interna-
tionally, and undermine the structures supporting such 
networks
–  Target the income generated through illicit drug traffick-
ing and the wealth generated by individuals involved in 
the illicit drugs trade
–  Tackle and reduce community drug problems through a 
co-ordinated, inter-agency approach
29. Joint Committee on Arts, Sport, Tourism, Community, Rural and Gaeltacht Affairs (2006).
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Policy approach Operational objectives
Prevention actions 
focus on the general 
population and on 
communities at par-
ticular risk
–  Develop a greater understanding of the dangers of prob-
lem drug/alcohol use among the general population
–  Promote healthier lifestyle choices among society 
generally
–  Prioritise prevention interventions on those in communi-
ties who are at particular risk of problem drug/alcohol use
Treatment and reha-
bilitation are focused 
not only on medical 
interventions, but 
also on reintegration, 
including education, 
accommodation and 
employment measures
–  Develop a national integrated treatment and rehabili-
tation service that provides drug-free and harm-reduction 
approaches for problem substance users
–  Encourage problem substance users to engage with, and 
avail of, such services
Research aims to gen-
erate information that 
can inform policy and 
practice
–  Ensure the availability of data to accurately inform deci-
sions on initiatives to counteract problem substance use
–  Provide appropriate research to fulfil the information 
needs of government in formulating policies to address 
problem substance use
Building on the Towards a Tobacco-free Society strategy document, in February 
2010 Ireland’s Health Service Executive (HSE) published a Tobacco Control 
Framework to provide an evidence-based approach to its work in addressing 
tobacco-related harm within the population as a whole and in particularly 
vulnerable groups such as children, adolescents and those at the margins of 
society. The framework is modelled on the MPOWER package of evidence-
based tobacco-control policies promoted by the World Health Organization 
and the nine elements of the HSE’s Population Health Strategy (see Table 3, 
below).
The Tobacco Policy Review Group was established in 2010 with the following 
terms of reference: (i) to examine Irish and international evidence and experi-
ence of effective measures and programmes to reduce smoking prevalence; (ii) 
to arrange a workshop of relevant stakeholders to identify what additional 
measures are feasible to reduce smoking prevalence rates in Ireland; (iii) to 
make policy proposals to the Minister aimed at reducing smoking initiation 
and prevalence. The report will be published in 2012.
Following the publication of the recommendations of the Steering Group, a 
consultation process will commence with an action plan being presented to 
Government during 2012. This is also expected to be framed with a popula-
tion health context.
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Table 3: Responses to tobacco-related problems: HSE’s Tobacco Control 
Framework, 201030 
WHO MPOWER 
principles HSE Population Health Strategy – nine principles
Monitoring of tobacco 
use and prevention 
policies
Protecting people from 
second-hand smoke
Offering help to people 
who want to quit
Warning of the dan-
gers of tobacco
Enforcing bans on 
advertising, promotion 
and sponsorship
Raising taxes on 
tobacco
1. Addressing the wider determinants of health and tackling 
health inequalities
2. Planning for health and social well-being, not just health 
and social care services
3. Developing and employing reliable evidence to improve 
health and social care outcomes
4. Making choices for health investment
5. Measuring and demonstrating the return for investment 
in health and social care services
6. Shifting the balance from hospital to primary care and 
health promotion
7. Integrating services across the continuum of care
8. Proactively engaging and working with other sectors to 
improve health
9. Engaging the population on the issue of their own health
5.7. Structures and resources
To what extent does the organisation of structures and resourcing support 
the co-ordination and/or integration of drug, alcohol and tobacco policies?
In their empirical study of the extent to which drug and alcohol policies were 
integrated in various jurisdictions, van de Mheen and Barendregt found 
that Ireland was unique in having separate policies on illicit drugs, alcohol 
and tobacco and only loose co-ordination mechanisms supporting dialogue 
between government departments in relation to policy (Muscat et al. 2010).
The structures and resources supporting the development and implementa-
tion of Ireland’s tobacco policy are quite separate and distinct from those 
supporting illicit drugs and alcohol policies. Until 2011, the Office of Tobacco 
Control (OTC), a statutory body established under the 2002 Public Health 
(Tobacco) Act, had responsibility, on behalf of the responsible minister, for 
developing and implementing policies and objectives to control and regulate 
tobacco products. It also organised research and disseminated the results, co-
ordinated a national inspection programme and advised the minister on the 
manufacturing and marketing activities of the tobacco industry. 
As of 1 January 2011, the Office of Tobacco Control was dissolved and its staff 
and functions were transferred to a National Tobacco Control Office within 
the Health Service Executive. The National Tobacco Control Office continue 
30. HSE (2010), Tobacco Control Framework, www.hse.ie. Accessed on 24 November 2011. 
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to have all of the functions of the dissolved Office of Tobacco Control. Within 
the Department of Health the Tobacco Control Office responsi bilities include: 
maintaining appropriate arrangements and structures for the implementation 
of tobacco-control policy and legislation; drafting legislation to implement 
EU directives/decisions on tobacco; monitoring enforcement of legislation; 
working with the HSE to build compliance; and representing Ireland on 
tobacco-related EU and WHO groups. The HSE’s environmental health 
officers are responsible for enforcing, among other things, tobacco-control 
legislation, including the restriction of advertising and marketing of tobacco 
products, under-age sales and enforcing the prohibition of the smoking of 
tobacco products in certain places.
The current structures supporting the development and implementation of 
illicit drug policy were put in place on foot of recommendations contained in 
the mid-1990s reports of the ministerial task force on measures to reduce the 
demand for drugs (whose work is discussed above under 5.2. Problem con-
ceptualisation and 5.3. Policy context). A strong emphasis is placed on social 
partnership, providing for ongoing dialogue on social and economic issues 
between government and the trade union, employer and business, farming, 
community and voluntary sectors. Fourteen local drugs task forces (LDTFs)
have been established in areas experiencing the greatest level of problematic 
drug use, with representatives from government, statutory bodies, and vol-
untary and community organisations involved in service provision locally. 
These task forces ensure the development of co-ordinated and integrated 
responses to tackling the drugs problem. In 2004-5, 10 regional drugs task 
forces (RDTFs) were established, covering all the country not included in 
the LDTF areas. All these DTFs are funded by and report to the government 
department with responsibility for developing drug policy and co-ordinating 
implementation of the national drugs strategy. Every quarter, an Oversight 
Forum on Drugs, with representatives of all relevant government, statutory, 
voluntary and community bodies, meets to review progress and to address 
any bottlenecks.
Between 1997 and 2011, responsibility for drug policy and co-ordination lay 
with government departments that also had responsibility for local and/or 
community development. In March 2011, when the newly elected government 
abolished the Department for Community, Equality and Gaeltacht Affairs, 
responsibility for illicit drugs was transferred back to the Department of 
Health, which had had lead responsibility until the mid-1990s. This depart-
ment is now tasked with implementing both the national drugs strategy and 
the new substance-misuse strategy, which will include both drugs and alcohol.
The Department of Health has had continuous responsibility for alcohol 
policy. Although its health promotion unit developed the National Alcohol 
Strategy in 1996, this document lacked teeth and was largely ignored; sub-
sequently, the department preferred to develop alcohol policy via temporary 
56
Policy on psychoactive substances and beyond
groups – a strategic task force on alcohol, which reported in 2002 and 2004, 
and a government alcohol advisory group, which reported in 2008. Alcohol-
related services have tended to be provided in tandem with drug-related 
services; for example, educational activities in relation to prevention include 
illicit drugs, alcohol and tobacco, and treatment services provided by the 
Health Service Executive, and those funded through DTFs, address problems 
associated with both illicit drug and alcohol use.
That these ad hoc arrangements may not always have had beneficial results is 
suggested by the findings of an epidemiological study, which has found that 
while policy in Ireland on the treatment of alcohol disorders shifted from the 
disease to the public health model as long ago as the mid-1980s, change on 
the ground was slow and some of the main tenets of the disease model still 
remained in place in some regions as late as 2007 (Cullen 2011).
From 2005 onwards, calls increased for combining alcohol and drug strate-
gies in order to ensure that the structures and resources available for tackling 
the illicit drugs problem could also be applied to tackling the nation’s alcohol 
problem.31 It remains to be seen how structures and resources will be organised 
in the forthcoming national substance-misuse strategy.
5.8. Discussion
The foregoing assessment indicates that tobacco is the policy area most con-
sistently aligned with a population-based approach to health. Defined as a 
public health problem, and causing a substantial number of deaths, Ireland’s 
tobacco policy focuses on prevention, of both individual use and environmen-
tal exposure to tobacco smoke. Research and monitoring are also designed 
and undertaken to support effective prevention efforts.
A population-based health approach has also been used in planning responses 
to problematic illicit drug use. However, in view of the criminal activities, 
public disorder, anti-social behaviour and violence that may be associated 
with illicit drugs, criminal justice responses have also been adopted. While 
these responses may achieve the desired criminal justice outcomes, such as a 
lower incidence of violent crime or safer communities, they may also serve 
to undermine the population-health ethos by criminalising and/or stigmatis-
ing problem drug users. The authors of a study of the impact of the Criminal 
Justice (Psychoactive Substances) Act 2010, introduced to target the prolif-
eration of head shops in Ireland, argue that while the Act may have resulted 
in “effective cross-cutting activity between the health and criminal justice 
sectors”, it has also had a deleterious effect on efforts to reduce the harms 
associated with illicit drug use (Ryall and Butler 2011).
31. Steering Group (2005); and Joint Committee on Arts, Sport, Tourism, Community, Rural and 
Gaeltacht Affairs (2006). For a full account of the issues associated with policy co-ordination, 
see Pike (2008), Ch. 4.
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With regard to alcohol policy, there has been considerable ambivalence. With 
no overall strategy to guide decisions, responses have included self-regulation, 
licensing and criminal justice responses. Moreover, implementation has been 
inconsistent. Authors of a recent study on alcohol-related violence in Ireland 
reported research showing a decline in the number of cases taken under the 
liquor licensing laws and an increase in the number of public order offences, 
suggesting a preference for controls in the public arena (street) rather than 
in the drinking environment (Hope and Mongan 2011).
This lack of coherence among policies on various psychoactive substances, in 
relation to an over-arching population-health objective, may be expected to 
have adverse effects in terms of realising “a complete state of physical, men-
tal and social well-being and not merely the absence of disease or infirmity” 
among the Irish population, as different measures undermine or cancel the 
effects of other initiatives.
One reason for this lack of coherence may be the different international 
conventions, charters, frameworks and directives to which Ireland is a party, 
which favour different approaches to achieving different outcomes. One 
means of tackling this source of incoherence is to challenge the conflicting 
approaches at the international level.
For example, in 2011, in order to support UNAIDS’ strategic target of “zero 
new infections, zero AIDS-related deaths and zero discrimination”, the UN’s 
Commission on Narcotic Drugs (CND) adopted a resolution supporting this 
target among injecting and other drug users. Addressing the CND session, 
a representative of UNAIDS explained why greater coherence between dif-
ferent policy domains was the way to go forward. Some of these reasons are 
outlined below.
Effective HIV responses among drug users can be quickly undone by counter-
productive policing or criminal procedures. For example, if drug users face 
criminal penalties because they are carrying a clean needle, then needle and 
syringe programmes are rapidly undermined. Programmes which have care-
fully and over years built up trust among drug users, and which may be able 
to reduce problematic drug use and avoid HIV and related health threats, can 
be devastated within weeks if legal or policing authorities demand names 
and addresses of clients with a view to prosecuting them. All too often, drug 
control and AIDS authorities seem to inhabit different worlds. UNAIDS 
mechanisms for a joint country programme of work at national level create 
a common UN system platform for joint action. The UNAIDS family looks 
to the United Nations Office on Drugs and Crime (UNODC) to ensure that 
this platform is also able to translate into effective support for co-ordinated, 
mutually supportive national programmes addressing drug users and the 
threat of HIV (Bartos 2011).
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Policy researchers have also begun to explore approaches at national level that 
can bypass the negative impacts of the law-enforcement approach on public 
health objectives. Thus, while complying with the abstentionist approach 
of the UN drug conventions and operating within a legislative framework 
that respects these international commitments, policy makers might prefer 
to design and implement policy initiatives that emphasise harm reduction, 
rather than a coercive law-enforcement response (MacCoun and Reuter 2001; 
Kleiman et al. 2011). Alternatively, policy makers might shift the goalposts: 
for example, in place of a legislative framework to address the drugs problem, 
they might adopt a pyramid of regulatory interventions, from “persuasion” at 
the base to “licence revocation” at the top (Seddon 2011), or drug policy might 
be placed within the context of a country’s equality policy, on the grounds that 
the distribution of drug-related harm is determined as much by how welfare 
policy distributes risks and benefits, as by the degree of “strictness” of drug 
policy (Stevens 2011).
The review of strategies and responses in sections 5.5 and 5.6 indicated a high 
level of coherence between illicit drug and tobacco policies in relation to the 
overall population-health objective, and the forthcoming national substance-
misuse strategy, incorporating policies for alcohol and illicit drugs, is expected 
similarly to reflect a population-health ethos and approach. However, Section 
5.7 revealed tensions at the level of structures and resources, especially in the 
co-ordination of efforts, differing expectations at national and local level and 
between statutory and voluntary, and the allocation of resources.
On a theoretical level, having compared US and Canadian institutions engaged 
in developing and implementing North American drug policy, and finding 
that the institutional dynamics of state structure, administrative capacity 
and policy legacies shaped the policy choices available within a polity, Benoit 
argued that these dynamics are a more useful means of explaining policy 
changes than a narrow focus on social control (Benoit 2003). Similarly, Seddon 
proposed that governance structures could be used as a way of mapping the 
distribution of power within a drug policy system and thereby gaining an 
understanding of its dynamics (Seddon 2011).
An empirical study at EU level demonstrated how allocation of responsi-
bilities can significantly influence the shape of policy (Elvins 2003). Elvins 
described how law-enforcement agencies across the EU, including Ireland, 
led the development of EU-level illicit drug policy, and how, as a result, drug 
policy has developed on the basis of notions of “protection”, and anti-drugs 
trafficking policies have converged across all member states, while harm-
reduction strategies have been left to the discretion of individual states. The 
outcome, according to the author, is a much more heterogeneous range of 
harm-reduction policies in different countries, as opposed to the increased 
similarity of anti-drug trafficking policies across the EU.
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In Ireland, the need to achieve a balance between competing departments was 
recognised as long ago as 2000, when the Review Group that drafted the first 
national drugs strategy explained why it was recommending that responsibil-
ity for co-ordination of the strategy should be left with a small government 
department rather than with the Department of Health and Children: “in the 
case of the Department of Health and Children – as it is a service provider – if 
it were to be accorded overall responsibility, its ability to drive issues surround-
ing supply control and education and awareness issues would be limited. The 
Department of Tourism, Sport and Recreation can, however, be objective in 
relation to all the thematic areas covered by the national policy.”32
Discussion of structures and resourcing brings the discussion full circle, to 
the conceptualisation of the policy problem, and, in particular, to the ques-
tion of how different stakeholder groups conceive and shape the definition 
of the problem. With regard to alcohol policy, the authors of a recent study 
on alcohol-related violence in Ireland posed the question fairly and squarely: 
“Will the cultural ambivalence in Ireland towards alcohol and its problems be 
changed? Will political leadership lead the change with an integrated alcohol 
strategy, and will communities take action to make their communities a safer 
place? Only time will tell. To adapt a well-known phrase in Ireland, alcohol’s 
problems haven’t gone away, you know”. (Hope and Mongan 2011).
It has been beyond the scope of this chapter to explore the historical develop-
ment of policy positions in Ireland. However, the importance of the historical 
perspective, and the potential for rapid change, are demonstrated by look-
ing at the changes in 2011 alone – the Office of the Minister for Drugs has 
been abolished and its functions absorbed into the Department of Health; 
the statutorily-based Office of Tobacco Control has been dissolved and its 
functions taken over by the Health Service Executive. How these changes 
will affect the conceptualisation of the problems associated with the three 
categories of psychoactive substances is difficult to predict, but change it 
they will.
5.9. Conclusions
This assessment has been selective, choosing certain items of evidence princi-
pally because they illustrate how the various indicators (or perspectives) can 
highlight matters relevant to thinking about the degree of coherency between 
policies. This approach is justified on the assumption that assessing policy 
coherence is not a means for measuring policies – for example, against an 
external benchmark such as an over-arching health objective – which would 
require rigour to ensure accuracy and comprehensiveness, but is rather a tool 
to facilitate discussion on how to strengthen the impact of policies relating to 
misuse of psychoactive substances.
32. Department of Tourism, Sport and Recreation (2001), paragraph 6.6.2.
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In line with the framework of possible objectives and related action areas 
outlined in Chapter 2, the following measures might be proposed to help make 
the different policies more coherent:
 − eliminate policy inconsistencies, for example ensure that coercive drug 
policies do not cancel out the benefits of harm-reduction measures; or 
ensure that taxes to disincentivise the purchase of legal psychoactive 
substances does not inadvertently incentivise participation in black 
markets in those substances;
 − identify opportunities for policy enhancement, for example seek wide-
spread acceptance of a “whole population” approach to reducing consump-
tion of various substances, rather than targeting problem or under-age 
users; design organisational structures and co-ordination and integration 
mechanisms in order to ensure a balanced approach to the over-arching 
population-health objective; or use research-based evidence to tackle the 
use of substances from the different categories, for example reducing the 
incidence of polydrug use involving both illicit drugs and alcohol;
 − develop mitigation policies to overcome the adverse effects of non-psycho-
active-substances policies, for example consider alternative regulatory or 
governance arrangements; set policies on psychoactive substances within 
a broader policy context such as equality or social inclusion; or review 
strategies in areas such as mental health, suicide prevention, education, 
training, employment and housing, to ensure they do not undermine 
policy initiatives in the psychoactive substances policy area;
 − ensure consistency in advocacy, for example use the national voice at 
international forums to put forward arguments and policy options which 
may help to resolve the contradictions between agreements at interna-
tional level which have an adverse impact on a health-related outcomes.
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6.  The evolution of an integrated and coherent 
policy on drugs and alcohol in Israel
Yossi Harel-Fisch 
Israel Anti-Drug Authority, Jerusalem
6.1. Background
The Israel Anti-Drug Authority (IADA), a statutory government agency set 
up in 1988, is the central body in Israel charged with leading the struggle 
against the plague of drugs and alcohol.
The vision of IADA is to lead the State of Israel in its efforts to fight the 
plague of drugs and the adverse consequences of alcohol abuse, and to ensure 
a healthy and ethical society in order to promote welfare and a high standard 
of living for its citizens.
The establishment of IADA was the culmination of a long process that began 
in the late 1970s, a consequence of the rising number of drug addicts lacking 
adequate care and demanding solutions to their problems. Until then, drug 
control efforts were sporadic and unco-ordinated. Not enough treatment facili-
ties were available. Different ministries and non-governmental organisations 
(NGOs) attempted to offer solutions to the best of their abilities, but there 
was a lack of co-ordination among the various organisations involved, as well 
as a lack of adequate and secured funding.
It became obvious that there was an immediate need to implement a uni-
form national policy to provide a co-ordinated, balanced approach to pre-
vention, training, treatment, rehabilitation and adequate law enforcement. 
Consequently, an inter-ministerial committee drafted the Israel Drug Control 
Authority Law 5748 in 1988. The law was approved by Parliament, leading to 
the establishment of the IADA in December of 1988. In addition to addressing 
internal needs, the creation of IADA was part of Israel’s efforts to comply with 
Article 6 of the 1971 UN Convention on Psychotropic Substances, which calls 
for a national anti-drug authority. Israel is signatory to all three international 
UN drug conventions (1961, 1971, 1988).
Because of the complex, multi-faceted nature of the drug problem, which 
touches on many areas and demands the involvement of various govern-
ment agencies, the Prime Minister of Israel is the minister responsible for 
implementing the Drug Control Authority Law. However, in 2009, Parliament 
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approved the government’s decision to grant the Minister for Internal Security 
responsibility over the IADA.
Between 2000 and 2010, there was an alarming increase in alcohol problem 
drinking among adolescent and young-adult populations in Israel. Concerned 
with this trend, the government decided, in 2005, to extend IADA’s mandate to 
include alcohol abuse. The comprehensive approach to drug prevention, treat-
ment and law enforcement was expanded to include alcohol abuse. National 
surveys, such as the Health Behaviour in School-aged Children (HBSC) and 
the national epidemiology survey on drugs and alcohol, have shown that drug 
use in Israel has remained relatively low and fairly stable among youth and 
young adults in recent years, placing Israel very low compared to most coun-
tries in Europe and North America. The fact that IADA was charged with 
combating alcohol abuse meant it could apply its successful experience from 
the field of drugs to the war against alcohol abuse, in an attempt to contain 
the rising trend.
Under IADA’s umbrella, professionals in government and non-governmental 
agencies work together to rid Israel of the plague of drugs and alcohol. This 
inter-ministerial and inter-institutional co-operation and co-ordination in pre-
vention, treatment and law enforcement enables IADA to fulfil its main duty, 
as defined by law: “to formulate all national supply- and demand-reduction 
policies on drugs and alcohol abuse”.
For example, the policy and goals related to the prevention of drugs and alco-
hol use among youth and young adults are carried out collaboratively by a 
coalition of partners that include the ministries of education, health, welfare 
and internal security, and are implemented throughout the formal education 
system and local municipalities in a integrated and co-ordinated effort using 
intervention strategies and programmes developed collaboratively. By doing 
so we can ensure the ongoing implementation of an integrated and coherent 
intervention strategy across the country.
In addition, IADA is charged with:
 − initiating and developing educational and prevention programmes 
nationwide;
 − promoting public awareness materials, organising communal awareness 
and leading community work in order to create a social climate which 
rejects substance use;
 − treating and rehabilitating victims of substance abuse, and their families;
 − supervising all areas related to law enforcement, and all institutions’ 
roles in this area;
 − implementing monitoring and research systems to ensure that policy and 
intervention strategies are evidence-based and evaluated;
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 − recruiting and training qualified professionals and volunteers to lead the 
war on drugs from the bottom up;
 − providing national informational services in many formats, through many 
vehicles and across the spectrum of Israeli society;
 − developing and maintaining contact with national and international 
bodies active in matters of drug abuse.
6.2. National alcohol strategy
The national alcohol strategy seeks to cover all areas related to the excessive 
use of alcohol, paying particular attention to youth and young adults, focusing 
on areas of prevention, awareness and change in youth culture. Nevertheless, 
it is a comprehensive strategy that takes into account the four pillars: preven-
tion, treatment, law enforcement and harm reduction.
Mediators, such as parents, teachers, mentors, social workers, doctors and 
counsellors, play a key role in the prevention and treatment of alcohol abuse 
among youth. In view of this, special attention is given to interventions 
and training aimed at providing significant adults with tools to enable more 
effective mentoring to facilitate effective prevention interactions with youth.
The main aim of the strategy is to significantly decrease the excessive con-
sumption and abuse of alcohol, reducing the physical and mental health out-
comes of alcohol use, influencing the social well-being of youth by influencing 
a youth culture that will be free of alcohol (and drugs) and addressing other 
social and economic hazards to society related to alcohol use.
The recommendations by the World Health Organization (WHO) and the 
target areas put forward in the: “Strategies to reduce the harmful use of alco-
hol: global strategy” were easily incorporated and adapted into the parallel 
key target area of Israel’s national strategy, owing to the high degree of cor-
respondence between these two strategies. The key target areas of the national 
strategy are: (1) leadership and awareness; (2) health services’ response; 
(3) community action; (4) drinking and driving; (5) law enforcement and 
legislation; (6) reducing the negative consequences of drinking and alcohol 
intoxication among youth; (7) protection of high-risk groups; (8) development 
of professional human resources; (9) research, monitoring and evaluation.
6.3. Evaluation of the national alcohol strategy
An evaluation study of the national alcohol strategy is planned for the begin-
ning of 2012. Among other things, this will map out current programmes 
and activities, rates of alcohol use in municipalities where the programme is 
being implemented, the extent of exposure to the awareness campaign and 
the efficacy of developments in law enforcement and legislation.
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6.4. Demand reduction
Israel devotes much effort to implementing a comprehensive demand-reduc-
tion strategy. Co-ordinated by the IADA (in co-operation with relevant min-
istries such as health, education, social affairs and social services and other 
governmental agencies and NGOs), evidence-based prevention and treatment 
programmes are implemented throughout the country, targeting the general 
and at-risk populations. IADA also addresses addiction as a chronic health 
disorder, and aims to provide adequate and accessible treatment and rehabili-
tation solutions to all drug and alcohol abuse victims.
A well co-ordinated and integrated infrastructure allows us to provide a 
continuum of prevention and treatment services to drug-abuse victims and 
their families. The comprehensive system of pharmacological and psycho-
social interventions provides a wide array of treatment solutions addressing 
the different needs of individuals based on gender, age, and cultural and 
religious background, in order to ensure accessibility to all. Addicts and 
substance abusers who seek treatment are referred to the type of programme 
which they will be most compatible with, based on personality, cultural 
considerations, substance abuse situation and prior treatment experiences. 
Among the solutions are physical detoxification, therapeutic communities, 
day-care centres, individual and group treatment sessions, family interven-
tion and rehabilitation, which includes legal counselling, help with housing 
and studies, vocational rehabilitation and follow-up counselling. Facilities 
for women patients have all women staffs and a treatment centre for moth-
ers with children. A special treatment centre addresses the needs of young 
adults, particularly those returning from backpacking excursions, suffering 
from mental imbalance from hallucinogenic or mind-altering drugs. The vil-
lage is internationally recognised as a unique centre specifically dedicated to 
the recovery and rehabilitation of non-addict young people.
Seeking to minimise the adverse consequences of drug abuse for society at 
large, Israel also developed a harm-reduction approach to reduce illicit drug 
use, beginning with methadone-substitution programmes in 1975. Today, 
other drug substitutes are available for addicts who are unable to undergo 
complete drug detoxification, affording these individuals a chance to lead 
normative lives. As part of this approach, needle-exchange programmes are 
available in several locations and walk-in clinics assist addicts with rapid 
admission into treatment programmes. These efforts have led to a significant 
decrease in the number of cases where individuals contract HIV/AIDS due 
to drug use. Special attention is given to drug-abuse victims suffering from 
co-morbidity. Treatment is offered as an alternative to incarceration, and in 
prison settings.
In co-operation with the Ministry of Education, IADA is involved in devel-
oping and evaluating a host of comprehensive school-based health education 
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programmes aimed at preventing alcohol and drug use. These programmes 
are age- and culture-specific and focus on children from kindergarten to 
12th grade. In addition to health education programmes aimed at all school-
children, there are specific programmes for schoolchildren identified as being 
at risk. They are usually followed up after school in the community in an inte-
grated manner. All new programmes undergo evaluation. The psycho logical 
counselling services of the Ministry for Education ensure comprehensive 
and integrated implementation of school-based programmes throughout the 
country.
A new national strategy being implemented by IADA is aimed at students in 
colleges and universities across the country. In co-operation with the academic 
leaders of higher education institutions, IADA is training and funding the 
activity of campus co-ordinators, who help to organise implementation of a 
host of awareness campaigns, peer education programmes and other drugs 
and alcohol prevention activities on campus. We believe that more than just 
reducing rates of substance use by college students is at stake here; this target 
population is important because they are future decision makers and can have 
an impact on the development of population attitudes and social norms that 
do not tolerate substance abuse.
Community action is an essential part of our strategy, and the national policy 
is implemented and adapted to the needs and requirements of individual 
municipalities at the local level. The community action framework is a multi-
disciplinary and integral structure that offers local responses in the areas of 
education, prevention and awareness; treatment and rehabilitation; and law 
enforcement. Action is led by IADA local co-ordinators, who are trained and 
skilled individuals in charge of bringing together all drug-related issues and 
social initiatives in the municipality, integrating activities carried out at the 
community level with regional and national action.
In 100 out of 250 municipalities, voluntary parent patrols are active at week-
ends, visiting local pubs and youth hang-out settings, engaging teens in con-
versation and offering advice and help, such as a ride home. Workshops and 
seminars on prevention of substance use and abuse are offered to parents, 
youth instructors and community leaders. Special programmes are aimed at 
engaging parents and youth, in order to enhance communication between 
parents and their children.
Other volunteers, particularly students of education, undergo special train-
ing at IADA and are active in school vacations at popular hang-outs, outdoor 
events and concerts, offering youth a listening ear, advice and assistance 
when needed.
The IADA community and prevention divisions, and the IADA local author-
ity co-ordinators who manage implementation of local drugs and alcohol 
policy and programmes, work closely with representatives of local education, 
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health and welfare professionals, the police and other organisations to ensure 
a well-integrated and coherent local strategy. For example, the Ministry for 
Internal Security has put into action a national strategy named Violence-Free 
Cities, but this programme is also implemented in municipalities across the 
country using local co- ordinators. The close proximity between the problems 
of alcohol and drugs, and the causes and consequences of youth violence, for 
example, points to a vital need to develop and implement an integrated strategy 
in each municipality so that the target population is exposed to a coherent 
and consistent set of messages and activities. This is achieved by structuring 
close collaboration between the two programmes at both national and local 
level, thus increasing the synergy between the policy and programmes being 
implemented.
6.5. Law enforcement
Even though it is not in itself a law-enforcement body like the police or DEA, 
IADA is by law the body responsible for co-ordinating effective collabora-
tion between the various law-enforcement bodies in Israel: the Ministry for 
Public Security (responsible for the Israel National Police and Israel Prison 
Services); the Israel Defence Force Police; the National Anti-Drug Money 
Laundering Unit (which belongs to the Israel Tax Authority); Ministry of 
Finance; Ministry of Justice and other ministries and law-enforcement  bodies 
in the community.
6.6. International co-operation
Israel takes an integral part in international efforts to combat the global plague 
of drugs. In recent years, delegations have visited a number of countries, 
establishing solid platforms for bilateral and multilateral co-operation and 
mutual learning. IADA has been honoured to host foreign delegations and 
experts who came to Israel to learn and share best practice and experiences in 
the field. IADA works closely with MASHAV – the Centre for International 
Co-operation of the Israeli Ministry for Foreign Affairs, organising courses 
for participants from developing countries around the world in Israel, and 
on-the-spot, short-term courses, given in the participants’ home countries.
On the multilateral front, Israel has strong working relations with interna-
tional organisations working to fight substance abuse, among them the UN 
Office for Drugs and Crime (UNODC), the International Narcotics Board 
(INCB) and WHO. Co-operation with European bodies, such as the Council 
of Europe and the European Union, has also risen to a new level, in particular 
collaboration with the Pompidou Group and the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA).
At a regional level, co-operation between neighbouring countries is essential to 
control the flow of illicit drugs and crime. A Memorandum of Understanding 
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agreed upon by Israel and the Palestinian Authority in Cairo in 2005 paved the 
way for information exchange on reducing drug demand and supply. Mutual 
study visits also took place with our Jordanian counterpart.
6.7. Measurement
The Office of the Chief Scientist at the IADA is responsible for the develop-
ment, implementation, dissemination and use of scientifically sound research 
and monitoring systems that provide comprehensive and coherent information 
to enable evidence-based policy and intervention strategies in the fight against 
drugs and alcohol. To do so, IADA implements a host of research systems. 
Those include national epidemiology surveys, monitoring systems, compre-
hensive and targeted evaluation studies and an extramural funded research 
programme supporting academic scientific studies ranging from laboratory 
experiments to psycho-social determinants research.
Ongoing national surveys include WHO-HBSC (ages 11-18), the Israeli 
Defence Forces (IDF) drug and alcohol survey (ages 18-21), the national 
epidemiology survey on drugs and alcohol (ages 18-60) and a finger-on-the-
pulse Internet survey that provides ad hoc information on a sample of about 
1 500 respondents ages 12-40 every three months. In addition, IADA is plan-
ning to conduct the ESPAD survey (ages 11-18) in 2012, thus having ESPAD 
and HBSC alternate every two years.
Since 1994, Israel has been collecting drug and alcohol information on rep-
resentative samples of school children aged 11-18, as part of the WHO-HBSC 
cross-national survey. In addition, IADA conducts periodical national epide-
miological surveys on the age groups 12-18 and 19-40.
The HBSC survey is funded jointly by the ministries of education and health, 
and IADA. The HBSC findings include complete information on smoking 
(cigarettes and nargila “water-pipes”), alcohol, drugs and related behaviours 
such as involvement in youth violence or truancy. It also includes an array 
of information on psycho-social determinants of risk behaviours covering 
most social settings such as home, community, school, peer group and the 
Internet. The comprehensive nature of the survey, and the way the findings 
are disseminated, contribute to an ongoing synergy between all government 
agencies involved in policy and programmes related to youth smoking, alcohol, 
drugs and violent behaviours.
The most recent data are from the 2011 HBSC survey. After 15 years in which 
the trend was an increase in alcohol problematic drinking, in 2011, for the 
first time, the data show declining rates (compared to 2007) of binge drink-
ing and getting drunk – especially in the younger age group of 11-13. This 
is a good sign, since for the past two years most intervention efforts in the 
educational system countrywide have focused on the 5th-9th grades (ages 
9-14). Learning from this success, we have extended the focus to include 
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older youth, a focus that will probably be reflected in the findings of the next 
survey in two years’ time.
Despite the increase in alcohol problematic drinking in Israel during the past 
decade, Israel is still ranked among the countries with the lowest rates of 
drinking problems among the 47 HBSC countries.
IADA’s national epidemiology survey, representing the different sectors in 
Israeli society, was last conducted in 2009, but is planned again for 2012. 
The younger age group in the survey included 7 700 students (ages 12-18) in 
175 schools around the country. About half of the students reported consum-
ing alcohol. These figures are similar to the previous survey (2005), but there 
was an increased intake of alcoholic spirits, compared to the previous survey 
(in the last year, month and week). About 30% of respondents reported they 
got drunk at least once in the past year. About 10.7% of students reported 
using an illegal drug of some kind; rates were similar to those of the previous 
survey. However, about 5.7% had used cannabis in the previous 30 days, 
an increase compared to previous surveys. The 2011 HBSC findings show a 
continued increase in cannabis use among schoolchildren, parallel to a drop 
in youth perceptions regarding the level of danger its use can cause.
Among the adult population (18-40), 11.4% reported using some kind of illegal 
substance, 8.9% reported using cannabis and 1.91% reported using “other 
drugs”. In general, the findings were similar to the previous survey. Even so, 
there was a decrease in drinking wine (other than for religious ceremonies) 
and a minor increase in the rate of drinking beer. In addition, there was a 
minor increase in the number of people who reported getting drunk.
Since its beginning, IADA has striven to implement evidence- and science-
based policy and intervention strategies. It recognises the importance of 
research as a means to achieving this end, and promotes national research in 
all areas related to drugs and alcohol.
As part of our collaboration with the EMCDDA in Europe, IADA has recently 
embarked on the development of the Israeli Monitoring Centre for Drugs and 
Alcohol. This has involved mobilising representatives from over 20 govern-
mental agencies to co-operate in providing information on the drug-related 
data they obtain and developing a structured mechanism to pool these data, 
together with a national observatory, which will be used by all agencies. This 
will provide a broad and updated picture on all aspects of drug and alcohol 
demand, supply and treatment across the country. We hope to produce the 
first national indicators to be sent for inclusion in the international European 
EMCDDA during the first half of 2012.
In sum, over the past couple of decades, the IADA has been developing, co-
ordinating and leading the implementation of an integrated national policy 
and intervention strategy aimed at the reduction of drugs and alcohol use 
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and their consequences. These policies and programmes are orchestrated 
on a national level in collaboration with all relevant ministries and national 
agencies, and on the local level, in close synergy and co-operation with local 
leadership and all relevant municipality agencies and organisations. This 
integrated approach uses round-table steering committees, both nationally 
and locally, to oversee activities and ensure a well-integrated and coherent 
implementation of policy and strategies aimed at reducing the drugs and 
alcohol problem in Israel.
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7.  Some contextual aspects of Dutch policy  
on psychoactive substances Netherlands
Cas Barendregt and Dike van de Mheen 
Addiction Research Institute, Rotterdam
The Netherlands has separate policies on alcohol, tobacco and drugs: they 
are based on different laws and there is no policy document that includes all 
psychoactive substances and addictive behaviours. Unlike most EU countries, 
the Netherlands has not developed a comprehensive “national drug strategy” 
and a subsequent “action plan”. The latest comprehensive national drug policy 
document was issued in 1995 (Ministerie van Volksgezondheid Welzijn en 
Sport 1995). With respect to health-related issues, the co-ordination of these 
different policies is executed by one ministry, namely the Ministry of Health, 
Welfare and Sport. The ministries of justice and internal affairs and security 
focus on the public order aspects of psychoactive substances.
The fact that substance policy in the Netherlands is not integrated does 
not necessarily imply that it is incoherent. Coherence means that policy 
actions mutually reinforce one another, or at least are not counteractive.33 
One problem with the term “coherent” is that proponents of a certain policy 
option will support this option by invoking arguments that make the option 
coherent. Parties that challenge a certain policy option will do so by trying 
to demonstrate that the prevailing policy is incoherent. In other words, it is 
virtually impossible to make any statements about coherence without taking 
a (normative) position. In the context of the Council of Europe, health and 
human rights are important values from which norms regarding substance 
policies may be derived. Nevertheless, in the arena of politics, shared values 
may still lead to other political standpoints and, thus, other ideas on what a 
coherent policy entails.
In this chapter we highlight some aspects of coherence within and between 
substance policies in the Netherlands.
The Netherlands borders on the North Sea in the west, Germany in the east 
and Belgium in the south. The rivers Rhine and Maas debouch into the North 
Sea, forming the Dutch delta and historically important trade routes to the 
hinterland. The fact that part of the Netherlands is a delta, and that a large part 
of the country is below sea level gave rise to the popular idea that the Dutch 
33. See www.oecd.org/about/0,3347,en_2649_18532957_1_1_1_1_1,00.html (accessed 
8 October 2011).
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are a pragmatic people. Since dikes had to be built to protect land from flood-
ing, people had to overcome their religious disagreements and collaborate to 
protect themselves. Historically speaking this might be too simple a view, yet 
people tend to cling to this idea. Pragmatism rules over dogmatism. Analogous 
to this is our self-image that the Netherlands is a country of tradespeople and 
reverends, based on the observation that, from the 17th century to the present, 
decisions of national significance have been a trade-off between (Calvinistic) 
principles and the interests of trade. Principles and pragmatism go hand in 
hand (Min. BZK 2010).
In 2009 the ministry of health commissioned a report from the National 
Institute for Public Health and the Environment on the harmfulness of 
psychoactive substances. In this report, the harmfulness of a substance was 
assessed on toxicology (short- and long-term), individual harm and social 
harm. Evaluation of harmfulness was deliberately asked for as an aid to 
evaluating Dutch drug policy on a rational basis (Amsterdam et al. 2009). 
If we were to match prevailing policies with the ranking of drugs based on 
harmfulness, the level of incoherence would be striking, especially if we 
compare one substance with another. This implies that current policies on 
substances are not based on the rationale of harmfulness alone, but also on 
other norms, interests and traditions.
7.1. Illegal drugs
To get an idea of how in the Netherlands illegal drugs are conceptualised, we 
could have a look at prevailing policies. However, policy documents often lack 
explicit statements on how the phenomena are viewed. It is only by justifica-
tions and other indirect statements on closely related issues that we can see 
how the substances are seen. It goes without saying that, in a domain like the 
drug field, policies do not go un-debated. Conceptualisation or framing of the 
subject is constantly at stake in a politicised debate.
7.2. Dutch policy on illegal drugs
In the case of illegal drugs, international treaties limit the latitude of govern-
ments to develop national policies. The three main international treaties on 
illegal drugs are the UN Single Convention on Narcotic Drugs, 1961; the 
UN Convention on Psychotropic Substances, 1971; and the UN Convention 
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. 
The Dutch Government has made a reservation to the 1988 treaty concern-
ing enforcement of the law that penalises psychoactive substances (Article 3, 
paragraph 6). The Opium Act of 1976 makes a distinction between cannabis 
and other drugs, in that the possession of small quantities of cannabis is con-
sidered as a minor offence. The reservation to the 1971 treaty expresses this 
distinction in the national legislation, and led the way to further development 
77
Netherlands
of the appeasement policy on the use and sale of cannabis, ultimately resulting 
in the coffee-shop system.
The legislative rationale behind the distinction between drugs with an “unac-
ceptable risk” and drugs with a “less serious” risk rests upon a notion of public 
health. So if we speak about the conceptualisation of illegal drugs, possible 
health consequences are part of the concept. On the other hand, illegal drugs, 
by definition, include aspects of criminal law, and thus also policies and prac-
tices in this domain have developed.
In 2009 the Trimbos Institute issued a brochure on Dutch drug policy. Its 
key messages are that drugs are illegal; drug use is not punishable; the law 
distinguishes between soft and hard drugs for reasons of different health risks; 
that coffee shops are tolerated because of public health; and that information 
and prevention are an essential part of public health policy that mainly focuses 
on young people. This brochure (Gouwe 2009) can be found on the website 
of the ministry of health (March 2011).
In 2009 the last-year prevalence34 of cannabis use among the general popu-
lation (ages 15-64) was 7%. Among schoolchildren aged 12-16, last-year 
prevalence of cannabis use was 9.3%. An increase was observed in the 
number of cannabis users that applied for treatment. Last-year prevalence of 
cocaine use among the general population (ages 15-64) was 1.2%. In 2007 the 
prevalence of last-month cocaine use among schoolchildren aged 12-18 was 
0.8%. Prevalence of opioid use is low among both the general population and 
schoolchildren. It is estimated that 1.6 persons per thousand inhabitants can 
be defined as problematic opioid users (2008). A relatively new trend is the 
use of gamma hydroxbutyrate (GHB). In 2009 the lifetime prevalence among 
the general population was 1.3%. It was highest among visitors to national 
and regional rave parties.
Over the past few years the Dutch Government has taken action to evalu-
ate and update its drug policy. In 2008 an extensive policy evaluation was 
co-ordinated by WODC35 and the Trimbos Institute36 (Van Laar et al. 2009), 
and in 2009 the government installed an Advisory Committee in Drugs Policy 
that “diagnosed” the situation and made recommendations for improvement 
(Donk et al. 2009). The committee underlined the successes achieved and 
critically examined the negative side effects of drug policy, notably cannabis 
policy. The execution of policy on substances like heroin and cocaine was not 
criticised by this committee.
The Ministry of Health set up the Co-ordination point Assessment and 
Monitoring new drugs (CAM) in 2000. Its task is to do risk assessments 
34. The prevalence figures in this paragraph are based on the National Drug Monitor 2010 (Van 
Laar 2011).
35. WODC: Scientific Bureau of the Ministry of Justice.
36. Trimbos Institute: a centre of expertise on mental health and addiction.
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(Amsterdam et al. 2004) of new drugs and inform the minister for health. 
CAM is a partner in the European early warning system for new psychoactive 
substances. Since then, assessments have been made on various substances, 
among them cannabis (2008), ketamine (2001), mushrooms containing psy-
clocine and psylocibine (2000, 2007) and GHB (1999, 2011).
7.2.1. Heroin and crack cocaine
Policy on hard drugs has been mainly focused on heroin and crack cocaine, 
as substances that have the most damaging effect on the user, their social 
network and society (Amsterdam et al. 2009). In the mid-1980s the threat of 
AIDS sparked the innovation of harm-reduction policy related to injecting 
drug use. In the same decade, crack cocaine made its appearance on the hard 
drug scene and its use became associated with marginalisation and public 
nuisance (Coumans 2005). In 1995 the government issued an action plan 
that explicitly included the fight against drug-related nuisance (Ministerie 
van Volksgezondheid Welzijn en Sport 1995).
Until the first years of the new century, the use of heroin and crack cocaine 
was the topic that ruled the local political agenda in many big cities in the 
Netherlands – partly because of the negative effects on many users, partly 
because of the negative effects on society. “Drugs-related nuisance” caused 
a major problem for the liveability of deprived urban areas. In the course of 
years, there was less and less tolerance for the marginalised drug user as a 
phenomenon of the city landscape. Marginalised drug users became almost a 
symbol of failing urban policy, feeding the growing dissatisfaction with tra-
ditional middle-of-the-road politics. As a result, increased policing of public 
nuisance was implemented, in parallel with a targeted approach to individu-
als identified as causing a public nuisance. In addition, in the mid-2000s the 
national government set up collaboration with the four big cities to fight 
homelessness, and explicitly targeted homeless drug users. The joint action 
of policing and caring has led to a situation where many problematic users 
of heroin and cocaine are housed, treated and employed in work training 
projects. A general tendency in Dutch society, which has contributed to the 
success of this approach, is that citizens are increasingly held responsible for 
their own lives. Social and economic participation in society has become an 
obligation rather than a right. Although the government continues to support 
vulnerable people, they are encouraged to take responsibility and participate 
in society. Labour training for drug users is not a right but an obligatory part 
of a trajectory towards “the highest level possible of self sufficiency”.
Dependent heroin users who have proved to be “treatment resistant” are now 
entitled to enrol in heroin-prescription treatment. After extensive scientific 
evaluation, prescribed heroin has now become a regular treatment option 
under strict clinical conditions, and 17 treatment centres in 15 cities are 
operational (2010), treating about 700 patients.
79
Netherlands
7.2.2. MDMA and similar substances
In the case of ecstacy or XTC (MDMA), a shift can be observed from concerns 
over the quality of pills on the black market and the short- and long-term 
effects on the brain, to concerns about XTC production. In the early 1990s, 
concerns with pill quality led to pill-testing services in recreational settings. 
This practice came to an end after intervention by Parliament (1999), though 
the quality of XTC on the black market continues to be monitored, basically 
as a tool to warn the public in case of dangerous adulterations. 
A second concern over XTC was an awareness that the Netherlands had 
developed into a country that produced and exported the substance. Taking 
into account international criticism on the Dutch cannabis policy, in the mid-
1990s the government decided to scale up action to control production and 
trafficking of ecstasy (and other hard drugs) in the framework of international 
collaboration (Neve et al. 2005).
7.2.3. Magic mushrooms
The case in 2007 of a deadly accident to a French tourist, who supposedly had 
used magic mushrooms, fuelled discussion on scheduling the substance. A 
majority of conservative parties in Parliament demanded a total ban on magic 
mushrooms, ignoring the advice of a committee (CAM 2000) that there was 
not enough rationale for prohibition. The Minister of Health commissioned 
new advice. The committee’s advice was, though more comprehensive, basi-
cally the same as that given earlier. Nevertheless, the minister proposed to 
put magic mushrooms under the restrictions of the Opium Act. In 2008 his 
proposal was accepted by Parliament.
7.2.4. Cannabis
The Netherlands is internationally known for its tolerant policy on canna-
bis. In 1976 the Opium Act was ammended and cannabis was classified as a 
substance that poses “less of a threat” to public health. The rationale behind 
this re-classification was a public health approach. The legislators wanted to 
keep the markets for hard drugs (“with unacceptable health risks”) separate 
from the cannabis market. After some years a policy of appeasement devel-
oped, resulting, among other things, in the emergence of the “coffee shops”. 
In the framework of appeasement, criteria37 were defined to which coffee 
shops should adhere to avoid prosecution. Over the years these criteria were 
tightened and will probably become more strict in the future. An example of 
tightened regulation was the introduction of the distance criterion (2008), 
by which coffee shops less than 250 metres from a school should be closed.
37. The so called AHOJ-g+ criteria include: no advertising, no alcohol, no minors, no hard drugs, 
no nuisance, no sales of more than 5 grams, no stocks of more than 500 grams.
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The Opium Act, and the subsequent system of appeasement, only regulates 
sales of cannabis to the consumer; it does not regulate the wholesale purchase 
of cannabis by the coffee-shop owner and supplying the coffee shop remains 
illegal. This is clearly an incoherent aspect of Dutch cannabis policy. When 
coffee shops started to emerge, most of the cannabis offered was imported 
from traditional cannabis-growing countries. International drug trafficking is 
a high-risk activity and these risks stimulated the development of home-grown 
cannabis. Initially amateurs grew their own supply, the rest being shared with 
friends or sold to coffee shops. This practice was gradually taken over by com-
mercial cannabis cultivators, increasingly coming from criminal networks. 
Enhanced law enforcement scared the amateurs away, leaving the business 
to criminals who are willing to take risks and use violence. The increased 
level of THC (tetrahydrocannabinol) in cannabis has been attributed to the 
criminalisation of cannabis cultivation. Profit-driven cultivators are said to 
have no “love” for the hemp plant and solely focus on growing crops with 
high THC percentages.
Under the system of appeasement this back-door issue has been addressed 
by several observers, including the police, several mayors of big cities and 
the co-ordination point assessment and monitoring new drugs (CAM 2008). 
However, international treaties and relations do not allow the government 
much space to move toward relaxation of legislation. Also, conservative 
political parties, which have always been critical of cannabis policy, have 
opposed any solution to the back-door problem. To them, closing coffee shops 
altogether is the best solution.
Another unforeseen effect of the tolerant attitude to cannabis has been 
the increasing quality of domestically grown cannabis. Crop-improvement 
techniques have led to THC levels in marijuana equalling those in imported 
hashish. The increased THC levels fuelled the debate on whether or not 
the perception of cannabis as a soft drug should be re-evaluated. Although 
THC levels in domestic cannabis seem to have stabilised (Niesink and Rigter 
2011), there is still worry about the effects on (young) people. In recent years 
an increasing number of requests for treatment related to cannabis use has 
been observed (IVZ 2011). The explanation for this trend is unclear: it could 
be related to increased cannabis potency; it could be related to lower barri-
ers to asking for help. A government advisory board has suggested putting 
cannabis with more than 15% THC on the list of drugs with “unacceptable 
risks” (Garretsen 2011). In October 2011 a majority of Parliament voted in 
favour of this.
The appeased cannabis policy in the Netherlands has led to tourism from all 
over the world, a phenomenon of which Amsterdam is the best known exam-
ple. Coffee shops in southern and south-eastern border cities, however, also 
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developed as well-known destinations for cannabis consumers from Belgium, 
France and Germany. In those cities, the large numbers of “cannabis visitors” 
in those cities caused considerable nuisance for the citizens, and coffee shops 
became a serious public order issue, resulting in dislocation and closure of 
coffee shops. The ongoing problems and subsequent debates on acceptable 
solutions led, along with other reasons, to the establishment of the earlier 
mentioned Advisory Committee in Drugs Policy.
The current government (2011) intends to limit access to coffee shops through 
the introduction of a mandatory consumer’s pass (“weed pass”), to be issued 
only to Dutch citizens. This plan goes much further than the advice of the 
Advisory Committee on Drugs Policy, which advised an experiment with the 
pass in certain border cities. The minister of interior and security has taken 
this advice further and insists, despite opposition from many big cities because 
of the fear of increased street dealing, on a “weed pass” for all coffee-shop 
visitors. Parliament had still to vote on this proposal in September 2011.
In sum, the current cannabis policy is subject to national debate. The govern-
ment, supported by a majority in Parliament, inclines towards a repressive 
standpoint by attributing negative characteristics to the substance and related 
phenomena. More liberal stakeholders do not praise the substance but argue 
that the health risks are limited and most adverse effects could be viewed as 
(undesired) side effects of a repressive approach.
7.3. Tobacco
In line with international developments, there is growing awareness that 
inhaling tobacco smoke is a serious threat to the health of the individual and 
subsequently to those who inhale second-hand smoke. Tobacco smoking is 
viewed as a public health concern because tobacco smoking is seen as the most 
important avoidable cause of death. The public health concern includes the 
high costs of medical care related to smoking (Ministerie van Volksgezondheid 
Welzijn en Sport 2006).
The prevalence of tobacco smoking is 28% among men and 26% among 
women (Stivoro 2010a). Among teenagers (ages 10-19) 21% reported they 
had smoked tobacco in the past four weeks (Stivoro 2010b).
The primary aims of Dutch tobacco policy are to discourage smoking and to 
protect the non-smoker. Several laws contribute to tobacco policy, of which the 
Tobacco Act is the most important. It is prohibited to sell tobacco products in 
government agencies, to children under 16 or provide free tobacco products. 
Besides that, there is a ban on advertising tobacco products. Advertisements on 
television or billboards and in newspapers or magazines are not allowed. Since 
May 2002, packets of cigarettes and tobacco have health warnings written on 
them. These measures are in conformity with the European Union guidelines 
on the presentation and sales of tobacco products (Directive 2001/37/EG).
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So far, the government has delegated the prevention of tobacco smoking to an 
expert organisation, Stivoro, which is the Dutch centre specialising in tobacco 
control. Its mission is to promote the health of smokers and non-smokers, by 
developing and applying knowledge about tobacco use and addiction. Stivoro 
plays a role in informing stakeholders on the execution of the Tobacco Act. 
The new government’s ministry of health has issued a policy document on 
health in which the use of tobacco is viewed as part of a lifestyle for which 
citizens themselves are responsible (Ministerie van Volksgezondheid Welzijn 
en Sport 2011). One of the consequences of this view is that financial support 
for Stivoro will terminate as of 2013. Another consequence is that medically 
assisted abstinence treatment (for tobacco) will no longer be part of statu-
tory health insurance. From a liberal point of view these decisions could be 
viewed as coherent; from a public health point of view the decisions might 
be seen as incoherent.
In an increasing number of public places the smoking of tobacco is prohibited. 
Most of these restrictions go without much debate. An exception to this is the 
ban on smoking in bars. As of July 2008 the catering industry is smoke-free. 
The main goal of this prohibition is the protection of non-smokers, especially 
staff that work in the cafés. From the very beginning this measure was con-
tested by café proprietors and visitors. The proprietors claimed that many 
of their clients were tobacco smokers and they would lose them because of 
the ban. Another argument put forward was that, in small cafés, proprietors 
are behind the bar themselves and do not hire staff. Although the legislation 
allowed the creation of ventilated smoking compartments in cafés, it was 
claimed that this would be unrealistic in small-area venues. Debate on this 
subject came to an end with an amendment of the Tobacco Act (2008) that 
relaxes the ban for small cafés (up to 70 sq.m.) without employees.38 This 
relaxation could be interpreted as a pragmatic solution to the tension between 
public health principles and the interests of small entrepreneurs. It is unclear 
what the influence of the tobacco industry lobby has been in this case.
7.4. Alcohol
The ministry of health puts emphasis on the undesirable consequences of 
“too much” alcohol consumption among adults and young people. Excessive 
alcohol use is related to adverse health effects, aggression and dangerous driv-
ing. These negative side effects should be reduced as much as possible. In its 
national alcohol policy the government focuses on minimising the number of 
individuals who use alcohol problematically. The goal of the alcohol preven-
tion policy is not to discourage the moderate use of alcohol or to prohibit it 
– it is seen as a socially accepted stimulant, which (if used moderately) will 
not cause harm for most people. The focus is on lifestyle education of young 
38. This relaxation is not applicable to cannabis coffee shops.
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people and on detecting and referring (young) people with risky consumption 
patterns to treatment. A second focus of the policy is to minimise the risk of 
alcohol-related problems in specific situations: family, work, traffic and night 
life. The prevention of problematic alcohol use is targeted at specific contexts 
rather than on general prevention.
The prevalence of recent (last-year) alcohol consumption among the general 
population is 84%; for current use, 76% report having consumed alcoholic 
drinks in the past month (Van Rooij, 2011).
Research has shown that the most effective way to decrease alcohol use is an 
alcohol policy that contains a mix of different measures. An integral alcohol 
policy includes limitation of access to alcohol (e.g., an age threshold) and 
targeted prevention aimed at alcohol users at risk (e.g., driving or at work). 
The most effective measures reduce the availability of alcohol: buying alcohol 
is made more difficult. Financial availability can be narrowed down by price 
rises, by means of excise/tax (Anderson and Baumberg 2006).
The European guidelines on alcohol focus on regulation of taxation of alco-
holic beverages. The guideline, dating from 1992, was modified in 2006 when 
minimum tax rates were introduced. The rationale for this guideline is regu-
lation of the internal market rather than the minimisation of health risks.
In 2001 the Council of the European Union issued a recommendation “on the 
drinking of alcohol by young people, in particular children and adolescents” 
(Council Recommendation 2001/458/EC). The recommendation explicitly 
took the interests of the alcohol industry into account. It addressed the 
form and content of alcohol marketing, but not its volume or timing. In the 
Netherlands alcohol marketing was left to self-regulation by the industry till 
2008. In that year Parliament adopted, after lengthy debate, the proposal of 
a complete ban on alcohol commercials between 06:00 and 21:00 on radio 
and television. As said, alcohol marketing is mostly shaped by self-regulation 
which, in turn, is shaped by negotiations between industry, government and 
health interest groups.
In 2006 the European Commission issued “an EU strategy to support Member 
States in reducing alcohol-related harm”, with goals to be attained by 2012 
(COM (2006) 625). The Alcohol Strategy could be viewed as important 
because it was the first time the commission had put alcohol-related harm on 
the European agenda. The strategy does not insist that national legislation 
be amended. Individual member states remain responsible for their national 
alcohol policies.
The current debate on alcohol focuses on (excessive) alcohol consumption by 
young people. There is increasing evidence that alcohol use could have a nega-
tive influence on their brain development (Brown et al. 2000). About the turn 
of the century, this notion coincided with the emergence of “booze barracks” 
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(zuipketen) and binge drinking (coma zuipen). These phenomena received a 
lot of media coverage and thus alerted politicians and health professionals.
Two important lobby groups operate in the field of alcohol policy. One group, 
Stiva,39 represents the interest of the alcohol industry and contributes to the 
reduction of “alcohol misuse”. This lobby group promotes responsible and 
moderate drinking at various websites. In doing so, they also protect and 
promote the image of alcohol as a sociable substance. The participation of this 
lobby group in the national campaign to promote the age limit of 16 years could 
be seen as an expression of its position as a reliable and respectable partner.
The other lobby group, STAP,40 takes a health approach and basically com-
municates the message that “less is better”. This lobby group is critical to the 
message that moderate alcohol use is part of a healthy lifestyle. They closely 
and critically monitor commercial expressions of the alcohol industry. They 
have lobbied strongly, in collaboration with some major health organisations, 
to raise the legal age to buy soft alcoholic beverage from 16 to 18 years, a 
proposition that was voted against by a majority in Parliament (2010).
The issue of binge drinking by young people has successfully been addressed 
by a medical doctor. In the hospital where he works, he opened an alcohol 
clinic for young people who have drunk themselves to unconsciousness. Over 
the years the topic has raised a lot of media attention and at the beginning of 
2011 Parliament agreed on a proposal to open similar alcohol departments in 
other hospitals throughout the country.
7.5. Reflection
Although Dutch policy on psychoactive substance is a non-integrated policy 
(different policy papers on different substances), the over-arching approach 
could be defined as pragmatic. All policies take into account a mix of public 
health and public order interests. But if we look a bit closer we discover 
that economic interests also play a role, notably the economic interest of the 
alcohol industry and to a lesser extent the interests of small entrepreneurs 
in the catering industry.
In the case of alcohol, it could be seen as ironic (but not incoherent) that 
there is no political majority to raise the legal age to buy alcoholic beverages 
to 18 years, and at the same time there is political support for alcohol clinics 
for young people.
With respect to scheduled drugs the approach is slightly different. Public 
health and public order arguments are the most important rationales in devel-
oping policies on psychoactive substances. However, normative arguments 
also seem to play a role in this field. The case of magic mushrooms illustrates 
39. Stiva: Stichting Verantwoord Alcoholgebruik (Foundation for Responsible Alcohol Use).
40. STAP: Dutch Institute for Alcohol Policy.
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the weakening influence of health arguments on drug policy and the direct 
influence of the political power balance. Political decisions do not take into 
account only health arguments, but also normative and electoral arguments. 
With the desire to update drug policy, notably cannabis policy, the government 
has commissioned an evaluation study and has appointed several advisory 
committees (van de Donk, Garretsen), alongside existing consulting structures 
(CAM). The extent to which the government follows up on advice seems to 
depend on prevailing political configurations. The rationality of weighing out 
substance-related risks remains subordinate to weighing out political stakes.
Both advisory committees (Donk et al. 2009, Garretsen 2011) recommended 
that alcohol use should be considered in designing drug policy, because alcohol 
use brings substantial harm to society and many individuals. This is a call 
for an integrated approach, coherent with a view that puts substance-related 
harm in a central position of the policy debate.
Although the policy on tobacco and alcohol are subject to competing interests, 
the political disagreements raise moderate media attention. The approach to 
cannabis, however, seems to be controversial. The debate on cannabis policy 
is partly rooted in the incoherent appeasement policy that allows sales to 
consumers and prohibits wholesale supply to retail distributors. Although 
the scheduling of cannabis with a high THC level (>15%) as a “hard drug” 
is motivated by health arguments, it is also a result of the unforeseen and 
unwanted side effects of an incoherent cannabis policy. It fits well into a 
general tendency to a strict approach to cannabis and reflects the shift to a 
more conservative political landscape.
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8.1. Introduction
Norway’s alcohol and drug policy has traditionally been based on regulations/
controls (alcohol) and prohibition (narcotic drugs), combined with help/treat-
ment services, and has been regarded by other countries as restrictive. The 
Norwegian alcohol and drugs policies are integrated and in principle seen as 
a coherent substance policy. This can be illustrated by the fact that in most 
official documents the terms “substance-related problems, abuse, addiction” 
and “treatment” are widely used instead of “alcohol problems, drug problems” 
and so on. The target groups, both with regard to prevention and treatment, 
are seen as much the same. So are the actors, interventions and methods. To 
emphasise that it is a coherent policy, action plans, both at national and local 
level, will normally address both alcohol and drug problems. Thus action 
plans will normally aim at providing the basis for broad-based strategies for 
measures that cover the entire alcohol and drug field. In general the Norwegian 
substance policy is deeply anchored in a public health perspective: life skills, 
health promotion and preventing behavioural risk factors.
Doping (drugs in sport) will be included in such plans from 2012, but tobacco 
has not been included so far. For tobacco there are separate action plans and 
strategies, but since people who start smoking at an early age are assumed to 
be more likely to use drugs than those who do not start smoking, tobacco is 
included/integrated in the broad prevention strategies.
Both at national and local level, the issues of alcohol and narcotic drugs are 
dealt with by the same agencies. This means that most prevention measures 
aim to address problems related to alcohol as well as problems related to nar-
cotic drugs. As early detection and intervention have been more emphasised, 
there is now more focus on predictors for problematic substance use than on 
the substances themselves.
In the same way, treatment for alcohol and drug problems is organised within 
the same treatment centres, even if some centres specialise more in treatment 
Norway en blanc
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of alcohol abuse and others in treatment for the abuse of narcotic drugs (such 
as substitution treatment).
The use of all the substances (alcohol, legal and illegal drugs, doping and 
tobacco) is considered to be a health risk and to cause harms both to the 
individual user and to society, in different ways or at different “levels”. Thus 
narcotic drugs are more strongly regulated than alcohol and tobacco, alcohol 
more strongly than tobacco, and doping cannot legally be distributed, though 
possession and use are not illegal. As a consequence of the differences in 
legal status of alcohol and narcotic drugs, they are separated when it come 
to legislation for the substances as such. Alcohol policy is regulated by the 
Alcohol Act and illicit drugs by the Medicinal Product Act and the General 
Civil Penal Code.
8.2. Intra-coherency
8.2.1. Alcohol
Compared to most other countries, alcohol consumption in Norway is low 
even if there has been a rather big increase since the mid-1990s. The main 
instruments of Norway’s alcohol policy are: the licensing system; the alcohol 
retail monopoly system (Vinmonopolet) for the sale of strong beer, wine and 
spirits; limited retail and serving times; specific orders and prohibitions such 
as advertising bans, statutory age limits; and restrictive tax policies. Under 
the Alcohol Act, beverages containing higher alcohol content than 2.5% by 
volume may only be sold and served by persons in possession of an appropri-
ate licence. The authority to grant licences lies in general with the municipal 
authorities.
The number of Vinmonopolet retail stores grew steadily between 1990 (106 
outlets) and 2010 (259 outlets). There used to be a limit determined by the 
Parliament of how many outlets the country should have, but that system 
was discontinued in 2005. Today, Vinmonopolet itself decides whether to 
apply for a licence, and the relevant municipal authorities decide whether to 
issue one. Municipal authorities are increasingly likely to grant such licences.
Licences to sell medium-strength beer/alcopops (up to 4.7% alcohol by 
volume) are generally issued to grocery stores and supermarkets. A major 
20-year-long restructuring process left the retail sector without many of the 
traditional grocery stores. As a result the number of retail outlets selling 
medium-strength beer fell, though municipal authorities are now increasingly 
likely to grant such licences. In 2003, for the first time it was possible to buy 
beer/alcopops in every municipality in Norway.
When it comes to bars and restaurants, the number of establishments with 
a licence to serve alcohol today is nearly three times what it was in 1980, an 
increase from 2 439 in 1980 to 7 376 in 2010.
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As can be seen, even if Norway still has a restrictive alcohol policy as such, 
in practice the policy is balanced and increasingly liberal and pragmatic – 
at the “sacrifice” of coherency. One challenge is the fact that commercial 
interests are often in conflict with public health interests; indeed, in many 
cases, commercial interests are given precedence over public health, though 
what is profitable for individual companies is not always best for society. 
Another challenge is the need to get sufficient support in public opinion and 
strong political support for measures shown by research to be most effective 
in reducing the supply of alcohol (high prices and low availability). Still, in 
terms of alcohol policy the Norwegian Government wants to take steps to 
ensure that the balance between public health considerations and commercial 
considerations globally, nationally and locally tips in favour of public health. 
Norway has to ensure that international trade agreements attach sufficient 
importance to public health, and that commercial interests do not sway the 
local authorities’ licensing policy. Although alcohol is a legal substance that 
the majority of the population consumes in a controlled manner, it is seen as 
important to stress that alcohol is not an ordinary commodity.
8.2.2. Narcotic drugs
While alcohol has been a part of the Norwegian culture for hundreds of years, 
real drug problems are a relatively young phenomenon. It all started on a 
relatively small scale in the late 1960s/early 1970s, and heroin was seized for 
the first time in 1976. Since then it has developed and changed, and we are 
still learning. Norway has traditionally shown a rather restricted approach to 
narcotic drugs, and all non-medical use of such drugs is illegal. Nevertheless, 
the Norwegian drugs policy has progressively changed over the years.
All non-medical use, possession, dealing and other forms of illegal handling 
of narcotic substances and prescription drugs may render offenders liable to 
prosecution. Illegal import and dealing can, in the most serious cases, carry 
the strongest penalties of the law. The intention is to control legal use and to 
combat illegal use of narcotic drugs.
Because of the HIV epidemic in the mid-1980s, drug use – and especially 
injecting drug use – became part of social and health workers’ agenda in a 
new way. As a result, harm-reduction measures were carefully introduced. 
One had to reconsider the fundamentals and assumptions on which the drugs 
policy was based. This can be illustrated by the fact that in 1988 free needles 
were handed out for the first time. Thus 1988 became a kind of turning point, 
and Norwegian drugs policy lost its virtue – though not overnight, and not 
without painful discussions and controversies. Today more than 3 million 
needles and syringes are handed out every year.
In 1994 a trial methadone programme was introduced, with 50 patients. In 
1998, substitution treatment was introduced on a permanent basis. At the turn 
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of 2011 about 6 500 patients were in substitution treatment. Furthermore a 
lot of low-threshold programmes (health care centres, day centres, etc.) have 
been built up.
One other important change in Norwegian drug policy took place in December 
2004 when a temporary Drug Injection Rooms Act was passed by Parliament 
(Stortinget). In 2009, the Storting decided to make the temporary act per-
manent, which means that municipalities that wish to establish injection 
rooms have a legal basis for doing so. So far only the municipality of Oslo has 
established an injection room facility.
Drug policy is hampered by many difficult trade-offs between legal and social-
political considerations. In Norway, narcotic drugs are, and will in all like-
lihood remain, illegal. Nevertheless it is seen as a duty to look after people 
who get into substance abuse problems, because everyone is entitled to a 
worthy life and to be treated with respect by society and the treatment system. 
This dilemma can be illustrated by the work on substitution treatment. This 
involves treating people with strong addictive medicine. At the same time 
we want as many people as possible to manage without addictive medicines. 
However, at present, pharmacotherapy appears to be the best option for many 
opioid addicts. Use of methadone/buprenorphine must, however, be recom-
mended only after a thorough, comprehensive assessment of the individual’s 
condition. One has to ensure that substitution treatment goes hand-in-hand 
with good psycho-social follow-up, which is not always the case.
Opponents to harm-reduction measures such as needle exchange and drug 
injecting rooms claim lack of consistency because on the one hand all use of 
narcotic drugs is illegal, while on the other hand such harm-reduction efforts 
can be seen as legalising it and thus giving inconsistent messages. Is this a 
lack of coherency?
8.2.3. Tobacco
Massive tobacco consumption started in Norway at the same time as the 
tobacco industry was automated about 100 years ago. The increase in the first 
half of the 20th century coincided with extensive commercial pressure that 
linked cigarette smoking with modernism, a refined lifestyle and elegance. 
After the Second World War, the authorities assigned a necessity status to 
tobacco and supplied it to people through Marshall Plan aid. As in other 
western countries, smoking was deeply rooted in social life; it was common 
among doctors and top athletes, and was projected visually through television 
programmes, films, newspaper pictures and commercials.
The pro-tobacco social climate in the 1950s and 1960s made it difficult to dis-
seminate information on the adverse health effects of smoking in an effective 
way. Commercials became more aggressive when final evidence of the health 
risks of smoking became available. Up to 1970, doctors and authorities had a 
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very low profile and did not inform people about the dangers of tobacco nor 
engage themselves in preventive work. The first Norwegian publicly financed 
information campaign on tobacco was launched in 1975.
From 1975 there was a total ban on all tobacco commercials. Health warn-
ings on cigarette and tobacco packs were introduced and an age limit of 16 
was set for the buying and selling of tobacco products. The law was later 
expanded to protect people against passive smoking in the work place, on 
means of transportation (1989), and in places where food was served (2004). 
New nicotine products were banned (1989), more and larger health warnings 
were introduced (2003) and the age limit for buying and selling tobacco was 
set at 18 years (1995). The real price of tobacco increased several times after 
1975, systematic preventive measures were instigated and campaign activity 
was intensified.
8.3. Momentous changes
Altogether since the 1980s there have been momentous changes in policy and 
approaches to substance abuse and substance abusers. This also goes for ideas 
on the best way of organising and delivering care and treatment for substance 
abusers. After a centralist approach was discarded in favour of decentralising 
treatment in the 1980s, in the early 2000s policy reverted to a centralised 
treatment model. From being classified as patients, in the 1980s substance 
abusers became clients, only to end up as patients again. In 2004 treatment of 
substance abuse became part of the specialised health care services provided 
by the state through four regional health enterprises. This meant that what 
is called interdisciplinary specialised treatment for substance abuse was in 
line with specialised somatic and psychiatric health care. At the same time, 
substance abusers were given the same patients’ rights as any other patient 
in the specialised health care system. Thus there has been a shift in recent 
years from understanding and treating substance abuse problems as a social 
issue to seeing them more as a health issue.
With the exception of substitution treatment for opioid dependency, inter-
disciplinary specialised treatment does not in general discriminate between 
substances. It is all a matter of substance abuse problem/addiction and is 
treated as such. For historical reasons, however, there are also institutions 
originally established for treating alcohol problems or narcotic problems, and 
some of these still remain in this traditional form.
As already mentioned, the public health perspective is a key element of 
Norwegian drugs and alcohol (and tobacco) policy, based on the assumption 
that there is a clear relationship between the amounts of drugs or alcohol 
used and the extent of harms. The extent of negative social and health-related 
consequences, including illness and accidents, increases in step with the use 
of drugs and alcohol. Whereas alcohol causes most harm, both socially and in 
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terms of health, the use of narcotic drugs is associated with considerable mor-
bidity and high mortality rates. Norway has a population of nearly 5 million 
and it is estimated that ±100 000 people are high-risk consumers of alcohol; 
the number of injecting drug users is estimated at ±10 000. The number of 
drug-related deaths is higher than in most European countries, even if there 
are problems comparing overdose statistics due to differences in registration. 
On the other hand, prevalence rates of drug use among young people are lower 
in Norway than in most other European countries.
The goal for Norwegian alcohol and drug policy is to reduce the population’s 
use of the substances overall, with a view to reducing the total amount of 
harm caused. Efforts will be aimed at reducing the availability of alcohol and 
narcotic drugs, and limiting demand for them. Supply reduction and law 
enforcement are, as already mentioned, different for each substance, and are 
in part differently organised. The legislation regulating licences for alcohol as a 
legal substance is within the ministry of health and care services; the authority 
to grant licences is in general delegated and lies with municipal authorities. 
Illicit drugs are partly regulated by the Medicinal Product Act, which also lies 
with the ministry of health and care services, and partly by the General Civil 
Penal Code, which is the ministry of justice’s responsibility. The ministries of 
foreign affairs and finance (Customs) are also involved. Tobacco legislation 
lies within the ministry of health and care services.
Demand-reduction efforts do in most cases include alcohol as well as narcotic 
drugs, especially when it comes to young people. Early intervention, targeting 
potential drug and/or alcohol problems, is emphasised as well as services for 
people suffering from substance use/abuse. Treatment is the state’s respon-
sibility, care services and prevention the responsibility of the municipalities.
8.4. International collaboration
One of Norway’s goals is to limit harms related to alcohol and narcotic drugs. 
Norway aims to contribute to improving the health situation in Norway’s 
immediate area as well as in other parts of the world. It is the goal of Norway’s 
international health collaboration to meet challenges by developing schemes 
for effective prevention and combating illness.
Norway’s international commitment occurs chiefly through the United 
Nations (Norway has ratified the three UN control conventions on the prohibi-
tion and control of narcotic substances), the Council of Europe, the European 
Union/European Economic Area, the Emus Northern Dimension, the Nordic 
Council of Ministers and other Nordic collaboration.
8.5. NGOs
Non-governmental organisations NGOs play an important role in the alcohol 
and drug field in Norway. They do invaluable work in preventing alcohol and 
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drug use and helping people with substance abuse problems. Furthermore, 
NGOs are important collaboration partners for local authorities and the spe-
cialist health services in providing treatment and for the government’s work 
in developing alcohol and drug policy.
8.6. National action plan on alcohol and drugs
Norway’s alcohol and drugs policy is set out in an action plan for the drugs 
and alcohol field. This plan, introduced in 2008, was intended to run until 
2010. However, the government has decided to extend the plan period until 
the end of 2012. The plan covers a broad range of measures, from universal 
and early prevention to treatment, rehabilitation and harm reduction, as well 
as addressing problem drug and alcohol users’ need for complex and coherent 
services over time. The over-riding goal is to reduce the negative consequences 
of drug and alcohol use for individuals and for society as a whole. As the action 
plan says, Norway’s alcohol and drug policy is about solidarity and society’s 
capacity for solidarity. Substance-use problems are seen as a matter of social 
inequality, social trends, exclusion of social misfits and overcoming challenges, 
at school and in the workplace. The action plan lays out the government’s 
areas of priority in the field of alcohol and drug problems. In the action plan 
the government is looking at the entire field of alcohol and drug problems in 
context, and work in this area is based on the government’s general policy. 
The goal is to offer good services that focus on the user of the services.
It is said that there is still no clear-cut solution for how to deal with the nega-
tive consequences of substance use for individuals and society as a whole. 
One must learn to live with the dilemmas and trade-offs. It is also said that 
it is impossible to come up with a successful alcohol and drug policy through 
organisation, funding or regulations alone. It is just as much a matter of atti-
tudes and conduct, of feelings, and of wanting to help people who, for some 
reason or other, have ended up in a difficult situation. All in all, the national 
action plan covers 147 specific and rather wide-ranging measures that address 
the challenges in the drugs and alcohol field.
The action plan has five main objectives, as follows.
8.6.1. A clear public health perspective
Norway has the ambitious goal of reducing consumption of alcohol. Alcohol 
is under pressure, from international bodies and business interests. Norway 
wants to improve support for the general Norwegian alcohol policy. With a 
view to reinforcing the work to combat narcotic drugs and illicit use of medi-
cines, the government is going to increase efforts, both internationally to limit 
availability of drugs and nationally to ensure that fewer people start using 
illicit substances. The government wants to focus more on targeted informa-
tion and greater participation from young people and parents. Knowledge 
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must be generated and attitudes must be changed to reduce the harmful side 
effects. There is a widespread consensus that the workplace should be an 
alcohol- and drug-free arena. As it is worrying that alcohol is increasingly 
being used in work-related situations, at seminars and courses for example, 
workplace alcohol and drug prevention will be bolstered. Norway has a tradi-
tion of taking international collaboration on alcohol and drug seriously. This 
will be continued and strengthened.
8.6.2. Better quality and increased competence
The government is investing in research on substance use: it has established a 
special research programme and a research centre aimed at clinical substance 
abuse research to supplement existing research institutes in the field. The 
result of the research is to be communicated outside the field, to be invested in 
more and better teaching in basic and further education. To improve expertise 
in the alcohol and drug field, more people must be given the opportunity to 
qualify and undertake further education. Recruiting people with the right 
academic knowledge and training is a long-term priority. The quality and 
content of services are going to be improved. 
The work requires a systematic approach and long-term investment, and is 
going to be done within the framework of “the National Strategy for Quality 
Improvement in the Health and Social Services for People with Substance 
Dependence Problems”. Existing alcohol- and drug-related data do not provide 
enough information about the scope of the problem, causes, input of resources 
and results. Better systems for reporting, statistics and documentation will 
be developed and implemented. NGOs play an important role in prevention, 
treatment and care. The government will continue supporting voluntary 
work and will take steps to ensure that NGOs are also involved in the quality 
improvement work in the substance-use area.
8.6.3. More accessible services
Services must be accessible to children and young people, who are especially 
at risk of developing alcohol- or drug-related problems. We must ensure that 
everyone at risk of becoming alcohol- or drug-dependent, and people in the 
early stages of developing alcohol and drug problems, receive appropriate 
help at the earliest possible opportunity. People with substance-use disorders 
must be given far better individual follow-up at municipal level. Services are 
to be made more accessible and more flexible. Greater priority will be given 
to social inclusion, rehabilitation and networking, and closer follow-up after 
discharge from a treatment institution or release from prison. Low-threshold 
schemes, outreach activities and ambulatory services will be strengthened 
in order to reach people who do not make use of ordinary services. Good, 
comprehensive services in the municipalities are critical for the success of 
our efforts in the alcohol and drug field. A good living situation is important 
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for rehabilitation, health and dignity. In recent years, many different models 
have been developed for housing and services. 
Regional health authorities have achieved significant increases in capacity 
in interdisciplinary specialised treatment for substance abuse (though the 
number of referrals for treatment has also risen), and services are largely 
organised in such a way that people with substance abuse problems receive 
varied, comprehensive treatment. Input and capacity will be increased to 
meet the need for treatment. Over half the people serving a prison sentence 
are estimated to have substance abuse problems. They are just as entitled as 
anyone else to have their need for help assessed and to receive adapted treat-
ment and follow-up, but the evidence is that they have poorer access to help 
services than other people. The government intends to change this.
8.6.4. More binding co-operation
Priority will be given to measures that guarantee good co-ordination for chil-
dren and young people; they are particularly vulnerable, and co-ordination 
often involves more people and agencies than services for adults. The treat-
ment and follow-up of people with substance abuse problems often entails a 
number of measures being implemented at once or consecutively, and many 
people experience the services as fragmented and poorly co-ordinated. The 
government wants to ensure better quality and use of resources by improving 
collaboration and continuity. 
People who need long-term and co-ordinated social and health services are 
entitled to have an individual plan drawn up for their treatment and follow-up, 
if they wish. Nevertheless, many reports show that few people with substance 
abuse problems have an individual plan. Changes have to be made that pro-
mote use of individual plans, which are tools to achieve collaboration on the 
individual level. On the system level too, we must ensure that systematic and 
target-oriented work is done to resolve collaboration challenges. Prevention 
requires measures that reduce both availability of intoxicants and demand for 
them. In many places, local authorities and NGOs separately run a range of 
preventive measures aimed at the same target groups. The government wants 
to facilitate the local authorities’ preventive measures being seen in an overall 
perspective and that they are considered in light of follow-up of people with 
substance abuse problems.
8.6.5.  Increased user influence and attention to the interests  
of children and family members
Children and young people whose parents have an excessive or hazardous 
use of alcohol and/or drugs are more frequently subject to parental neglect, 
abuse and violence than others. They must be identified and helped at the 
earliest possible opportunity. Planning and design of services in collaboration 
with service-users is a statutory requirement and a necessary condition for 
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good quality. Services must be arranged in such a way that the users are given 
real influence and relatives are well looked after. Work in this area must be 
based on the Directorate of Health’s quality strategy for the social and health 
services. Systematic gathering of experiences from users and their relatives is 
important to be able to develop good, effective services. These experiences are 
necessary correctives and help stimulate continual improvement. The govern-
ment wants to make sure that user experiences are used more systematically 
in the work to improve quality.
8.7. Systems and structures
There is a high degree on the overall objectives, values and means of Norwegian 
alcohol, drugs and tobacco policy and thus it is long-term. Every fourth year 
there are parliamentary elections. Each political party states its goals for the 
alcohol and drugs policy in its manifesto though this is usually not among the 
top 10 issues. For some years the government has been a coalition of certain 
political parties, which negotiate to end up with a common programme, usu-
ally expressed in a declaration where the final political goals are set. These 
goals, as a result of party political processes, set the agenda for ministries and 
directorates, and set the direction for policy, usually stated in action plans, 
sometimes in white papers; most often they adjust policy and do not draw up 
totally new policy. The minister for health and care services is responsible for 
co-ordinating the policy area.
Ideas forming and translating to political goals are both formal and informal 
in character. The media plays a central role in drawing attention to what 
are often more acute issues; and responsible politicians are expected to give 
immediate answers. To a certain extent this contributes to day-to-day adjust-
ments of policy , not always in accordance with long-term goals. Civil society, 
NGOs and more professional actors are well aware of (and take advantage of) 
the role the media plays in influencing policy. Several actors, professional as 
well, seek influence by lobbying via the media, Parliament and the opposition.
Public engagement and involvement is a general political goal, and several 
initiatives have been taken and channels opened to facilitate this. Now and 
then public meetings to discuss alcohol and drug policy are arranged, people 
are invited to write letters and ministers have regular meetings with different 
groups and individuals. Every ministry has a secretariat responsible for receiv-
ing and interpreting all these kinds of ideas and initiatives, and transforming 
them into political and operational goals.
Formally there are several processes, actors and levels in formulating and 
transforming ideas into political goals. This is a dynamic process. When 
the government draws up action plans or white papers, it accepts input 
from a wide range of actors: relevant directorates, councils, research institu-
tions, regional health authorities, municipalities, counties, NGOs and user 
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organisations. Challenges, suggestions, recommendations and good examples 
are requested. This dialogue ends up in a final plan worked out by the ministry, 
with a political stamp. The same actors as mentioned above are then given 
responsibility to implement and carry out the policy. For the duration of the 
plan, there is a dialogue between these actors and the ministries and every 
year new initiatives and actions are launched in state budgets.
8.8. Selected reading
Edland-Gryt M. (2011), Alcohol and drugs in Norway. Norwegian Institute 
for Alcohol and Drug Research
Norwegian Ministry of Health and Care Services (2008), Norwegian National 
Action Plan on Alcohol and Drugs
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9. A Portuguese insight into coherent policyPortugal
Fatima Trigueiros 
Instituto da Droga e da Toxicodependência, Lisbon
9.1.  Historic overview of the Portuguese context  
for drugs
The first Portuguese drug laws, dating back to 1924 and 1926, remained 
unaltered until 1962. They aimed to regulate the import and export of drugs 
and associated drug addiction with mental illness treatment.
Until the end of the 1960s, drug use and abuse was not seen in Portugal, 
remaining confined to very close knit circles, such as artistic and beaux arts 
people, with the exception of Macao, a Chinese territory under Portuguese 
administration until 1999, where the use of opium was forbidden in 1946 
(Foreword of Law Decree 5/91/M). In view of Macao’s geographical situation 
and cultural environment – Macao is on the western side of the Pearl River 
Delta, just across from Hong Kong – drug use was seen as a problem confined 
to an overseas territory under Portuguese administration.
Following Portugal’s ratification of the United Nations Single Convention on 
Narcotic Drugs of 1961, in 1970 a piece of legislation was approved introduc-
ing a legal framework that illegalised and criminalised traffic in narcotic drugs.
Drug use in the Portuguese African colonies, which until the end of the 1960s 
had been confined to ethnic groups, spread through the contingent of men 
sent from Portugal to fight guerrilla movements and thus to people associated 
with their economy, namely recreation during breaks from jungle fighting. 
“The increase in the abuse of psychotropic and narcotic substances worldwide 
from the beginning of the 1970s has also been seen in Portugal in ever greater 
proportions” (SPTT 2001: 4). According to Poiares, “During the 1960s and 
1970s, war mobilisation … of a large percentage of male youngsters caused 
the initiation of many of them into drug worlds, a process made easier by the 
environment and the culture in which they found themselves, as well as by 
the typical psychological conditions of a war scenario”41 (Poiares 1998: 239).
It was around 1970 in this context of profound political, institutional, eco-
nomic, social and cultural changes that the first public campaign in Portugal 
was launched to alert people about the use and abuse of drugs (Dias 2007: 41). 
According to Poiares, the campaign, whose slogan was “Drug, madness and 
41. Free translation by the author.
Portugal en blanc
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death”, was the expression of the relationship between drugs and a very spe-
cific political fact, the war overseas (Poiares, 1998: 242).
With the independence of the colonies, one million people returned to Portugal 
and the colonial army was dismantled. The 25 April 1974 Revolution fostered 
freedom and the loosening of social morality, so a desire for experimentation 
and therefore drug consumption rose. Portuguese institutions were not ready 
to respond to this outbreak, since law-enforcement agencies had been based on 
a repressive model and there were no specifically targeted health structures. 
Heroin injection in particular became problematic.
The treatment of addictions was targeted for the first time under Portuguese 
legislation in 1963, when it was incorporated in the Mental Health Law, 
which established the treatment framework for mental illnesses. However, 
drug addiction treatment as such was never regulated within this framework. 
The 1963 law was replaced in 1998 by the current Mental Illness Law, which 
no longer includes drug addiction treatment.
In view of the emergence of an alarming drug-consumption pattern, a spe-
cialised government structure, the Centre for the Study of Drug Prophylaxis 
(CEDP), was created in November 1976 to address the problem specificities 
and the difficulties faced by care-and-treatment institutions (Trigueiros et 
al. 2010: 28-35).
After the 25 April 1974 Carnation Revolution, democratic governments pur-
sued, with the agreement of Parliament, policies to address the issues related 
to drug use and abuse.
9.2. Signature and ratification of UN drug conventions
After the ratification by Portugal of the UN Single Convention on Narcotic 
Drugs of 1961, it entered into force in 1970.
The newly democratic regime established in Portugal after 1974 opened up 
the country’s diplomatic relations. No longer subject to the stigma attached 
to being a colonial power in an era of self-determination by former colonies 
worldwide, the Portuguese authorities picked up multilateral ties.
Portugal adhered to the 1972 Protocol to the Single Convention on Narcotic 
Drugs of 1961 in December 1978 and in January 1979 to the UN Convention 
on Psychotropic Substances of 1971.
In June 1991 the Portuguese Parliament ratified the 1988 UN Convention 
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, which 
Portugal had signed in December 1989.
With this framework of conventions in place, Portugal proceeded to adapt its 
internal legal and institutional framework.
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9.3.  Evolution of the institutional framework  
for illicit drugs
In view of the need to address the growing problem of drug addiction, fol-
lowing the exposure to drugs of a large contingent of men in the military, in 
1973 Lisbon’s Hospital Santa Maria started an outpatient clinic specialising 
in consultation for drug addicts, who were transferred from other medical 
services. Hospital Santa Maria was, and still is, a medical school as well as 
the central hospital for metropolitan Lisbon (Dias 2007: 77).
However, the most remarkable result of the evolving institutional framework 
for illicit drugs in Portugal was that the first dedicated treatment units as such 
were created within the ministry of justice structure, rather than under the 
ministry of health.
The criminalisation of personal drug use and possession, in accordance with 
the United Nations conventions, was transcribed into the Portuguese legal 
framework from 1970, raising an urgent need to address the concern of grow-
ing numbers of young people approaching the criminal system due to drug 
use and abuse. Both they and their parents used the services in the ministry 
of justice structures according a biopsychosocial model.
Following the 25 April 1974 Carnation Revolution, “faced with the increasing 
scale and enormous complexity of the problem, the democratic governments” 
approved legislation “to counteract the trend”, having youngsters in mind, in 
particular (SPTT 2001: 4). Thus, in 1975 the CEJ (Youth Study Centre) and 
the CIJD (Judicial Investigation Centre on Drugs) were created. The CEJ’s 
purpose was to study problems associated with drug use, particularly those 
related to medical treatment and social support for addicts. The CIJD was 
responsible for investigating, monitoring and tackling crime related to drug 
use and abuse and trafficking (SPTT 2001: 5).
The CEJ was restructured in November 1976, to be replaced by the CEPD, 
whose purpose was to address the prevention, treatment and social reintegra-
tion of drug addicts. The law decree that created the CEPD laid down that it 
would have regional services. They operated in Lisbon, the capital, Oporto, 
Portugal’s second largest city, and Coimbra, a university town and third larg-
est city at the time. The Preamble of Law Decree No. 792/76 that created the 
CEPD clearly stated that ideally the criminal model should be replaced by 
clinical treatment, with the drug user qualifying as a patient rather than a 
criminal, because drug use leads to “a weakening, and even an enslavement 
of the will and, therefore should be immune to an ... imputation of guilt” 
(Trigueiros et al. 2010: 28).
The Co-ordination Office for the Fight against Drugs (GPCCD) was created 
at the same time (1976) to co-ordinate the CEJ and the CIJD activity and to 
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study and propose legislative proposals, to focus on bilateral and multilateral 
co-operation, namely at the United Nations, and to pursue research and data.
The first dedicated specialised hospital unit under the ministry of health was 
created in 1987. The Taipas Centre’s mission was to prevent and treat drug 
addiction; it was the basis of the later SPTT, the Service for Drug Addiction 
Prevention and Treatment. The Taipas Centre started as an outpatient clinic 
that included detoxification and emergency services. Most of its medical peo-
ple had previously worked at Hospital Santa Maria outpatient consultation 
(Dias 2007: 77).
The next year, in 1988, the Faro health centre in Algarve opened an extension 
for the prevention and treatment of drug addiction, SPAT (Drug Addiction 
Prevention and Treatment Service). Algarve, at the southern point of Portugal, 
was, as it still is, a well-known holiday resort. All-year, all-weather amenities, 
the affluence of foreign and Portuguese tourists, closeness to traffic routes, a 
natural coastline that fostered illegal landings and a holiday mood favoured 
a leisure environment for drug addiction and led local health authorities to 
open SPAT.
The illegality and criminalisation of drug consumption naturally posed a 
problem to medical and nursing personnel, since they were bound to report 
drug addicts to the criminal justice system. This duty was overruled by pro-
fessional secrecy, which they had pledged to uphold.
The year 1990 was pivotal. Apart from the existing GPCCD, the Co-ordination 
Office for the Fight against Drugs, the presidency of the Council of Ministers 
reformulated Projecto VIDA, headed by a high commissioner with the position 
of Under Secretary of State for Prevention Issues, who acted as national co-
ordinator. SPTT, the Service for Drug Addiction Prevention and Treatment, 
was created in 1990. From then on, the treatment centres within the ministry 
of justice were absorbed by SPTT and the ministry of health regained sole 
competence for the treatment of drug addiction. That same year, a National 
Directory for the Investigation of Drug Trafficking was created at the Judiciary 
Police.
The institutional design would be reformulated over the years, but in sub-
stance it remained very close to the 1990 framework.
In 2000 the GPPCD was restructured as the IPDT, the Portuguese Institute for 
Drugs and Drug Addiction, which one year later absorbed Projecto VIDA; in 
2003 the IPDT absorbed the SPTT to become the IDT, the Institute for Drugs 
and Drug Addiction. This, the current government institution, depends on the 
ministry of health and encompasses transversal areas such as international 
co-operation, research, training, data, communication and demand reduction. 
Since the president of the executive board is the national co-ordinator, IDT 
also carries out national co-ordination tasks.
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9.4. The illicit drugs situation
Using data from the internal evaluation report on the Action Plan on Drugs 
and Drug Addiction 2008, along with data from the 2009 Annual Report on 
Drugs and Drug Addiction as presented to Parliament (data for 2010 not being 
released until November 2011), we find the illicit drugs situation is as follows.
The Portuguese General Population Surveys, conducted in 2001 and 2007 for 
the 15-64 age group, evidenced an increase for every age group of lifetime 
prevalence of consumption of any drug, except for a decrease of lifetime 
prevalence in the 15-19 age group, from 10.8% to 8.6% (Balsa et al. 2008).
Lifetime prevalence of illicit drug use among Portuguese school students aged 
16 in 1995 and 2007 showed a decrease in all illicit drugs taken together, as 
well as for cannabis, ecstasy, amphetamines, cocaine and heroin.
A study conducted by the IDT found a decrease in the lifetime prevalence of 
illicit drug use among Portuguese secondary school students of all ages. Illicit 
drug use was 14.2% (under 16) and 27.9% (16 and over) in 2001, and 8.4% 
(under 16) and 19.9% (16 and over) in 2007 (Feijão 2008).
Within the public network the number of patients has steadily grown, from 
30 266 in 2004, when an external evaluation to the Portuguese National 
Strategy was conducted, up to 38 875 in 2010. First treatment demands grew 
from 5 023 in 2004 to 7 643 in 2010. Follow-up treatment episodes grew 
from 374 149 in 2004 to 614 213 in 2010, this being the only indicator with 
a decrease from the year before: it was 616 658 in 2009 (IDT 2010). However, 
new patients’ intravenous consumption in the 30 days before first consultation 
had decreased from 36% in 2000 to 7% in 2010 (IDT 2010).
The prevalence estimates among problematic drug users (estimated prevalence 
rates per 1 000 inhabitants aged 15-64) decreased from 6.4-10.7 in 2000 for 
opiates, cocaine and/or amphetamine consumption to 6.2-7.4 in 2005. As 
for intravenous consumption (current or recent) it was 2.3-4.7 in 2000 and 
1.5-3.0 in 2005 (Negreiros et al. 2009).
In 2010, outreach teams, support teams and low-threshold treatment pro-
grammes contacted 15 263 users, with an average of 7 032 contacts monthly. 
The harm-reduction network works with hospitals, day centres, tuberculosis 
and HIV attendance units, treatment structures, therapeutic communities, 
detoxification units, shelters and social security services in providing care to 
users and signalling their need for treatment.
HIV transmission notifications among drug users had fallen from 1 430 in 
2000 to 164 in 2009, whereas HIV transmission among heterosexual partners 
decreased much more slowly, from 1 032 in 2000 to 677 in 2009, and among 
homosexual partners it went up from 214 in 2000 to 218 in 2009 (transmis-
sions reported until 31 December 2009).
106
Policy on psychoactive substances and beyond
The proportion of inmates sentenced for drug and other offences reporting 
the use of heroin before confinement fell from 44.1% in 2001 to 29.9% in 
2007, while those acknowledging intravenous consumption fell from 27% 
to 18.21%; the proportion of inmates sentenced for drug and other offences 
reporting the use of heroin during confinement fell from 20.1% in 2001 to 
13.5% in 2007, while those acknowledging intravenous consumption fell 
from 11.4% to 3.1% (Torres et al. 2009).
The proportion of inmates convicted under the Drug Law (production, posses-
sion of more than 10 days’ average doses, trafficking, money laundering) relative 
to the total decreased substantially between 2003 and 2009, from 3 558 in 2003 
to 2 026 in 2009 (IDT 2010). However, illicit substances seized between 2003 
and 2009 rose; it is believed that, after drug decriminalisation on 1 July 2001, 
law-enforcement agencies no longer concentrated on charging drug users.
Within the Drug Addiction Dissuasion Commissions (DADC) 7 870 files were 
instructed in 2010, from a mere 2 246 in 2001. From 2001 to 2010 a total of 
66 378 processes were filed. Between 2007 and 2009 there was an increase of 
39% in indicters (that is, persons due to be presented to the DADC) assessed 
as drug addicts who pursued voluntary treatment.
In 2010 indicters were 93.9% male and 36.38% employed, whereas 27.4% 
of the indicters were unemployed and 19.59% were students. The most com-
mon illicit drug in indictment applications was cannabis, 60.98%, followed 
by heroin, 16.71%, and cocaine, 10.68%.
9.5. The alcohol situation
The first Portuguese Action Plan against Alcoholism was published in 2000 
as a Council of Ministers resolution, but due to the lack of regulation it was 
not enforced properly.
Three facilities were established in Oporto, Coimbra and Lisbon, dedicated 
to the treatment of alcoholism, receiving patients from a referral network of 
public hospitals and health centres. In 2007 the three alcohol centres were 
merged in the structure of the Institute of Drugs and Drug Addiction, which 
was granted an enlarged mandate “to promote the reduction of licit and illicit 
drugs, as well as the decrease of toxic addictions”.
With the restructuring of the Institute of Drugs and Drug Addiction the 
treatment of alcoholic patients was integrated into the treatment centres 
already addressing drug treatment. Patients are now sent to IDT treatment 
structures, including for detoxification, through a reference network, which 
is also being redesigned.
In support of the design of the new National Plan on Alcohol Related Problems, 
a study was conducted on behalf of the IDT (Lourenço 2008) that compiled 
best practice on alcohol.
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The prevalence of alcohol consumption, as shown by general population sur-
veys for the 15-64 age group, was 75.6% in 2001 and 79.1% in 2007. last-year 
prevalence was 66% in 2001 and 70.6% in 2007; last-month prevalence was 
59.1% in 2001 and 50.6% in 2007 (Balsa et al., 2008).
According to World Drink Trends 2005, Portuguese consumption of wine, 
beer and distilled drinks in 2003 amounted to 42.8, 58.71 and 1.4 litres per 
capita, respectively. Portugal was then the fourth world consumer of wine.
According to the 1995/6 INS study, the age groups with highest consumption 
of alcoholic drinks were 25-44 and 45-64. The 1998/9 INS study showed 
that the 25-44 age group had increased its consumption of alcoholic drinks, 
whereas last-year prevalence had increased in the over-75 age group. In the 
15-24 age group, the most common drink was beer, several times a week.
Still according to the 1995/96 INS study, men’s last-year prevalence was twice 
that of women, last-month prevalence was three times that of women, and 
men consumed more wine. The prevalence of male consumers was higher in 
northern Portugal and there was increased consumption among women and 
young people from the southern area of Alentejo.
According to the 2005/6 INS study, there was an increase of last-year preva-
lence, with women’s consumption increasing 5% and men’s increasing 2.4%.
Eurobarometer 2007 reported that 15% of the Portuguese population showed 
a binge pattern, with 11% reporting having three to four units and 4% drink-
ing more than four units.
Gameiro estimated (Gameiro, 1997) that there were 750 000 excessive con-
sumers (9.4% of the general population over 15 years old) of which 580 000 
were alcohol-dependent (7% of the general population over 15).
Among young people (16 to 18) 44% did not agree that alcohol is harmful to 
health, with only 11% agreeing that alcohol is a “very dangerous” substance 
(Eurobarometer, 2004). Lifetime prevalence of alcohol among secondary 
students (under and over 16) in 2003 was 47% (16+) and 94% (under 16), 
and in 2006 it was 59% (16+) and 88% (under 16) (Feijão and Lavado 
2006, Aníbal 2006).
In 2006 nearly 44.9% of children and youngsters under 16 who were under 
the scrutiny of the Children’s and Youngsters Protection Commissions had 
one or both parents with alcoholic dependence (Aníbal 2006). Also in 2006, 
1 876 (15.3%) children and youngsters who were institutionalised had been 
withdrawn from their families for reasons of alcoholic dependence (ISS 2006).
According to APAV, the Portuguese Association for Victim Support, 24% of 
the perpetrators of violent crimes are alcohol-dependent and 25% of violence-
related situations reported are related to alcohol dependence.
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In 2006, in the 503 900 alcohol tests conducted by road enforcement agen-
cies, 7.3% of drivers (37 011) presented rates of blood alcohol of more than 
0.5 grams/litre, with 54% (19 986) committing a criminal offence, that is, 
having more than 1.2 grams/litre blood rate.
In 2007 the road enforcement agencies registered 1 584 (1.6%) out of 99 835 
accidents were probably due to alcohol (GNR), with 6 031 people involved 
in driving accidents monitored by the National Institute on Legal Medicine 
(INML). Of those, 3 574 (60%) reported rates of blood alcohol of more than 
0.5 grams/litre. Out of the 3 546 drivers involved in car accidents and moni-
tored, 2 091 (59%) had rates of blood alcohol of more than 0.5 grams/litre 
and 43.3% had rates of more than 1.2 grams/litre, classed as a crime. Out of 
the 970 victims of car accidents with autopsies conducted by INML, 35.4% 
had rates of blood alcohol of more than 0.5 grams/litre.
In 2006 a total of 6 454 people were diagnosed with cirrhosis and alcoholic 
hepatitis, which corresponds to a total of 67 565 hospital inpatient days. They 
represented 6.7% of all patients admitted in 2006.
Currently alcohol-related problems intervention is addressed through the 
National Plan for the Decrease of Alcohol Related Problems 2010-12, which is 
the backbone of Portuguese intervention. It was designed as a result of a debate 
with much participation by public administration, industry, marketing and 
NGO representatives. Ideally, the National Plan for Drugs and Drug Addiction 
and the National Plan for the Decrease of Alcohol Related Problems 2010-12 
should have been one single document, but the time frames were different, so 
it was agreed that the two plans might become one in the strategic framework 
of 2013-20. The National Plan for the Decrease of Alcohol Related Problems 
2010-12 was approved by the Inter-ministerial Council on Drugs, Drug Addiction 
and Alcohol Related Problems in May 2010, though it was enforced from 2009.
The National Plan for the Decrease of Alcohol Related Problems 2010-12 sets 
strategic objectives and operational goals for seven priority areas: youngsters, 
children and pregnant women; road accidents; adults and workplace; preven-
tion, training, communication and education; data collecting and information 
systems; treatment; reintegration. Quantitative goals have been set for the 
seven priority areas, namely:
1. To reverse the growing trend of consumption prevalence and:
a. To decrease from 20.7% (2007) to 18% the prevalence of drunken-
ness in the past year within the general population;
b. To decrease from 34.6% (2007) to 30% the prevalence of drunken-
ness in the past year among young people aged 15-19;
c. To decrease from 48.3% (2007) to 43% the prevalence of binge drink-
ing (more than three or four drinks on one occasion) at least once a 
year among young people aged 15-24.
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2. To decrease from 305 (2007) to 250 the number of deaths in car accidents 
associated with a rate of blood alcohol equal to or higher than 0.5 grams/
litre.
3. To decrease from 18.8% (2006) to 14% the random pattern rate for 
sicknesses assigned to alcohol for people under the age of 65.
4. To decrease from 9.6 litres (2003) to 8 litres the per capita annual 
consumption.
The National Plan for the Decrease of Alcohol Related Problems 2010-12 
has also assigned special goals for national co-ordination, international co-
operation and information, research, training and evaluation.
Other than the existing three levels of the National Co-ordination for Drugs, 
Drug Addiction and Alcohol Related Problems – that is, inter-ministerial (the 
Inter-ministerial Council), between ministries (the Inter-ministerial Council’s 
Technical Commission) and with the main constitutional organs and civil 
society (the National Council) – a fourth level was created for alcohol-related 
problems composed of parties representing the interest groups that partici-
pated in drafting the National Plan on Alcohol, namely public administration, 
industry production, retail and NGOs, which are part of the newly created 
Alcohol Forum.
9.6. The tobacco situation
Tobacco-related problems are addressed in the technical-normative guidance 
of the General Directorate on Health. Hospitals and health centres provide 
outpatient anti-smoking consultations.
In 2007 a bill of law that prohibited smoking indoors in any collective place, be 
it public or private, was approved. Law 37/2007 was published in 14 August, 
approving norms for the protection of the population involuntarily exposed 
to tobacco smoke and regulations to reduce demand for tobacco and foster 
consumption cessation or non-dependence. Enclosed areas for smokers in 
areas of collective use can be provided only when separate air renewal is 
assured. Penalties vary from €50 to €750 for smokers and €50 to €250 000 
for owners of public and private facilities. The bill establishing tobacco stand-
ards to protect citizens from exposure to involuntary tobacco smoke entered 
into force on 1 January 2008. Its implementation marked a turning point in 
tackling this issue at national level.
The main conclusions of the report covering the years 2008 to 2010, to be 
delivered to the state minister responsible for health with a view to its sub-
sequent submission to the National Assembly42 (INFOTABAC 2011), are as 
follows. Portugal was the European country with the highest prevalence of 
42. www.min-saude.pt/portal/conteudos/a+saude+em+portugal/noticias/arquivo/2011/5/
relatorio++tabaco.htm, accessed on 20 October 2011.
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smoking-decreased liabilities in the workplace from 2005 to 2010, ranking 
6th in Europe out of 27. There is evidence of reduced tobacco consumption 
in the home after the entry into force of the law. There was a clear change of 
smoking patterns among smokers, both in reducing active smoke as well in 
reducing exposure to second-hand smoke. In 2009 the number of episodes of 
hospital admittances for ischemic heart disease decreased for the first time 
in 16 years; the rate of episodes of hospitalisation for chronic obstructive 
pulmonary disease observed a slight decrease. There is technical incompat-
ibility between the enforcement of legislation on indoor air quality and the 
current law on tobacco.
The law is perceived very positively by the population, with room for improve-
ment in the reduction of second-hand smoke. There is a majority in favour of 
banning smoking in public places and supporting policies on tobacco control. 
The population recognises that the law has helped to change habits, improve 
health, protect non-smokers and improve air quality in public indoor spaces.
Studies are not conclusive about changes in the prevalence of smoking in 
Portugal. There is a sustained decrease of tobacco consumption in pupils of 6th 
to 8th grades (mandatory school is from 1st to 12th grades), with one of the 
series pointing to a downward trend in consumption tobacco estimated at 5% 
decrease. None of the series studied showed a trend of increasing prevalence 
of smoking among women, and smoking cessation consultations increased 
62% between 2007 and 2009. However, there is some evidence that tobacco 
advertising is still in place in Portugal.
9.7.  National co-ordination structure for drugs,  
drug addiction and alcohol-related problems
In April 2010 the National Co-ordination Structure for Drugs and Drug 
Addiction was enlarged by Law Decree 40/2011 to include alcohol-related 
problems. The national structure is composed of: an Inter-ministerial 
Council of the competent ministers; an Inter-ministerial Council’s Technical 
Committee, composed of ministers’ representatives; a member of government 
responsible for Drugs, Drug Addiction and Alcohol Related Problems, who 
is the minister for health; a national co-ordinator, who is the president of the 
IDT’s executive board; and a national council composed of representatives of 
other sovereign organs; the Azores and Madeira autonomous regions’ govern-
ments; the public prosecutor; and an array of institutions from civil society, 
including representatives of alcohol production, trade and marketing.
The national co-ordination structure is in charge of designing, monitoring 
and evaluating the national strategy on drugs and drug addiction and alcohol-
related problems. At the top level, the Inter-ministerial Council approves the 
national strategy, national plans and action plans. Ten sub-commissions were 
created within the framework of the Inter-ministerial Council’s Technical 
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Committee, with representatives of public institutions and general direc-
torates that are in charge of implementing the National Plan on Drugs and 
Drug Addiction 2005-12 and the National Plan for the Decrease of Alcohol 
Related Problems 2010-12.
These sub-commissions are: monitoring and evaluation; international co-
operation; public expenses; data and research; communication, information 
and training; prevention, harm reduction, treatment and reintegration; drug 
addiction dissuasion; intervention in school, university, work, recreation 
and road contexts; illicit substances supply reduction; and regulation and 
monitoring of licit substances.
In spite of having two different national plans for licit and illicit substances, 
that is the national plans on alcohol and drugs, the fact that either organ of 
the national co-ordination structure (and in particular the sub-commissions) 
can monitor and evaluate the two national plans within the same structure 
allows for a growing commonality and integration of policies on alcohol and 
drugs. These organs are also in charge, at different levels, of proposing and 
adopting the national strategy on drugs, drug addiction and alcohol-related 
problems and its operationalisation. It is expected that for the next strategic 
cycle, 2013-20, there may be a single plan for drugs, drug addiction and 
alcohol-related problems.
9.8. Conclusions
Drug, drug addiction, alcohol and tobacco public policies in Portugal have 
evolved differently in line with international and national contexts. These 
contexts may vary from international convention law, issued from the United 
Nations drug conventions framework, World Health Organization guidelines 
or European Union common policies and supranational agreements. In all 
cases, national circumstances as well as actual needs have shaped policies and 
determined their evolution.
Policies in drugs, drug addiction and alcohol-related problems are at present 
organised under national plans and action plans co-ordinated by the same 
office, though (owing to different time frames) policy is conducted under two 
separate strategic plans. It is expected that from 2013 a common plan may 
address drugs, drug addiction and alcohol-related problems.
Drug addiction and alcoholic issues are already addressed by a common social 
and health structure. The National Plan on Drugs and Drug Addiction 2005-12 
has introduced a change of paradigm regarding intervention in the demand-
reduction area. The widening of the Institute on Drugs and Drug Addiction’s 
mission provides for inclusion of alcohol-related problems, with an integrated 
approach to prevention, harm reduction, treatment and reintegration, though 
patients’ referral may vary.
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As for tobacco, the policy pathway has been different and was chosen to protect 
non-smokers and prohibit passive smoking by enforcing severe prohibitions.
9.9. Acronyms
APAV Associação Portuguesa de Apoio à Vítima (Portuguese Association 
for Victim Support)
CEJ Centro de Estudos da Juventude (Youth Study Centre)
CEPD Centro para o Estudo da Profilaxia da Droga (Centre for the Study of 
Drug Prophylaxis)
CIJD Centro de Investigação Judiciária da Droga (Judicial Drugs 
Investigation Centre)
CSDP Centre for the Study of Drug Prophylaxis
DADC Drug Addiction Dissuasion Commissions (Comissões para a Dissuasão 
da Toxicodependência)
GNR Guarda Nacional Republicana (National Republican Guard)
GPCCD Gabinete de Planeamento de Coordenação e Controlo de Droga 
(Co-ordination Office for the Fight against Drugs)
IDT Instituto da Droga e da Toxicodependência (Institute of Drugs and 
Drug Addiction)
IPDT Instituto Português da droga e da Toxicodependência (Portuguese 
Institute of Drugs and Drug Addiction)
INME Inquérito Nacional em Meio Escolar (National School Inquiry)
INML National Institute of Legal Medicine
SPAT Serviço de Prevenção e Atendimento de Toxicodependentes (Drug 
Addiction Prevention and Treatment Service)
SPTT Serviço de Prevenção e Tratamento da Toxicodependência (Service 
for Drug Addiction Prevention and Treatment)
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10.1. Introduction
10.1.1. The Swiss political system
Switzerland, lying at the centre of western Europe and bordering on Germany, 
France, Italy, Austria and Liechtenstein, is one of the continent’s smaller 
nations. It has a population of 7.5 million, with four different local linguistic 
cultures (German, French, Italian and Romansh). Foreigners account for 
20% of the population, and about half of them are native speakers of a non-
Swiss language.
Switzerland’s political and administrative system is of a strongly federalist 
character, with responsibility for many state tasks being shared by the federal 
authorities, 26 cantons and more than 2 500 communes. In particular, the 
cantons are primarily responsible for health and education policy. Popular 
initiative and referendum rights mean that the public influences the country’s 
political constitution to a considerable extent. Any amendments to the consti-
tution and numerous laws have to be approved by a popular vote before they 
come into effect. The government – a collegiate body of seven ministers – is 
made up of representatives of the country’s four main parties, collectively 
representing about 80% of the electorate.
10.1.2.  Substance use/misuse: some data on consumption, demand 
and supply reduction
Drug problems – in the sense of consequences of the use of illegal psycho active 
substances, as perceived by the public – have existed in Switzerland, as in 
many other European countries, since the social upheavals of the late 1960s 
and early 1970s. For a long time, popular and expert perceptions centred on 
heroin use and the associated multiplicity of health, psycho-social, economic 
and social problems, as well as the use of cannabis products. As will be shown, 
the consumption of tobacco and alcohol became a subject of Swiss public 
health strategies only at the end of the last century.
Switzerland en blanc
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However, the epidemiological data (for lifetime prevalence among people 
aged 15-39, 1992 to 2002) show that consumption patterns and associated 
problems have undergone significant changes over this period.
The quantity of pure alcohol consumed per person per year has been steadily 
decreasing since 1990 (8.5l in 2010, down from 10.3l in 1990). In parallel, the 
number of persons consuming alcohol in a non-risky way increased between 
1997 and 2007 (from 94.2% to 95.5%). In contrast, the number of young peo-
ple between 15 and 24 years old consuming alcohol riskily slightly increased.
In 2001, 33% of the population (ages 14 to 65) smoked. Since then, this 
number has steadily decreased until, in 2010, only 27% of those aged 14 to 
65 smoked (poll on the consumption of tobacco, yearly). 
In 2007, 19.7% of all persons over 15 had consumed illegal drugs at least 
once in their life. Among persons aged 15-39, the proportion using any illegal 
drug had risen from 16.7% in 1992 to 28.2% in 2002. This was mainly due 
to the strong rise in the number of people consuming cannabis. From 1997 
to 2007, the proportion of persons over 15 having ever used cannabis rose 
from 14.2% to 19.4%. Over the same period, there was also a considerable 
increase in cocaine use in the same population, from 1.6% to 2.8% (Swiss 
Health Survey). In contrast, there was almost no increase in heroin use, up 
from 0.5% to 0.7%, and the number of dependent heroin users, as estimated 
by the Federal Office of Public Health, fell by about 25%. We can judge that 
heroin use has stabilised by looking at the statistics for heroin and methadone 
substitution treatment, which show that now only a few patients each year 
begin a substance-based treatment, while most such patients have been in 
one of these programmes for years. The average age of people in treatment is 
rising by about one year every year (methadone statistics). 
Statistics on treatment show an important decrease in persons aged 16 to 29 
coming into contact with any kind of help structure (ambulant or stationary) 
because of heroin since 1997, but they show a continued increase in persons 
in need of help or counselling due to cannabis. The reasons for this increase 
are increased prevalencies for cannabis and continuing co-operation by justice 
and police with the addiction aid system for (mainly) very young users. The 
same tendency, though less marked, can be shown for cocaine until 2006 
(statistics on the addiction aid system).
Data collected during prevention actions in night-life settings (surveys car-
ried out at the same time as drugs are being checked by qualitative laboratory 
analysis) show a very high rated prevalence of tobacco and alcohol as well 
as cannabis, ecstasy, amphetamines and cocaine (all more than 74%, up to 
98%). This shows that at least in certain settings, the use of substances does 
not depend on their legal status, but on the effects the substances might have.
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The data above, from the Swiss Health Survey, Health Behaviour in School-
aged Children (HBSC) studies and other polls by social and health institutions, 
must be complemented by data on drug seizures by police and customs, by 
waste water tests and other data on disposables.
10.2.  The political and legal context, and perceptions  
of addiction issues
10.2.1. The development of Swiss addiction policy
Alcohol policy
The oldest domain treated by politics in the whole prevention and addiction 
field is alcohol. The federal state started the taxation of alcoholic products in 
the 1880s. The first national Alcohol Act was passed in 1887 and was expected 
to stop the increase in numbers of alcoholic citizens by raising the prices of 
beer and wine. Nevertheless, prevention aims were always less central than 
a possibly liberal taxation system. Only after 2005 did the Swiss federal state 
start to define a national alcohol programme with the focus on public health, 
not least because of the experience of increasing numbers of young people 
consuming alcoholic drinks to excess. However, this first programme under a 
public health umbrella was partly pre-set to fail, since no structural measures 
were designated.
The antagonism between public health issues/prevention and a liberal taxa-
tion system is illustrated in the actual debates on revision of the national 
Alcohol Act. Whereas addiction professionals favour an extended catalogue 
of structural measures like minimum prices or a ban on “happy hours”, pro-
ducers and the economy hold up all of these recommendations and fight for 
the status quo or even liberalisation of charges and restrictions.
Drug policy
Current Swiss drug policy has its origins in the 1970s. During this decade, 
drug use was still considered as a criminal act. The partial revision of the 
federal Narcotic Drugs Act in 1973 penalised every use of illicit substances. 
The punishment was at that time explicitly extended to personal use and was 
as strict as that for production and dealing. Drug consumers were still con-
sidered as delinquents who must be prosecuted. The principle was, through 
punishment, to achieve abstinence.
In the 1980s the incursion of HIV marked a very important moment in Swiss 
drug policies. The fast propagation of the virus within drug consumer groups 
and the misery of the heroin consumers caused law-enforcement measures 
to fail. The open drug scenes challenged not only the law-enforcement side, 
but also the social and public health side. Due to this situation several bigger 
towns established the first harm-reduction offers such as needle exchange, 
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consumption rooms and emergency overnight accommodation. At the same 
time, specific therapy and caring offers were developed, for example opioid 
maintenance or heroin-based treatment programmes. In addition, the open 
drug scenes were closed down by the police. This marked the most important 
turnaround in Swiss drug policy.
During the early 1990s, federal drug policy was consolidated. In 1994, the 
government officially endorsed the fourfold approach (prevention, therapy, 
harm reduction and law enforcement) as the basis of its drug policy. In 1991 
and then again in 2002 and 2006, the government approved packages of 
measures, each running for several years, to reduce drug-related problems in 
Switzerland. Each package contained a large number of individual measures 
whereby the federal authorities proposed to fulfil their drug policy responsibili-
ties while supporting the cantons, which bear primary responsibility for drug 
policy and its implementation in Switzerland. In 2011, the third package of 
measures – originally planned to run for a five years from 2006 to 2011 – was 
extended by another four years to give time to develop alternative strategic 
approaches (see below).
Until a few years ago, the focus of the policy makers and federal administra-
tion was on illegal substances. This pattern is gradually changing. Illegal drugs 
are losing public attention while tobacco and, to a lesser extent, alcohol are 
gaining importance in public perception as well as in political actions and 
regulations.43
Tobacco policy
The Swiss Government took its first steps in the 1990s. The Federal Office 
of Public Health launched campaigns spreading the message of smoking 
harm. But it was only at the beginning of the new century, when strategies 
were changed and campaigns started focusing on passive smoking, that there 
were also influences on cantonal and federal legislation. Within a few years 
a federal act and cantonal acts – in all cantons – were passed or amended to 
accomplish smoke-free public spheres. 
Tobacco policy is much more than drug policy, where thinking is defined 
under the umbrella of the public health approach, focusing in this case on 
the defence of the people (potentially) harmed by smokers. Since NGOs as 
well as policy makers have to confront a powerful tobacco industry, it is quite 
difficult to put in place well functioning structural measures to regulate more 
heavily the production of and trade in tobacco products. Therefore, tobacco 
policies stress complete abstinence and smoking cessation rather than less 
harmful forms of consuming tobacco.
43. For a good overview of drug policy making in Switzerland, see Joanne Csete (2010), From 
the mountaintops: What the world can learn from drug policy change in Switzerland, Open Society 
Foundations, Lessons for Drug Policy Series, Warsaw/New York. 
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10.2.2. Comparisons
If we compare the three sectors – alcohol, drug, and tobacco – some points 
attract attention.
Drug policy is noticeably affected by a black market that undermines every 
interest of the consumer as well as being completely free of every form of active 
regulation. This leads to various specific problems for consumers (access to 
prevention messages, social disintegration and squalidness) and for the state 
(substance control, taxation and market supervision are all impossible). In 
contrast, tobacco and alcohol policies are – or at least can be – determined in 
co-operation between the interests of prevention and production.
Within the whole domain of illegal substances, nothing is more fixed than 
the acceptance that the persons concerned are already consuming and are 
therefore ready to take risks (health, life, social disintegration and criminal 
prosecution). With a little less certainty, this accepted point of view is also 
true for alcohol consumers. Nevertheless, an important branch of the alcohol 
prevention field is that followed by the temperance movement. In tobacco 
policy, by contrast, abstinence is set as a norm, following the credo that every 
cigarette is harmful, and tobacco industries should not be allowed to propa-
gandise a “healthy form of smoking”. Therefore the drug policy pillar of harm 
reduction is often excluded as an effective approach to users.
After 1995, professionals from the demand- and supply-reduction sides drafted 
models of co-operation between the police and harm-reduction professionals. 
This happened predominantly at municipal level, starting from the assump-
tion that all agencies were working on the same problem and pursuing similar 
goals, with the aim of getting more co-ordination in measures by police and 
the aid system. This led to a common understanding of what had to be done 
by professionals of the two pillars, harm reduction and repression. These 
models now have new interest because of increasing numbers of people con-
suming alcohol (and other psychoactive substances) in public and because 
of major problems with clandestine drug traffic that nevertheless invades the 
public sphere. Whereas police intervention in drug use was mostly aimed at 
criminality, today’s police interventions are much more linked to the duty 
of public order. This has set new challenges to the co-operation models for 
police and aid services.
Drug policy was, for a time, a response to a specific problem, namely the huge 
number of socially disintegrated heroin users and open scenes of drug use. 
Since the public considered the “drug problem” a high priority, politics had 
to propose strategies urgently. Since the problem was mainly located in the 
bigger cities, and since it was in the national interest to close down “needle 
parks”, it was at the beginning communes and the confederation who jointly 
started finding new solutions to the problem. The confederation took over at 
first a lot of local initiatives, for example, the prescription of heroin, which was 
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first practised in Zurich and Bern. At that time, the Federal Office of Public 
Health (FOPH) judged this plan as promising and a practical component of 
a wider answer to these major problems. It found a scientific umbrella that 
allowed it to offer this new therapy legally. Because of this very field-oriented 
approach, Swiss drug policy is still quite close to the institutions offering 
therapy or harm-reduction measures. 
Unlike this fieldwork approach, alcohol and tobacco policies were always 
focused on public health issues (if that, since alcohol policy was for 100 years 
determined by fiscal policies). The co-operation between confederation and 
cantons is notable in this different approach. The actions of FOPH, for exam-
ple, are mainly concentrated on promoting projects by financing them or by 
promoting networks. In tobacco and alcohol policies, it is hard to imagine 
FOPH creating a quality-assessment instrument or a catalogue of recom-
mended products for (substitution) treatment. On the other hand, it is hardly 
imaginable that FOPH could lead a campaign on illegal drugs like those it has 
led on smoking or problematic alcohol use.
Drug policy always stresses addiction, whereas alcohol and tobacco policies 
also emphasise chronic or non-communicable diseases (NCDs). Therefore we 
must say that tobacco policies focus largely on the prevention of NCDs and 
less on the treatment of tobacco consumers.
Rethinking policy
In view of all that, and having talked about addiction policies, we are close to 
thinking about addiction policies by starting to rethink drug policies. Since 
drug policy has been, from the start, regularly confronted by use, by impor-
tant changes in behaviour, by central social questions like disintegration and 
squalidness, its instruments are hardly restricted to the drug policy field, 
apart from specific instruments like the prescription of heroin which cannot 
find any use with tobacco or alcohol users. Drug policy is characterised by an 
openness between the four pillars – prevention, therapy, harm reduction and 
repression – but it is also open to measures on illegal and legal substances. A 
last point to mention is the fact that drug policy has never been considered 
as uniquely a matter of public health and an instrument to prevent non- 
communicable diseases. In the case of addiction, this approach is urgently 
needed, since therapy or harm reduction cannot deal only with health ques-
tions, but also with social, integrative, criminal and other matters.
This thinking had its effects also on the legal situation in Switzerland. At 
the end of the 1990s, the federal Parliament was willing to anchor the four 
pillars in the federal Narcotic Drugs Act. Since liberalisation of cannabis was 
included, amendment of the act was refused by the low chamber (Nationalrat) 
in 2004. In 2006, the parliamentary commission for social security and health 
adopted a new proposal for partial revision of the federal act.
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The aims were to set aside the cannabis question, but to:
 − adapt the law of 1951 to recent societal and political changes;
 − fix four-pillar politics in the federal Narcotic Drugs Act and improve 
government measures on prevention, therapy and harm reduction;
 − anchor heroin-based treatment (heroin prescription);
 − strengthen youth protection measures with a focus on early intervention;
 − find answers to the increasing phenomenon of drug consumption, as 
well as to the more and more prevalent mixed consumption of alcohol 
and illicit drugs;
 − give a legal framework to the medical use of cannabis.
In its report, the commission declared (on the purpose clause of the project): 
“It is about to improve efficacy and efficiency by promoting a more coherent, 
more co-ordinated view of the measures and of the stakeholders. Complete 
abstinence may be an aim of these. Yet Article 1a enumerates explicitly the 
four pillars. To achieve these objectives, the Confederation and the Cantons 
will take measures over all four pillars. All of these measures are applicable, 
independently of the substance. In other words, they are intended not only 
for illicit substances but for all substances with addiction potential. This dis-
position embodies the will to follow integral policies on addiction matters.”44
Thus the legislative authority, in revising the federal Narcotic Drugs Act, 
clearly wishes to focus on real and potential addiction problems due to sub-
stance use and abuse, integrating all psychoactive substances. Whereas the 
act itself only refers to psychotropic substances, the report mentioned above, 
the popular vote provoked later and the resulting legal ordinance (on narcotic 
addictions and other addictive disorders) clearly refer to all psychoactive 
substances.
10.2.3.  Different conceptual approaches to a more integral addiction 
policy
The segmentation found in the professional arena can also be observed in 
the Federal Office of Public Health (FOPH), which for many years has had 
largely unco-ordinated administrative sections – with separate programmes 
and budgets – for illegal drugs, alcohol and tobacco. However, in 2002, the 
FOPH responded to growing calls from specialists for an integrated view by 
commissioning a report from an external expert, in which foundations and 
materials were presented to support greater integration of federal activities in 
44. Initiative parlementaire: Révision partielle de la loi sur les stupéfiants. Rapport de la Commission 
de la sécurité sociale et de la santé publique du Conseil national, Bern, 4 May 2006, pp. 8155-6 
(report by the commission on social security and public health of the lower chamber on partial 
revision of the federal Narcotic Act). 
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the area of addiction policy. The report45 employs a broadly defined concept of 
addiction, including both substance-related and non-substance-related forms 
of dependence, together with eating disorders. It contains an empirically based 
account of the need for action on addiction policy, provides an overview of 
current federal practice in this area and sets forth requirements and recom-
mendations for a new addiction policy in Switzerland.
Around the same time, the question of greater integration of federal drug 
policy activities was also addressed by the Federal Commission for Drug Issues 
(Eidgenössische Kommission für Drogenfragen; EKDF), which advises the 
government on drug-related matters. In its report46 the EKDF analysed the past 
and present state of Switzerland’s drug policy and called on the government 
to increase the coherence and credibility of its addiction policy for the future. 
Taking the fourfold drug-policy approach as a starting point, the commission 
proposed a new, three-dimensional model as a basis for the reorientation of 
addiction policy. As well as the various illegal drugs, this model encompasses 
alcohol, tobacco and medicines with psychoactive effects. It declares the four 
pillars – prevention, therapy, harm reduction and law enforcement – to be a 
valid model for all these substances, and it distinguishes in each case between 
low-risk use, problematic use and dependence.
Taking up the recommendations from both reports, the FOPH requested the 
three federal commissions – on drug issues, on alcohol issues and on tobacco 
control – to jointly develop a coherent addiction policy framework based on 
a public health approach. From 2008 to 2010, a steering group of members 
of all three commissions assessed what had been achieved and identified the 
present and future need for action. In their report, The challenge of addiction,47 
they widened the scope of the framework of addiction policy by stating that 
addiction is more than dependence, more than a question of legal status and 
more than substances. 
Subsequently the steering group presented their policy framework for the chal-
lenge of addiction, based on three new strategic directions. Beyond personal 
responsibility, they saw a need to develop structural measures and to promote 
skills; beyond youth protection, there was a need for appropriate approaches 
for different sections of society; and, beyond health policy measures, they 
found a need for an inter-sectoral addiction policy. Finally, the steering group 
defined 10 principles that should guide implementation of this new policy, 
45. Markus Spinatsch (2004), Eine neue Suchtpolitik für die Schweiz? Grundlagen und Materialien 
für eine verstärkte Integration der suchtpolitischen Aktivitäten des Bundes/Une nouvelle politique en 
matière de dépendances pour la Suisse? Bases et prémisses pour une politique fédérale plus intégrée en 
matière de dépendances. Bern, www.mspinatsch.ch/d/DetailsPublikationen/.
46. Swiss Federal Commission for Drug Issues (EKDF), Von der Politik der illegalen Drogen zur 
Politik der psychoaktiven Substanzen. Verlag Hans Huber, Bern, 2006 (www.psychoaktiv.ch). 
47. Challenge of Addiction Steering Group, The challenge of addiction – foundations for a 
future oriented policy on addiction in Switzerland. Bern, Federal Office of Public Health. www.
challengeaddiction.ch. 
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including the prevention of problematic consumption and behaviours, and 
reduction of the harmful effects on health and the impact they have on indi-
viduals, their environment and society.
Figure 1: The Cube, Federal Commission for Drug Issues (EKDF), 2006
10.3. Structures, measures and stakeholders
As policies on alcohol, drugs, and tobacco are separated, we see the structures 
of these three policies also differ. Within the Federal Office of Public Health 
all prevention and addiction measures are integrated in the sense that it is the 
same administration unit. However, the responsibilities of the three substance 
specific units are very different.
FOPH is the leading body of Swiss federal drug policy, and its drugs section 
is charged with the development and operational realisation of measures 
defined by FOPH. The Federal Office of Police (Fedpol) and the Federal Office 
of Justice are associated with FOPH, since all three agreed to and support the 
current measures on drugs (Massnahmepaket Drogen; MaPaDro). Similarly, 
FOPH is charged with all prevention matters of tobacco consumption and pas-
sive smoking. Its tobacco section is responsible for the development and opera-
tional realisation of the National Tobacco Programme (Nationales Programm 
Tabak NPA), but is not the executing body for the tobacco prevention pool 
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which funds federal, cantonal and prevention projects of NGOs and com-
munes to prevent tobacco consumption. For that purpose, a separate adminis-
trative unit, the Tobacco Control Fund, is led by an expert commission. Only 
in 2011 did the strategic direction of the national programme and the fund 
converge to co-ordinate and adjust the strategies and measures undertaken 
or promoted by each. As already mentioned, FOPH has been charged with a 
national alcohol programme only since 2008. Although the Federal Council 
(government) charged FOPH with developing and realising the programme, it 
is the Swiss Alcohol Board that administers alcohol taxation and the resulting 
fund. This unit is part of the financial administration, the leading body for all 
kinds of alcohol policies and as such also a member of the strategic guidance 
of the programme.
10.3.1.  Stakeholders of Swiss addiction policy, and their 
competences
In Switzerland, drug policy is a joint venture between the federal state, the 
cantons, the municipalities and private actors, mainly non-profit NGOs. 
Co-operation between these actors is guided by the principles of subsidiarity 
and federal policy implementation. The principle of subsidiarity states that, 
as long as a lower level of the political-administrative organisation is in a posi-
tion to accomplish a public task, it should not be allocated to a higher level. 
The principle of federal policy implementation attributes major legislative 
enactments to the federal state, whereas the cantons are primarily responsible 
for implementation of these laws. These two principles delimit the range of 
action of the federal state and make the cantons the most important actor in 
Swiss drug policy.
As presented above, the main legal basis of Swiss drug policy is the Narcotics 
Act and its “four pillars” model of prevention, therapy, harm reduction and 
law enforcement. Within this frame, the various actors have different and 
complementary responsibilities.
At the federal level, in the fields of prevention, therapy and harm reduction, the 
Federal Office of Public Health is the main actor. Its responsibilities include:
 − developing national programmes of prevention as an umbrella programme 
for cantonal, regional and communal measures;
 − supporting the cantons, communes and relevant NGOs in their imple-
mentation work, and co-ordinating their activities;
 − promoting quality control, further education and programme evaluation;
 − documenting and informing the nation about drug problems, and promot-
ing scientific research on illegal drug problems;
 − participating in international conferences and representing Switzerland 
on international bodies.
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At another level, Swissmedic, the Swiss Agency for Therapeutic Products, is in 
charge of the authorisation and supervision of therapeutic products, including 
narcotics and other psychotropic substances and controlled precursors. The 
Federal Roads Office is responsible for problems related to driving and drug 
consumption, and the State Secretariat for Economic Affairs is the body in 
charge of addiction problems at the workplace.
In the field of law enforcement, the Federal Office of Police supports and 
co-ordinates the cantons in enforcing drug laws. It is also responsible for 
international police co-operation and arrangements for law enforcement. 
The Federal Criminal Police investigate cases of serious organised crime and 
money laundering. Fedpol also publishes police bulletins on the drug situ-
ation, acts in precursor control, and co-operates with international police 
organisations and the UN Office on Drugs and Crime (UNODC). The Federal 
Office of Justice plays an important role in drug-related legislative enactment, 
in international judicial assistance and in promoting model experiments in 
prison and penal regimes. Finally, the Federal Customs Administration is 
in charge of drug smuggling control and of preventing the illegal import of 
prohibited substances.
The cantons are responsible for the implementing most drug-related regu-
lations and programmes, including programmes in primary and second-
ary prevention, inpatient and outpatient treatment, medical prescription of 
heroin, substitution therapy, injection rooms and law enforcement of the 
ban on producing, trading, possessing and consuming illegal substances. The 
cantons have a high degree of autonomy in how they shape and implement 
their drug policies.
The drug-related administrative settings for prevention, therapy and harm 
reduction in the cantons are very heterogeneous. In some cantons, the unit 
in charge is the health department, in others it is the social department. Some 
follow an integrated philosophy concentrating all addiction related activities 
(except tobacco) in the same unit; others have a sector oriented approach with 
separate units for each addiction form.
Although the Narcotics Act does not delegate any drug-related tasks directly 
to the communes, many cantons do transfer many such tasks to their com-
munes. This is particularly the case with medium and big cities that are most 
immediately concerned by drug problems.
Law enforcement is in all cantons exclusively a police task. Responsibility 
for enforcing national drug laws lies almost entirely with the cantonal and 
municipal police forces of Switzerland.
Besides these public authorities, there are many NGOs which are mandated 
and financed by cantons or communes to fulfil tasks in the fields of preven-
tion, therapy and harm reduction. These institutions have been playing a 
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vital role in the definition and implementation of Swiss drug policy for a long 
time. In some cantons, they are in charge of (almost) all implementation of 
non-repressive drug-related measures.
Besides these actors in charge of defining and implementing drug-related regu-
lations, there exist many co-ordination and consulting bodies, among them:
 − the Federal Commission for Drug Issues (EKDF), composed of 14 experts 
from various scientific disciplines who advise the government and its 
administration on all aspects of the Narcotics Act;
 − the Conference of the Commissioners of the Cantons in Addiction Affairs, 
composed of the responsible civil servants of all 26 cantons, which is in 
charge of co-ordinating policies and programmes between the cantons 
as well as between the cantons and the federal state;
 − the Conference of the Commissioners of the Cities in Addiction Affairs, 
which consists of representatives of the addiction departments and the 
police of 26 cities, its task being to promote exchange and co-operation 
between the administrative units of social affairs, health and police con-
cerning drug and other addiction problems at city level;
 − the National Committee on Drug Affairs, composed of representatives 
of the federal administration, the cantons and the cities, is in charge of 
co-ordination and exchange between the three administrative levels of 
the state; and
 − the National Co-ordination Committee on Addictions, which is a plat-
form for exchange and co-ordination of NGOs involved in drug-related 
activities.
Most of these committees and commissions are co-ordinated by, and are part 
of, the Co-ordination and Service Platform in Addiction Related Matters. The 
platform includes most of the relevant bodies of the federal state, cantons, com-
munes and NGOs dealing with addiction matters. This platform was convened 
in the 1990s, when communes and the confederation recognised an important 
need for co-ordination work. Until 2011 the platform was constituted via a 
government enactment. Both the platform and co-ordination itself came into 
effect by a specific article of the amended national act on illicit drugs. 
Co-ordination on a federal level is all the more important since the federal 
Narcotic Drugs Act assigns some important duties and responsibilities to 
the cantons, whereas the confederation is charged with co-ordination. Also, 
politics in Switzerland are always realised by co-operation between cantonal, 
municipal and civil society. Therefore co-ordination assures at least a mini-
mal common standard of approaches. Experiences of recent years have led to 
the expectation that the whole addiction and drug field will sample another 
catalogue of important changes, such as concentration and specification in 
the whole treatment offer, an approximation between the different substance 
policies or even abolition of the differentiation corresponding to substances.
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10.4. Measurement and evidence
From the beginning of its drug-related measurement packages in the early 
1990s, the FOPH tried to base the shaping of its activities on relevant data. 
What began with a rather pragmatic use of available statistical data and 
incidental research materials developed over the years into a more and more 
sophisticated information system for steering and evaluating programmes 
and projects. This development was a consequence of fundamental changes 
in the organisation and management of the public sector in Switzerland. By 
making effectiveness and efficiency part of the focus of state action, concepts 
like “taking informed decisions” and “evidence-based decision making” 
required accurate and timely information. Some of this information has been 
collected for a long time and is continually updated. Other data sources had to 
be newly developed and produced for the specific management and account-
ability needs of the policy.
10.4.1. Statistical and epidemiological data
Statistical and epidemiological data are collected and published regularly. They 
are generally produced for multiple users and purposes including monitoring 
and evaluation. In Switzerland, there are three such databases (discussed 
below) that play an important role in the shaping, steering and evaluation of 
drug programmes.
The Swiss Health Survey (SHS), conducted by the Federal Office of Statistics, 
provides information about the health status and health behaviour of the adult 
population, and includes data about drug consumption. The survey has been 
conducted every five years since 1992, covering a random sample of 12 000 
persons with telephone interviews and postal questionnaires. On demand, 
this sample can be increased to serve the particular needs of single cantons. 
In 2012, the Swiss Health Survey will for the first time include questions of 
the Minimum European Health Module (MEHM) and the European Health 
Information System (EHIS). This will allow for future international compari-
sons on some central indicators.
Health Behaviour in School-age Children (HBSC) is a World Health 
Organization cross-national collaborative study which is conducted every 
four years. It is carried out by the NGO Addiction Info Switzerland (formerly 
the Swiss Institute for the Prevention of Alcohol and Drug Problems, or SIPA) 
and financed by the FOPH and the cantons. Health behaviour being the focus 
of the study, it includes a number of questions related to drug consumption as 
well as other addictive behaviour. Switzerland has participated in this study 
since its beginnings in 1986. The survey covers a sample of about 10 000 
11- to 15-year-old pupils who complete a questionnaire in their classroom. 
The international character of this study allows cross-national comparisons 
with 43 countries.
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The Swiss Statistics on Narcotics, published by the Federal Office of Statistics, 
has provided each year since 1975 statistics on police arrests for dealing, 
consumption, smuggling and seizures of drugs. Numbers of drug-related 
deaths were reported until 2008. These statistics are based on data provided 
by the cantons.
10.5. Monitoring
Since 2004, FOPH in co-operation with three NGOs has been running a moni-
toring system called Act-Info on consultations for and treatment of addictions. 
This monitoring system was created by integration and harmonisation of 
five separate statistical systems covering different aspects of addiction treat-
ment. The information is collected from all clients (about 9 000 per year) in 
specialised inpatient and outpatient treatment centres in Switzerland at the 
beginning and end of the treatment process. The data collected come from 
five different sources: the Treatment Demand Indicator Standard Protocol of 
the EMCDDA, the Documentation Standards III of the Deutsche Gesellschaft 
für Suchtforschung und Suchttherapie, the Addiction Severity Index, former 
questionnaires of the integrated statistical systems and selected standardised 
screening tests.
This monitoring system provides data on treatment conditions, socio-demo-
graphic variables and substance consumption before and after treatment. 
These data are intended to serve the following objectives: general knowledge 
about the clients and their addiction problems, early detection of trends, 
documentation of treatment system structures, feedback to practitioners, 
international comparability and exchange, and data for further research.
A more comprehensive Addiction Monitoring System in Switzerland (AMIS) 
is currently under construction. It aims to integrate data from ongoing popu-
lation surveys (SHS, HBSC, Study in low-threshold centres) with specific 
modules of yearly surveys as well as regularly collected data on mortality, 
treatment and repression. The system is planned to be functional by 2012.
10.5.1. Evaluation
Again following the definition of the OECD, “evaluation is the systematic and 
objective assessment of an ongoing or completed project, programme, or policy, 
including its design, implementation, and results. The aim is to determine the 
relevance and fulfilment of objectives, development efficiency, effectiveness, 
impact, and sustainability. An evaluation should provide information that is 
credible and useful, enabling the incorporation of lessons learned into the 
decision-making process of both recipients and donors”.
From the start of its first package of measures, FOPH began also an external 
evaluation programme that was intended to continually provide relevant 
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information about the basic essentials of current activities. Since 1991, four 
global evaluations and several other evaluation studies have been conducted.
The first global evaluation covered the years 1990-92. This preliminary step 
was intended to show up the various indicators (needed or available) for the 
consumption of drugs. Based on this study, the first global evaluation report 
contained a statement about the general drug-related situation in Switzerland 
as well as a methodological frame for future evaluations. Major criteria 
included in this frame were that the evaluation should be global (in the sense 
of including all relevant aspects of the activities) and primarily goal-based, 
but it should at the same time include information about decision making 
and implementation of measures.
The second global evaluation covered the period 1990-96. It was based on 
the reframed results of the first evaluation and included an assessment of the 
measures taken by FOPH and by cantons. Like the first evaluation, it contained 
also an analysis of epidemiological data on drug consumption.
The third global evaluation (1996-9) was methodologically based on action 
theory and logic modelling in order to access the objectives of the singular 
measures of the package. The analysis was particularly focused on the con-
ceptualisation and planning of the programme and on the relation between 
objectives and implementation.
Covering the period from 1999-2002, the fourth global evaluation was par-
ticularly focused on implementation of the package. Simultaneously, a team 
of political scientists was mandated to evaluate the political anchorage of the 
measure package.
These global evaluations covered the first two packages of measures and a time 
period from 1990 to 2003. They consisted of several partial studies focusing 
on selected aspects. Besides, additional singular evaluations of institutions, 
measures and instruments were commissioned by FOPH, among them the 
upskilling programme of MaPaDro, the function of consulting centres for harm 
reduction, the role of police and juvenile courts in prevention and many others.
After 2003, FOPH continued to regularly commission evaluations on particu-
lar aspects of drug policy, for example, an international comparison of drug-
related state interventions, an assessment of the Act-Info monitoring system 
and an analysis of a nationwide information platform on drug-related matters.
Before starting with the activities of the third package of measures in 2006, 
FOPH initiated an ex ante evaluation to survey the state of the central suc-
cess indicators of the package before intervention. In 2011, a second survey 
of these indicators was conducted to identify the net effects of the package. 
Simultaneously, a comprehensive evaluation of ongoing programmes (drugs, 
alcohol, tobacco, nutrition and movement) was commissioned. This evaluation 
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should provide inputs to develop integrated programmes including all rel-
evant addiction fields, as suggested by the report The challenge of addiction 
mentioned above.
10.6. Conclusions
When talking of coherence of policies, it is not enough to define the meaning 
of coherence as such. We should take a look at its practicability or its realis-
able character. Therefore addiction policies cannot be judged as coherent only 
when they are self-consistent. Coherence means then to adjust measures so 
they are more consistent, or – with a view on systemic theories – to attune 
the objectives of different subsystems by formulating them as common objec-
tives. In addition coherence can mean to promote exchange of good practice, 
of experience and of concepts to more easily develop measures answering 
similar problems. Let us give some examples.
We can adjust objectives of subsystems, for instance in models of co-operation 
between demand and supply reduction. When looking at the mission of the 
police and harm reduction, measures against demand and supply stand in the 
way of each other, because the offers of harm reduction create consumption 
rooms and offer needle exchange, whereas the police should, in a traditional 
understanding, be taking substances and needles away from the arrested users. 
Thanks to adaptation of the missions and objectives on both sides, it has 
been possible in Switzerland since the 1990s, to offer a set of harm-reduction 
institutions in bigger cities with the acceptance of the supply-reduction side. 
Actually, due to the initiative of FOPH, Fedpol and the Swiss association of 
police constables, it was possible, co-ordinated by Infodrog, the Swiss co-
ordination body in addiction matters, to agree on an offer of continued training 
and conferences advocating co-operation and actions common to both sides.
We can also broaden concepts to other substances by analysing experience. For 
instance, after the turn of the century, in several Swiss towns discussions were 
held on neglected people similar to the drug users in earlier years, but now for 
their alcohol abuse. To guarantee a minimal protective offer by channelling 
their appearance in public space, the City of Bern developed for the first time 
a low-threshold recreation room for alcoholics. The main idea was borrowed 
from the harm-reduction offers for illegal drug users. As to promoting the 
health of this new group, the offer was slightly adapted, because there is no 
separation of habitable and consumption rooms. Even though since then only 
four low-threshold offers have been established for neglected alcohol users, 
enlargement of the concept has shown that experiences within one field can 
be adapted to others.
Thus, Swiss addiction policy cannot be judged as coherent or consistent. But 
there are initiatives to attempt a more coherent policy by adjusting measures 
and enlarging concepts. Nor is Swiss addiction policy integral, in the sense 
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that structures correspond to the responsibilities of the different involved state 
bodies. Whereas a more coherent direction is – relatively – easy to arrange 
by adjusting subsystems, the alignment of state structures is more difficult 
and risks being fought by different stakeholders. If the people responsible 
within the separate structures do succeed in adjusting subsystems, or objec-
tives, there is little need for integral structures. Coherency in this sense can 
then be understood as the readiness of all stakeholders to co-ordinate their 
strategies and actions.
Concerning the Swiss experience, the initial position is quite comfortable. 
There is a long tradition of not only developing measures focusing on one 
form of addiction, but of considering similar needs within different fields 
as a reason to develop instruments and measures integrating several fields, 
for example concerning quality-control instruments for therapy and harm-
reduction institutions. These were developed not only for institutions focusing 
on illegal drugs, but for every addiction. This choice is all the more justified 
by having a look at the changes in the therapy institution field.
Last but not least, Switzerland has, as remarked before, a legal basis not within 
the federal Narcotic Drugs Act itself but in the will of the legal authorities 
and in the regulations of the act.
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11. Summary and conclusion
Richard Muscat 
Department of Biomedical Sciences, University of Malta
The eight contributions herein attempt to provide an overview of the develop-
ment of policy in the area of psychoactive substances and the current state 
of affairs with regard to integration and coherence of such policies using the 
six indicators developed by the group.
The salient feature from all the eight contributions is the fact that health 
seems to be the main prerequisite for having a policy in place that addresses 
the issue of substance use and possibly beyond.
A second attribute seems to be the move from considering individual sub-
stances on their own within their specific domain – and hence the respective 
government ministries that over the years have been responsible for policy 
on their respective substances. In turn this follows on from above in that the 
main ministry responsible for policy on substance use is health, irrespective 
of whether there is a single document that encompasses more than one sub-
stance or a single document for each of the substances.
Thirdly it would appear that there is a move afoot to consider better integra-
tion of polices related to substance use and hence better co-ordination of 
actions resulting from those polices.
Finally, at last, it is also being acknowledged that a policy for psychoactive 
substances and possibly beyond – for example, addictions in general – does 
not stand alone among a number of national policies in place, and thus the 
question of coherency seems to be surfacing. In the wider picture this also has 
implications with regard to international organisations such as the European 
Union (EU), the World Health Organization (WHO), Council of Europe and 
the United Nations (UN) who also have their own agendas and conventions 
that need to be transposed by their respective member countries.
In light of above, each of the four points will now be considered in the frame-
work developed in the course of the project and outlined at the start of this 
text.
11.1. Context
The context in which drug policy has evolved over the past century provides 
one with an eye opener in explaining what that policy has come to look like 
today. In most countries drug policy came into being in the 1960s and 1970s 
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but it really came into focus during the HIV epidemic of the 1980s. Possibly 
with the exception of Austria, the Netherlands and Portugal, where the drug 
issue was to some extent addressed in the legal sphere at the start of the 20th 
century, in Belgium, Ireland, Israel, Norway and Switzerland drug policy came 
much later, only after the 1960s. This scenario may be similar to that of alcohol, 
which became a major social issue at the start of the 20th century, whereas 
drugs became an issue in the latter half of the 20th century and the start of the 
21st century. So the use of substances and their social impact would seem to 
be the prime driving force in the arena of policy development. The introduc-
tion of harm-reduction measures would appear to be a good example of this 
particular aspect, in that actions were put in place to remedy a major social/
health issue, that of the spread of HIV through the use of shared paraphernalia.
This in turn raises two issues in relation to the object of this exercise. The 
first is that of bottom-up activities – harm-reduction measures such as needle 
exchange and substitution treatment – that were introduced by the services 
on the ground and then at a later stage made “formal” in that they were 
ingrained in later drug policies of the said country. Consequently, the issue 
of top-down/bottom-up approach to the development of policy has now 
become more acknowledged with the presence of interest groups and NGOs 
on national councils, for example, the National Co-ordination Committee on 
Addictions (NCCA) in Switzerland, .
The second issue is the introduction of top-down policy making in the wider 
sphere, notably to differentiate the hard drug and soft drug markets, which 
resulted in the problem of the back-door sales of cannabis to coffee-shop own-
ers in the Netherlands. The appeasement policy can be in turn considered to 
be a consequence of the introduction of the 1998 UN convention in which 
all psychoactive substance use was deemed to be punishable by law, and not 
a minor offence, whereas the Opium Act of 1976 had considered use of can-
nabis to be a minor offence. Without entering into the merits or not of the 
appeasement policy, the fact of the matter is that international bodies have 
influence over the development of policy in individual countries, but this is an 
example of the top-down approach that has resulted in problems of coherency 
with respect to national policy in relation to implementation.
Also of interest is the development of policy in Portugal in 2001, by which use 
of minor amounts of substances was deemed to be an administrative offence 
and not a criminal offence and so was handled by a specific body, namely the 
Drug Addiction Dissuasion Commission. Once again, whether or not this 
development in policy can be considered counter to international norms is 
not the point, but what may be highlighted is that activity by international 
organisations does have some impact on the way a country addresses the issue 
and at times may be thought to be counter to international norms.
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So all in all on the issue of context, policy development today in the field of 
psychoactive substances, mainly drugs, alcohol and tobacco, is influenced by 
background factors, be they internal or external, that have shaped the type 
of policies we see today.
11.2.  Integrated and coherent policy for psychoactive 
substances
As described in Chapter 1, the issue of integrated and coherent policies for 
psychoactive substances is one that needs to be tackled if a major leap in 
policy development is to occur.
At the start of this work, we described how the concepts “integrated” and 
“coherent” mean different things to different people. So much so that, in the 
discussion on the framework it was noted that using the first notion of these 
ideas resulted in a two-dimensional scale – that of integrated/not integrated 
versus coherent/incoherent – which did not work. Thus the need arose to 
clarify these terms and as a result the following was suggested, namely that 
integration implies how well the pieces fit together and coherence, how dif-
ferent policies complement or support each other. It is also interesting that, 
in some chapters herein, coherence and consistency are used interchangeably, 
and thus another factor seems to have slipped in to the equation.
Taking the three terms, “integrated”, “consistent” and “coherent”, it would 
seem from a hierarchical perspective that they take the following order: 
coherent at the top of the tree and integrated at the bottom, with consistent 
somewhere in between. If we now adopt the definition used in the coherency 
chapter, and cited above, then this would suggest that the term “coherency” 
is used, both within a policy and across policies, to signify the positive aspect 
of the said policy both nationally and internationally. However, “consistent” 
would be used where there are no negative connotations within the policy per 
se or within different policies across government. The term “integrated” has 
been used within policy mainly to suggest that different aspects of the same 
policy are held together to make a neat whole – in other words the different 
shapes that make up a jigsaw fit neatly into each other.
Using this type of analogy it emerges that it is imperative to be clear about the 
level of analysis one is referring to. For example, at the topmost level it is the 
overall objective of international organisations and government to provide 
the necessary policies to achieve a particular goal. Following on from this, 
the next level may be how government per se draws up policies to achieve 
these and then the next level of analysis how each policy per se fulfils its 
functions in striving to reach the over-arching goal. In effect, it is like those 
lovely Fabergé gold eggs, where each fits neatly into the next but each has 
its own design and therefore identity. Each egg may stand on its own as an 
object of art, but that is not the whole picture: the concept of the artist was 
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to render all and consequently the art work can be appreciated in full only 
with the presence of all the eggs.
In turn, therefore, an overall objective/goal may be considered that indeed goes 
beyond psychoactive substances. It was expressed by WHO in the preamble 
to its 1946 constitution: “Health is a state of complete physical, mental and 
social well being and not merely the absence of disease or infirmity”.
Moreover, well-being is thought to comprise the following elements: (Seligman, 
2011)
 − positive emotion;
 − engagement with the people you care about;
 − maintenance of good relationships;
 − achieving work goals;
 − having a meaning in life.
In addition, since the Council of Europe also upholds democracy and human 
rights, and has in place a Social Charter that provides for the right to health, 
it may be appropriate that the Council of Europe now consider the addition 
of social well-being as exemplified above.
The eight contributions in this publication have demonstrated that, at least 
at national level, the issue of psychoactive substances is currently the domain 
of health. This in turn would suggest that at least two of the criteria, those of 
physical and mental health, are being addressed by the countries participat-
ing in this exercise. Some further examination may show that some countries 
are doing more and possibly entertaining the factor of social well-being, and 
doing it in a coherent manner.
In Austria, for example, all substances fall under the responsibility of the 
ministry of health and the approach is one of protection, but this is man-
aged in tandem with regulatory controls and it would appear that these are 
increasing, mostly as result of international obligations. At the level below 
government, the local level, prevention and treatment of the problem is based 
on the individual level and apparently works well, except for the fact that 
there are some problems relating to the type of substance used which prevents 
having one service for all.
In Belgium the problem of “coherency” seems to have struck a chord in 1996, 
following a parliamentary working group report that resulted in 2001 in the 
first government policy notice on drugs. The problem was put in the domain 
of public health and, more to the point, the minister for health was to chair the 
inter-ministerial group of 24 ministers that was to tackle the problem in the 
areas of prevention, treatment and social policy. Consequently over the years 
there has been better co-operation between the criminal justice system and 
the treatment providers, following pilot projects such as the drug-treatment 
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courts. This is not only due to the projects per se but also due to the fact 
that structures for monitoring and evaluation have been put in place, at fed-
eral and local level, and at present seem to be working well. However, it is 
not clear that these are the only critical factors in view of the findings that 
better results may be obtained by including the means to house and employ 
former users following treatment. It is stressed that the funds for these fall 
short of what is required, but the direction seems to be the right one in that 
it upholds the Belgian philosophy of “repression towards the users as a last 
resort”. A final comment is the fact that both alcohol and smoking are also at 
federal level, being the responsibility of the ministry of health, and it is the 
inter-ministerial group that provides direction such as the joint declaration 
on alcohol policy of 2008.
In Ireland also it was the joint parliamentary committee in 2006 that cleared 
the way for government to consider substance use from the health perspective 
and thus provide the basis for a substance-misuse policy that also addresses 
well-being. At present there is an interim strategy that combines drugs and 
alcohol; previously, separate strategies for each substance were in place and 
these had evolved to different degrees. However, when a substance-misuse 
strategy is finally drawn up, it is envisaged that drugs, alcohol and tobacco 
will be included since now the Office of Tobacco Control, an independent 
statutory body, is to be merged into the Health Service Executive. This at least 
will “integrate drug and alcohol abuse strategies at local level”. A major issue 
is that of co-ordination and this is reflected in the tensions between health 
and justice, which may be counter-productive in the pursuit of coherence.
In Israel, the main player in the field is the Anti-Drug Authority (IADA), 
which has evolved since 1988 to include both drugs and alcohol (from 2005). 
One other development is the move of the authority from the office of the 
Prime Minister to that of the ministry of internal security. This is the only 
such case among all the countries in this exercise and could be viewed, at first 
glance, as a move to a more repressive policy. In effect, this is not so at all, as 
IADA’s mission is to foster a “healthy and ethical society in to order to pro-
mote welfare and a high standard of living for its citizens”. Consequently this 
has provided for better coherence between the ministries of internal security, 
health and education; thus, what may appear to work in one country may not 
be the case in another in with respect to structures.
The Netherlands, as described in this and the previous publication, has 
separate policy papers for each substance but, as in other countries, it is the 
ministry of health, welfare and sport that co-ordinates the activities related to 
these policies. With the advent of a number of advisory committees, notably 
the one for drugs and evaluation, it has now been recommended that drugs 
and alcohol be considered in one policy document that takes its central theme 
as “substance-related harm”. It is argued that such substances produce sub-
stantial harm to both the individual and society and that to address this in a 
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coherent manner a more integrated approach is required. In relation to drugs, 
joint action on policing and caring is an example of both reducing negative 
effects of problem drug use in deprived city areas and helping users confront 
their problem, together with the provision of housing and better prospects of 
employment. In essence it is an attempt to provide the basis to achieve physi-
cal, mental and social well-being.
Norway is said to have a coherent substance policy on alcohol and drugs, 
centred around the public health domain. It is exemplified by the action plan 
on alcohol and drugs which was introduced in 2008 and has been extended to 
run on to 2012. It has five main objectives: a clear public health perspective, 
better quality of service and increased competence, more accessible services, 
better binding co-operation, and greater attention to the interests of children 
and family members. The ministry of heath and care services is responsible 
for co-ordination of policy, with the ultimate goal of reducing substance use 
by the whole population and thus “reducing the total amount of harm caused”. 
Although tobacco has not been included in the action plan, it is treated in the 
same way as other substances in the broad prevention strategies. The biggest 
changes to date concern the organisation and delivery of treatment and care, 
which includes housing and other social services, for substance users.
As in Ireland, Portugal has decided to wait a little longer to have a single 
strategy for both drugs and alcohol. There are currently in operation single 
strategies for each, and the ideal time to integrate them into one has been set 
for 2013. As in other countries, the ministry responsible is the one related 
to health, and over the years the different bodies operating in the field have 
now been amalgamated into one, namely the Institute for Drugs and Drug 
Addiction within the said ministry of health. The inter-ministerial council is 
responsible for national co-ordination for drugs, drug addiction and alcohol-
related problems; it is served within the ministries by technical commissions 
and from the outside by what is known as the National Council, which is made 
up of constitutional bodies and members of civil society. Tobacco, however, 
as in Norway, does not feature and is addressed separately but still under the 
auspices of the general Directorate of Health.
Switzerland is undergoing a major reform in the area, started by actors in 
the addiction aid system, in the communes and in the cantons. A major 
recurring criticism was the fact that for each substance there was a separate 
body, strategy and budget. This need for reform provided the opportunity to 
go beyond psychoactive substances per se by promoting an addiction policy 
that includes other forms of addiction not related to substances, such as gam-
bling, Internet misuse and other behavioural addictions. At federal level, this 
development was taken into account, and at the turn of the century a phase 
of conceptual work was begun, along with a review of the federal Narcotic 
Drugs Act. Again, from a policy perspective, all fall under the Federal Office 
for Public Health and as in other countries it would seem that the perspective 
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prior to and beyond this phase was and is one of health. But it is the local level 
(communes and cantons) that is responsible for implementation of policy and 
thus the ways in which policy is actuated in the forms of programmes and the 
like. The key here is that Switzerland is attempting to go beyond what was 
customary and introduce an addiction policy that has in place the relevant 
structures at federal level to respond to needs and developments at regional 
and local level, all to provide for a coherent policy in this area. However, for 
this to mature into a coherent policy, the overall objective will need to give 
credence to the construct of social well-being – which, in part, it has by stat-
ing that an addiction policy is more than just personal responsibility, youth 
protection or for that matter health measures.
The foregoing overview has been an attempt to put into perspective the salient 
points of what may be termed a coherent policy on psychoactive substances 
and beyond. It is now time to remind ourselves of the six indicators suggested 
in Chapter 2, namely:
 − Conceptualisation: how are the problems associated with different psy-
choactive substances, illicit drugs, alcohol and tobacco, described? How 
do research evidence, media coverage, cultural mores and social, economic 
and political considerations shape the nature of the “problem”? To what 
extent do these elements converge? (This dimension is comparable to the 
model of policy influencers outlined in phase 1 of the project.)
 − Policy context: where are psychoactive-substances policies located within 
the overall policy document? In criminal justice, in the medical context 
or within a value set such as social inclusion, human rights or equality? 
To what extent is there a consistent approach across different psycho-
active substances?
 − Legislative/regulatory framework: how are various psychoactive sub-
stances controlled and regulated? How far are controls complementary 
and supportive of the desired outcomes?
 − Strategic framework: what are the goals and aspirations, the objectives, 
of drug, alcohol and tobacco policies? To what degree do they overlap 
with one another?
 − Responses/interventions: are interventions logically consistent and mutu-
ally supportive?
 − Structures and resources: to what extent does the organisation of struc-
tures and resourcing support the co-ordination and/or integration of 
drug, alcohol and tobacco policies?
It would appear that all the countries discussed herein have taken into account 
these six indicators of coherency and that the development of policy in this 
field is leading to one in which most substances are incorporated. This analy-
sis, however, is a first attempt and possibly needs further work to better focus 
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on the defining features that may lead to a better measure of efficiency and 
effectiveness of coherency.
11.3. Conclusion
The results herein may be a surprise to some in the field in that in all eight 
participant countries are putting the issue of a psychoactive substance policy 
(and beyond) under the spotlight at present, together with the issue of whether 
how this may achieved in a coherent manner. It is to the greater good that the 
issue of coherency is currently at the forefront of policy making at national 
level because this is also a matter of international urgency, as can be seen 
in the attempts by the EU and OECD in the sphere of policy coherence for 
development. It is also to say the least timely that coherence has been brought 
to the fore by this group in light of the fact that a number of current issues 
in the EU, like foreign policy and monetary union, imply coherency. It has 
been argued elsewhere that such an attempt is not possible in that national 
governments tend to compromise because of different interests. However, 
as suggested in Chapter 2, the over-arching goal of coherency and the tools 
developed over the past 15 years or so to achieve it may over-ride “conflicting 
and competing interests”.
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